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Abstract
Cardiovascular disease remains the primary cause of morbidity and mortality in
the UK and EU, accounting for more than 2.0 million deaths per year across the
EU. The economic consequences of cardiovascular disease are equally grave, with a
total estimated annual health care expenditure of e 109.7 billion in the EU, rising
to e 192.5 billion if informal health care costs and productivity losses are taken
into account. The precise mechanisms underlying arrhythmogenesis in heart fail-
ure are not fully understood, however there is an increasing body of evidence
identifying the Purkinje bre (PF) network as both a major source and contrib-
utor to the sustenance of ventricular arrhythmias. Mathematical models of the
electrical action potentials (APs), and their propagation through the cardiac con-
duction system, compliment, and present a unique alternative to, experimental
observations and investigation. They enable fundamental physiological mecha-
nisms to be dissected and theories rigorously tested in a consistent and ecient
manner. In this thesis, a 3D wedge model of the canine Purkinje-ventricular junc-
tion (PVJ) is developed incorporating details of the transmural AP heterogeneity,
tissue geometry, and bre orientation of the left ventricular free wall, completed
with a single PF entering the endocardium. The relationships between the tissue
heterogeneity; AP conduction velocity; and the safety of conduction at the junc-
tion are explored and pharmacological eects on conduction through the junction
are studied. A new mathematical model for the AP of the canine PF cell is de-
veloped to support the construction of the PVJ model and additionally, a new
model for the AP of the human PF cell is developed. Biophysically detailed,
species specic models are necessary for a complete understanding of the cardiac
conduction system, yet PF models have been largely neglected since the early
work of DiFrancesco & Noble in 1985. The models are proven in the analysis and
dissection of the mechanisms underlying experimental phenomena including the
Bowditch eect; rate dependence of the AP; and overdrive suppression.
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Chapter 1
Introduction
In spite of the successes of extensive preventative screening strategies (Chamnan
et al. 2010), cardiovascular disease remains the primary cause of morbidity and
mortality in both the United Kingdom (UK) and the European Union (EU) as
a whole, accounting for more than 2.0 million deaths per year across the EU.
This represents a staggering 42 per cent of the total number of recorded deaths
each year (Allender et al. 2008). The economic consequences of cardiovascular
disease are equally grave. Health care costs alone are estimated to cost the
National Health Service (NHS) e 18.9 billion in the UK. In total, e 109.7 billion
is spent across the EU, equating to approximately 10 per cent of total health
care expenditure. If productivity losses from death and illness of working age
adults are taken into account, in addition to informal care costs, the total cost of
cardiovascular disease to the UK economy is estimated to be e 40.4 billion and
to the EU, e 192.5 billion (Allender et al. 2008). Clearly cardiovascular disease
is a signicant burden both nancially and emotionally and given its impact,
substantial investment in research is demanded into both the causes and potential
treatments for the disease. Whilst signicant progress has already occurred -
indicated by the apparent trend across the majority of the EU of a reduction in
mortality related to the disease (Allender et al. 2008) - the prevailing incidence
of mortality as a consequence of cardiovascular disease suggests regrettably, there
is still much to be done.
Heart failure is one of the most common and deadly medical conditions in
developed countries, aecting between 1 and 2 per cent of the adult population
(McMurray & Pfeer 2005). Approximately 1 million people in the UK require
treatment for heart failure by the NHS each year, accounting for almost 2 per cent
15
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of total NHS expenditure (Stewart et al. 2002). The prevalence of the disease is
believed to be increasing year upon year (McMurray & Pfeer 2005) and conse-
quently the burden to society is expected to worsen. Suerers of severe heart fail-
ure have a high risk of sudden cardiac death - up to half die unexpectedly (Kannel
et al. 1988; Kjekshus 1990; Nuss et al. 1999; Priebe & Beuckelmann 1998). Often,
sudden cardiac death cases are a result of ventricular tachycardia or brillation
(Bayes de Luna et al. 1989; Luu et al. 1989; Stevenson et al. 1993), with death
typically occurring within an hour of the onset of acute symptoms (Greene et al.
1989; Hinkle & Thaler 1982). The precise mechanisms underlying arrhythmogen-
esis in heart failure are not fully understood, however there is an increasing body
of evidence identifying the Purkinje bre (PF) network as both a major source
and contributor to the sustenance of ventricular arrhythmias (Bogun et al. 2006;
Boyden et al. 2010; Hassaguerre et al. 2002; Ideker et al. 2009; Murakawa 2009;
Scheinman 2009; Sinha et al. 2009). The PF network is an important part of
the cardiac conduction system, responsible for ensuring the synchronized timing
and sequencing of ventricular contraction (Fozzard et al. 1991). It has remarkably
dierent intrinsic electrical properties compared to other cardiac tissue, including
those of the ventricle (Cordeiro et al. 1998; Dumaine & Cordeiro 2007; Han et al.
2001a, 2002; Tseng & Boyden 1989; Yu et al. 1995). In addition to electrical het-
erogeneities between the two tissues, the morphology of the junctions between the
thin PFs and the much larger mass of ventricular tissue causes potentially unsafe
discontinuous conduction of electrical waves (i.e. action potentials, APs) which
can lead to conduction block (Mendez et al. 1970; Overholt et al. 1984; Veenstra
et al. 1984; Wiedmann et al. 1996) or re-entry (Gilmour & Watanabe 1994). The
underlying relationships between the heterogeneity at these junctions, and the
safety of conduction through them remains uncertain, yet understanding such
relationships could be critical in the selection of treatment for arrhythmias (e.g.
pharmacologically) which may potentially have an adverse eect on conduction
through the junction.
The pioneering work of Hodgkin & Huxley (1952), i.e. the derivation of a
mathematical description of the ionic currents and AP of the giant squid axon,
which was later applied to cardiac cells by Noble (1962), has provided science with
a valuable addition to the arsenal of techniques available for the investigation of
the electrophysiology of biologically excitable cells. Mathematical descriptions
of the electrical APs of cardiac cells, and their propagation through the cardiac
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conduction system, compliment, and oer unique alternatives to, experimental
observation and investigation. They enable fundamental physiological mecha-
nisms to be dissected, and theories rigorously tested in a consistent and ecient
manner, which may be dicult or even impossible to carry out experimentally
without a detrimental eect on the validity of the results (e.g. a catastrophic
failure of cell function). The sophistication and physiological accuracy of modern
techniques in mathematical modelling has reached a level whereby they enable
the predictive dissection of a novel condition prior to experimental verication
(e.g. Butters et al. 2010).
Early models typically described mammalian cardiac cells, more often than
not, PF cells (e.g. DiFrancesco & Noble 1985; McAllister et al. 1975; Noble 1962),
however an emphasis on species specic models later emerged (e.g. Benson et al.
2008; Luo & Rudy 1991; ten Tusscher et al. 2004), in addition to a focus on
dierent cardiac tissues (e.g. Courtemanche et al. 1998; Iyer et al. 2004). In
almost half a century of development in cardiac cell models, detailed descriptions
for most of the major distinctive regions in the cardiac conduction system have
been assembled for a variety of species. A notable exception however, is the
PF cell, which has been largely neglected since the DiFrancesco & Noble (1985)
model. Aside from a somewhat simplistic approximation of a human PF cell (ten
Tusscher & Panlov 2008), biophysically detailed, species-specic PF models are
hitherto sorely lacking if a complete understanding of the cardiac conduction
system is to be attained.
1.1 Aims and objectives
The focus of this thesis centres on the potentially unsafe discontinuous conduction
of APs through the morphologically diverse Purkinje-ventricular junction (PVJ)
and in addition, a treatment of the pharmacological eects on conduction through
the junction. Detailed anatomical and electrophysiological data are combined
to create a biophysically accurate model of the PVJ and relationships between
tissue heterogeneity (structural and electrical), conduction velocity and safety of
conduction are ascertained and their implications discussed. Furthermore, and
aside from the focus on the PVJ, the capability of modelling to dissect complex
physiological phenomena is enlisted in the examination of the physiologically
important rate dependence of the AP and the Bowditch eect, whereby the force
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of contraction of the heart is dependent on the rate and rhythm of stimulation
(Bowditch 1871; Langer 1971; Whalen 1958). The relevance of the phenomena,
both to modelling and the functioning of the heart is discussed. In order to
achieve these aims, it is necessary to rst address the denite lack of detailed,
species specic PF cell models and so here models of the human and canine PF
cell are developed and veried against a variety of experimental observations.
1.2 Organization of the thesis
The thesis begins with a brief familiarization of the heart, introducing the anatomy
and physiology of the organ and a discussion of the various sections of the car-
diac conduction system. Following on from this is an introduction to cardiac
electrophysiology and the mathematical basis with which excitable cells are de-
scribed. Signicant existing models are introduced and discussed. Chapter 3,
introduces a newly developed model of the human PF cell. The model is ver-
ied against available experimental data and its ability to reproduce complex
experimental phenomena such as all-or-nothing repolarization and overdrive sup-
pression is demonstrated. The role of major individual ionic currents is explored
and discussed. Following in Chapter 4, the development of a model of the ca-
nine PF cell is documented and again veried against experimental data. The
Bowditch eect (or tension staircase), and the rate dependence of the AP, are
both physiologically important phenomena, yet their underlying mechanisms are
the subject of wide speculation. Combining the newly developed PF cell mod-
els with existing ventricular models, the phenomena are introduced, and their
underlying mechanisms dissected in Chapter 5. The importance of the junction
between the PFs and the ventricle is explored in Chapter 6, with a treatment
of the safety of conduction through the junction with varying heterogeneity us-
ing a two-dimensional model of the canine ventricular wall and an idealized PF
entering the endocardium. Following on in Chapter 7, the model of the PVJ is
extended to the third dimension and incorporates details of AP heterogeneity, tis-
sue geometry and bre orientation obtained experimentally. Conduction through
the junction is investigated during normal propagation and additionally with the
intervention of pharmacological agents including class III anti-arrhythmic drugs.
The nal chapters summarize, and place into context, the ndings of the thesis,
and discuss possible directions for further research.
Chapter 2
Background
2.1 The heart
The heart is the central component of the circulatory system. Through rhythmical
contraction, it is responsible for the pumping of oxygenated, nutrient-rich blood
throughout the body and deoxygenated blood through the pulmonary circuit to
the lungs. In the human, it located in the middle of the chest (with a bias towards
the left) between the two lungs, posteriorly from the sternum and anteriorly from
the vertebral column. It is contained and protected within a sac known as the
pericardium which anchors the heart to its surroundings. The precise size and
location of the human heart varies (Oberman et al. 1967), however in adults, it
is typically double the size of a clenched st, weighing between 250 to 300 g for
a female and 300 to 350 g for a male (Kumar et al. 2005, p. 556). At rest, a
human heart beats between 50 and 100 times per min (Levick 2003, p. 48) and
in a typical 65 yr lifetime will contract approximately 2.5 billion times (Kumar
et al. 2005, p. 556).
2.1.1 Cardiac anatomy and physiology
The vertebrate heart is composed largely of involuntary striated cardiac muscle,
distinct from voluntary muscles by bres with `neither origin nor insertion ...
continuous alike at the apex ... and at the base', providing the heart with `consid-
erable latitude of motion' during each contraction (Pettigrew 1864). The brous
nature of cardiac muscle is highly complex in its arrangement, beautifully illus-
trated and dissected by Pettigrew (1859, 1864) in which a gradational sequence
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right atrium
right ventricle
left ventricle
left atrium
inferior vena cava
superior vena cava
aorta
interventricular septum
pulmonary arteries
pulmonary veins
tricuspid valve
mitral valve
Figure 2.1: Anatomy of a typical mammalian heart. Major structures are labelled,
including the four active chambers: left/right atrium and left/right ventricle.
Regions coloured red contain oxygenated blood and regions coloured blue contain
deoxygenated blood. Figure adapted from work by `ZooFari' and licensed under
the `Creative Commons Attribution-Share Alike 3.0 Unported license'.
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in the direction of the bres is identied from the inner to the outer surface of the
ventricular wall, beginning in a nearly vertical direction, changing to a transverse
direction and then back again to a nearly vertical one.
Mammalian hearts are divided by septa into two distinct pumps termed the
left heart and the right heart (see gure 2.1). The function of the right heart
is to circulate deoxygenated blood around the pulmonary circuit to the lungs
and exchange waste carbon dioxide gas dissolved in the blood from the body
with oxygen, and then return the newly oxygenated blood to the heart. The left
heart then circulates the oxygenated blood though the systemic circuit around the
body, delivering oxygen and nutrients to maintain its normal function. The left
and right heart are further divided into two chambers, the atria and ventricles,
separated from each other by valves to prevent back-ow during contraction.
The atrial walls are thinner than those of the ventricles because blood enters the
heart into the atria at low pressure and is pumped out at high pressure by the
ventricles. The left ventricular wall however, is thicker than the right ventricular
wall because of the greater pressure (Bjork et al. 1954) necessary to pump blood
through the systemic circuit around the body (cf. shorter length of the pulmonary
circuit to the lungs).
2.1.1.1 Atria
The atria are the thin-walled chambers into which blood enters the heart. They
form approximately the upper third portion of the heart. Deoxygenated blood
enters the right atrium from the body via the superior and inferior vena cava.
The right atrium is separated from the right ventricle by the tricuspid valve which
opens during ventricular diastole and closes during ventricular systole to prevent
back-ow. Similarly, in the left atrium, oxygenated blood from the lungs enters
via the pulmonary vein and during ventricular diastole, ows into the left ventricle
through the mitral valve. The contents of the right and left atria are prevented
from mixing by the interatrial septum which divides the two. The relatively
low pressures generated during atrial systole compared to those generated during
ventricular systole (Bjork et al. 1954) determines that the walls of the atria are
not required to be of a comparable thickness to those of the ventricles.
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2.1.1.2 Ventricles
The ventricles receive blood from the atria during diastole and then force the
blood out under high pressure through arteries during systole. They form ap-
proximately the lower two thirds of the heart. The right ventricle collects deoxy-
genated blood from the right atrium and then pumps it through the pulmonary
artery to the lungs, returning oxygenated blood to the left atrium. The left ven-
tricle then pushes the oxygenated blood from the left atrium through the aorta
to the body under a much greater pressure that the right ventricle attains as it
must travel a much greater distance to reach the extremes of the body. In adults,
the left ventricular wall can be three times thicker than in the right ventricle as
the pressure in the left ventricle reaches between ve and six times that in the
right (Bjork et al. 1954). The ventricular wall is composed of three distinct layers,
each with diering electrical and structural properties. At the outer surface of the
wall is the epicardium; at the inner surface is the endocardium; and in-between
is the mid-myocardium (Drouin et al. 1995). The orientation of the muscle -
bres changes gradually from the endocardial to the epicardial surface (Legrice
et al. 1997; Pettigrew 1859, 1864), a phenomena known as rotational anisotropy
(Streeter et al. 1969). Cross-contamination of blood between the left and right
ventricle is prevented by the interventricular septum, although in rare circum-
stances, a ventricular septal defect can occur (Barclay et al. 1967), impairing
cardiac function and typically requiring surgical intervention.
2.1.1.3 Cardiac myocytes
The bulk of working muscle in the heart wall (i.e. the myocardium) and its fun-
damental contractile cell is the cardiac myocyte (Walker & Spinale 1999). Car-
diac myocytes typically range between 10{15m in diameter and have a length
> 100m, resulting in a lament-like shape. They are excitable cells, diering
from skeletal muscle cells (i.e. muscles such as those which cause the movement
of limbs) in that they must work continually, and without the use of tendons,
to squeeze blood out of the chambers in the heart (Russell et al. 2000). Car-
diac myocytes are highly specialized cells with varying structural and electrical
characteristics depending on their role and location in the heart.
The boundary of the extracellular and intracellular space is the sarcolemma,
or cell membrane. The sarcolemma is formed of a lipid bilayer, composed of phos-
pholipids which are amphipathic, having a hydrophilic head and a hydrophobic
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ion extracellular concentration intracellular concentration
(mM) (mM)
Na+ 140 9
Ca2+ 2 0.0001
K+ 5.4 136
Cl  100 18
Table 2.1: Typical ion concentrations at rest for intracellular and extracellular
environments in a cardiac cell.
tail, which spontaneously aggregate into a bilayer with their tails shielded from
the aqueous cellular environment and their heads exposed (Alberts et al. 2002, pp.
584{593). The resulting hydrophobic core of the sarcollema makes it imperme-
able to charged molecules (ions) providing a signicant barrier for diusion from
one space to the other (Walker & Spinale 1999). The sarcolemma is invaginated
by T (transverse) tubules which extend deep into the myocyte.
Within the intracellular space, a number of important structures exist in my-
ocytes, including the sarcoplasmic reticulum (SR) and the sarcomere. The SR is
a specialized structural region close to the sarcolemma and acts as a Ca2+ store.
The sarcomere is the fundamental contractile unit in a myocyte and responsible
for the striated appearance of cardiac tissue (Huxley 1971). Essentially, the sar-
comere is two overlapping laments which cause the contraction of the myocyte
through the variation of their overlap (Katz 2006, pp. 15{29).
Neighbouring myocytes are linked (mechanically and electrically) at special-
ized junctions (Katz 2006, pp. 15{29), i.e. the intercalated discs at the `ends'
of the myocyte (Shimada et al. 2004). These junctions enable communication
between myocytes, allowing them to function as a tissue.
2.2 Cardiac electrophysiology
The sarcolemma demarcates the intracellular cytosol from the extracellular envi-
ronment. Dierent ion concentrations (see Table 2.1) in the two spaces create an
electrochemical gradient across the membrane. However, the impermeability of
the sarcolemma to ions precludes diusion down the gradient aside from through
specialist structures which either passively, or actively transport ions across the
membrane.
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2.2.1 Ion channels
Ion channels are macromolecular pores in the sarcolemma (Hille 2001, p. 1). They
enable the passive transport of ions down an electrochemical gradient (gure
2.2). Ion channels have selective permeability (Hille 2001, p. 4), i.e. a particular
channel restricts transport to a selected ion, hence channels are typically labelled
by the ion they carry: Na+, K+, Ca2+, or Cl . An ion channel is, in general,
`gated', i.e. it will open or close to ion transport in response to a stimulus (e.g.
membrane potential). Many of the gating processes in cardiac myocytes are
voltage-dependent, although there are other dependencies, e.g. Ca2+-dependent
inactivation of the L-type Ca2+ channel (Hille 2001, pp. 61{167). A gate may
be in one of three possible states: open, closed or inactive (although a channel
may not have an inactive state). A channel which is inactive cannot contribute
to ion transport until the stimulus which has caused the inactivity subsides. As
ions are charged molecules, their motion through an ion channel across the cell
membrane causes an electrical current to ow.
2.2.2 Pumps and exchangers
The electrochemical gradient for K+ is `outward' - the intracellular concentration
is greater than the extracellular concentration. However, for Ca2+ and Na+, the
gradient is `inward', with a larger extracellular concentration than intracellular
(Levick 2003, pp. 28{31). Active transport of Ca2+ and Na+ out of the cell and
K+ into the cell preserves intracellular ion concentrations, thereby preventing the
concentrations from reaching equilibrium, which would inevitably destroy the
function of the cardiac myocyte as there would no longer be a electrochemical
gradient. The two mechanisms for active transport in the myocyte are ion pumps
and ion exchangers (gure 2.3). Ion pumps metabolize energy in the form of
ATP to move ions against the electrochemical gradient. The simplest pump is
the Ca2+ pump, which extrudes approximately one quarter of the Ca2+ concen-
tration elevation. A more complex pump is the Na+/K+ pump which transports
three Na+ out of the cell and brings 2 K+ into the cell (Levick 2003, pp. 31{32).
Ion exchangers, as their name suggests, exchange ions in opposite directions. The
Na+/Ca2+ exchanger is the predominant mechanism for Ca2+ extrusion, exchang-
ing a single Ca2+ for three Na+. It is a reversible mechanism, with the direction
dependent on the concentrations of ions on either side of the sarcolemma (Walker
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Figure 2.2: Ion channels traverse the lipid bilayer sarcolemma, allowing the pas-
sive diusion of ions. The channels are selective to a particular ion and open and
close as a result of stimuli such as membrane potential.
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+
Figure 2.3: Ionic pumps and exchangers actively transport ions across the sar-
colemma against the electrochemical gradient. The two examples here, the
Na+/K+ pump and the Na+/Ca2+ exchanger move ions in opposite directions,
`exchanging' one (or more) for the other, however other pumps, e.g. the Ca2+
pump, only transports Ca2+ out of the cell.
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& Spinale 1999). It is not powered by ATP, instead driven by the electrochemical
gradient of Na+, resulting in a net ow of charge in the direction of the Na+
gradient (Levick 2003, pp. 31{32).
2.2.3 Cardiac action potential
The cardiac action potential (AP) is the time evolution of the membrane potential
following an electrical stimulus. It arises from the motion of ions across the
membrane following the stimulus. The morphology of the AP illustrates ve
phases (0{4), which reect the underlying ionic processes:
0. Rapid upstroke - activation of fast Na+ channels causes a rapid inux of
Na+ and the depolarization to a positive potential of the membrane.
1. Brief, early repolarization - rapid inactivation of the Na+ channels, slow
entry of Cl  ions and activation of a transient outward K+ current causes
a brief repolarization of the membrane.
2. Plateau - counterbalancing of Ca2+ inux through the the L-type Ca2+
channel, and K+ eux through the rectier K+ channel, both of which
activate during the upstroke, but reach their peak current during the plateau
phase (Walker & Spinale 1999).
3. Rapid repolarization - inactivation of the Ca2+ channels and activation of
the delayed rectier K+ channels at the end of the plateau phase causes a
rapid eux of K+, and hence the repolarization of the membrane.
4. Resting - the membrane returns to the resting potential, delayed rectier
K+ channels inactivate. Inactivation of some Na+ channels persists and the
myocyte remains in a refractory state, being only partially excitable.
The duration and morphology of the AP varies signicantly between cell types.
The AP duration at 90 per cent repolarization (APD90), a commonly measured
property of APs, can be 350 per cent larger in ventricular myocytes than atrial
(Hume & Uehara 1985). In the specialist tissue of cardiac Purkinje bres (PFs,
see x2.3.3), APs have unique features, including a larger upstroke velocity, lower
plateau and longer AP duration than ventricular cells (Balati et al. 1998; Burash-
nikov & Antzelevitch 1999; Lu et al. 2005; Schram et al. 2002).
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2.2.4 Excitation-contraction coupling
Excitation and contraction are closely linked in the cardiac myocyte. Sarcomere
length is dependent upon the concentration of intracellular Ca2+ - increases in
[Ca2+]i increase the degree of overlap of the laments in the sarcomere, causing
the contraction of the myocyte (Katz 2006, pp. 15{29). The T tubules (invagi-
nated regions of the sarcolemma), contain a high density of L-type Ca2+ channels
and extend deep into the myocyte and in close proximity to the SR (Walker &
Spinale 1999). The SR regulates cytosolic Ca2+ concentration through its up-take
and release. During an AP, Ca2+ inux occurs through the L-type Ca2+ channels,
in the main via the T tubules, accounting for approximately 25 per cent of the
observed free Ca2+ increase in the cytosol. The presence of this increased Ca2+
at the Ryanodine receptors on the surface of the SR triggers the Ca2+ release
channel in the SR to immediately activate and release a large amount (approx-
imately 75 per cent of the observed increase of [Ca2+]i in an AP) of Ca
2+ into
the cytosol, causing the myocyte to contract (Berridge 1997; Bers 2001; Williams
1997). Following the release into the cytosol, the increased [Ca2+]i triggers the
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump to actively pump the
majority of the free Ca2+ back into the SR, with the remainder, around 25 per
cent, removed to the extracellular environment by the Na+/Ca2+ exchanger (Lev-
ick 2003, pp. 37{40).
2.2.5 Action potential conduction
Non-selective gap junction channels through the intercalated discs provide a path
of low electrical resistance for rapid conduction of the action potential between
neighbouring myocytes. Ions can diuse freely across the intercalated discs
through these junctions with almost as much ease as diusion in an aqueous
medium (Katz 2006, pp. 387{390).
2.3 Cardiac conduction system
The cardiac conduction system is a succession of connected, specialized tissues
which together are responsible for the initiation and co-ordination of excitation
in the heart. There are three major components of the system (gure 2.4): the
sino-atrial node, the atrioventricular node and the His-Purkinje system (Boyett
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sinoatrial node
atrioventricular
node
His bundle
Purkinje
fibres
Figure 2.4: Schematic illustration of the cardiac conduction system. Major
components identied, including the sinoatrial node, the atrioventricular node
and the His-Purkinje system. Heart outline illustrated for orientation. Figure
adapted from work by Maen, K. H. and licensed under the `Creative Commons
Attribution-Share Alike 3.0 Unported license'.
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2009; Hudson 1963).
2.3.1 Sino-atrial node
The initiation of heart excitation begins in the sino-atrial (SA) node, a group
of cardiac cells near the junction of the superior vena cava with the right atrial
wall (Anderson et al. 1979). The SA node is the primary pacemaker of the heart,
determining the rate, and rhythm of excitation. It is autorhythmic, i.e. it spon-
taneously depolarizes without external electrical stimulation resulting in an AP
which then propagates to the neighbouring atrial myocardium. Conduction of the
AP throughout the atria causes their contraction (i.e. atrial systole) and hence,
ventricular lling. However, direct conduction to the ventricles is prevented by a
layer of non-conductive brous tissue (Boyett 2009), thereby avoiding premature
ventricular contraction.
2.3.2 Atrioventricular node
Located at the base of the right atrium, near the ventricular septum, is the
atrioventricular (AV) node (Anderson et al. 2009), the only pathway through the
plane of atrioventricular insulation for the conduction of excitation from the atria
to the ventricles (Anderson et al. 2009; Boyett 2009; Tawara 1906). The AV node
serves a number of vital purposes aside from simply acting as the sole conduction
pathway to the ventricles. Primarily, AP conduction through the AV node is slow,
prolonging the delay between atrial and ventricular systole to ensure adequate
ventricular lling (Anderson et al. 2009). The AV node also acts as a `rate limiter',
protecting the ventricular myocardium from premature excitation (e.g. during
atrial utter) by blocking conduction of premature APs (Boyett 2009). Finally,
the AV node is one of the subsidiary pacemakers in the cardiac conduction system
in the sense that it can assume the function of excitation initiation in the event of
a sustained failure of the dominant pacemaker, however it is normally suppressed
by the SA node (Vassalle 1977).
2.3.3 His{Purkinje system
The His{Purkinje system rapidly conducts the AP from the AV node to the ven-
tricles, ensuring their simultaneous contraction and hence the expulsion of their
contents through the arteries (Boyett 2009). The conduction must be rapid, or
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else the ventricles would contract slowly and unevenly, diminishing the pressure
generated during ventricular diastole and impairing circulation around the body.
Beginning at the AV node, the common bundle (i.e. the bundle of His) conducts
the AP to the left and right bundle branches (which reside along the ventric-
ular septum in the left and right ventricle respectively) and into the Purkinje
bre (PF) network with terminal points throughout the ventricles (Boyett 2009;
Hudson 1963). Like the AV node, PFs are also subsidiary pacemakers, although
they spontaneously depolarize at the slowest rate (cf. SA and AV node) and are
therefore normally suppressed (Vassalle 1970, 1977).
2.4 Mathematical and physical basis
Modelling the electrical behaviour of the heart requires the knowledge of a number
of physical laws and principles, in addition to a variety of mathematical techniques
for the numerical solution of the dierential equations which arise in the models.
2.4.1 Nernst equilibrium potential
Any system is naturally in motion towards equilibrium, in cardiac cells towards
the point at which the electrochemical gradient, and hence the electrical potential
is zero. The equilibrium potential (sometimes called the reversal potential since it
describes the potential at which the gradient is reversed) for an arbitrary ion, S, is
determined by the Nernst equation (Nernst 1888) and is important in modelling
ion channels as it determines the direction of current ow.
The Boltzmann equation relates the relative probability at equilibrium of a
particle assuming state 1 or state 2 for an energy dierence u2   u1 and is given
by,
p2
p1
= exp

 u2   u1
kBT

(2.1)
where kB is the Boltzmann constant and T [K] is the absolute temperature.
Changing to a chemical formalism by substituting in concentrations, c, and molar
energies, U , equation (2.1) is recast as,
c2
c1
= exp

 U2   U1
RT

(2.2)
where R = kBNA is the molar gas constant (n.b. NA is Avagadro's number).
CHAPTER 2. BACKGROUND 31
Furthermore, for a mole of an arbitrary ion, S, of charge zS, separated by the
membrane potential dierence, E1  E2, the dierence in molar energy, U1   U2,
can be rewritten as zSF (E1 E2), where F is Faraday's constant. By rearranging
equation (2.2) and substituting for U1   U2, the Nernst equation is,
ES = E1   E2 = RT
zSF
ln

[S]2
[S]1

(2.3)
in which, due to convention, membrane potentials are measured inside out, and
hence,
ES =
RT
zSF
ln

[S]o
[S]i

(2.4)
where S is one ion from Na+, K+, Ca2+ or Cl  and will determine the direction
of the ionic concentration gradient for the specic ion (Hille 2001, pp. 13{17).
2.4.2 Membrane potential
The electrochemical gradient caused by the dierence in concentrations of ions
on either side of the cell membrane results in a potential dierence across the
membrane, V , dened as the dierence between the intracellular potential, i,
and the extracellular potential, o:
V = i   o (2.5)
The cell membrane is a lipid bilayer, approximately 5 nm in width (Lewis &
Engelman 1983; Marsh 2001; Rawicz et al. 2000). The separation of charge, Q,
either side of such a narrow insulating lipid bilayer, forms an electrical capacitor
across the membrane, with a potential dierence, V , as in equation (2.5) and,
V =
Q
C
(2.6)
where the capacitance, C, for a parallel plate capacitor is given by,
C =
0A
d
(2.7)
with A, the area of the plates, d, the separation distance of the plates, , the
dielectric constant of the insulator and 0, the permittivity of free space.
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2.4.2.1 Resting potential
At rest, an imbalance of intra- and extracellular ion concentrations results in
a negative potential dierence across the membrane. The Nernst potential in
equation (2.4) for a single ion type can be extended to consider several ions in
the Goldman{Hodgkin{Katz equation (Goldman 1943; Hodgkin & Katz 1949),
E =
RT
F
ln

PK[K
+]o + PNa[Na
+]o + PCl[Cl
 ]i
PK[K+]i + PNa[Na
+]i + PCl[Cl
 ]o

(2.8)
where PS is the permeability of the membrane to the ion, S, via diusion through
ion channels. However, Ca2+ contribution is missing because it has a valence of
zCa = 2 (cf. zNa and zK are both 1 and zCl =  1). The relationship is however
more complicated when valence diers. Fatt & Ginsborg (1958) demonstrated
that for two ions with dierent valence, e.g. Ca2+ and K+,
PCa
PK
=
[K+]i
4[Ca2+]o
exp

EF
RT

exp

EF
RT

+ 1

(2.9)
which can be rearranged to give,
E =
RT
F
ln
0@s4PCa[Ca2+]o
PK[K+]i
+
1
4
  1
2
1A (2.10)
When all ions are taken into account, resting potential in a cardiac cell typically
varies between  40 and  90mV (Hille 2001, p. 27) depending on the particular
cell type.
2.4.2.2 Action potential
Perturbing the cell from its rest state results in a dynamical response - an action
potential (AP) - as ions move across the cell membrane through ion channels
along their electrochemical gradients, eventually returning the cell to its resting
potential. The rate of change of the membrane potential, from equation (2.6), is
given by,
dV
dt
=
1
C
dQ
dt
(2.11)
which can be written as,
C
dV
dt
= I (2.12)
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where, I = dQ=dt, is the capacitive current across the membrane. According to
Kirchho's law of charge conservation, the capacitive current must equal the sum
of ionic, Iion, and any stimulus current, Istim applied to the cell, and so,
C
dV
dt
=  (Iion + Istim) (2.13)
with the negative sign necessary due to the inside out convention adopted earlier.
2.4.3 Membrane current
Typically, ions traverse the membrane either passively, along electrochemical gra-
dients through ion channels, or actively through ion pumps and exchangers. As
a result, the membrane, or ionic current, Iion, is actually a summation of ionic
currents, each typically selective of a particular ion, and each of which operates
with dierent kinetics and at dierent stages of the action potential, depending
on the ion concentration gradient related to the particular channel.
The movement of ions across the membrane results in an electrical membrane
current, since I = dQ=dt. In general, the current, I, between a potential dier-
ence, V , is given by Ohm's law,
I = gV (2.14)
where g is the conductance along the conductor, or the reciprocal of the resistance.
However, for a selective ion channel, as a result of the electrochemical gradient,
Ohm's law must be adapted to take into account the Nernst equilibrium potential,
which acts like a battery with an electromotive force (Hille 2001, pp. 17{20). First
introduced by Hodgkin & Huxley (1952), for an ion, S, the current thus becomes,
IS = gS(V   ES) (2.15)
where gS is the conductance to a particular ion. However, unlike for a simple
ohmic conductor, gS is nonlinear: membrane conductance changes with membrane
potential (and in some cases, ion concentration), indicating ion channels open and
close in response to changes in the cell.
2.4.3.1 Hodgkin{Huxley equations
Hodgkin & Huxley (1952) pioneered the quantitative description of ionic currents
using equation (2.15) and hence the AP of an excitable cell. They decomposed the
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conductance, gS, into the maximum conductance, gS, and coecients representing
the fraction, , of the ion channels that are `open',
gS = gS (2.16)
where the fraction, , may include the product of activation, deactivation and
inactivation coecients, depending on the gating mechanisms in the channel.
The coecients all vary between 0 and 1 and therefore for any coecient, if the
fraction of the gates being in a particular state (e.g. active or inactive) is , it
follows that the fraction not in the state is (1  ),
(1  )  *) 

 (2.17)
where the gating coecients transition from one state to the other with voltage-
dependent rate constants,  and . The time evolution of  can thus be de-
scribed by,
d
dt
= (1  )   (2.18)
2.4.4 Action potential propagation in tissue
2.4.4.1 Bidomain model
The bidomain model treats cardiac tissue as two continuous, overlapping domains
(intracellular and extracellular), separated by the cell membrane and assumes the
conservation of both charge and current (Clayton et al. 2010). In electrostatics,
the electric eld at a point, E is dened as,
E =  r (2.19)
where  is the electric potential at the point and r is a spatial gradient operator.
The current density, J is given by,
J = E =  r (2.20)
n.b. Electrostatics is a very mature eld of physics. For an introduction, the reader would
be best served by consulting any good textbook on the matter (e.g. Jackson 1998, pp. 24{56).
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where  is an electrical conductivity tensor. Applying equation (2.20) to the
intra- and extracellular domains in turn,
Ji =  iri
Jo =  oro
(2.21)
Assuming only membrane sources of current and charge,
r  Ji =  I
r  Jo = I
r  (Ji + Jo) = 0
(2.22)
where I is the transmembrane current per unit volume, given by,
I = m

C
dV
dt
+ Iion

(2.23)
with m, the surface area to volume ratio of the cell. Substituting equations
(2.20) through (2.23), the bidomain equations are obtained,
r  i(rV +ro) = m

C
@V
@t
+ Iion

r  ((i + o)ro) =  r  (irV )
(2.24)
2.4.4.2 Monodomain model
The monodomain model is a simplication of the bidomain model which assumes
that the electrical conductivity in the extracellular domain is proportional to that
in the intracellular domain (Clayton et al. 2010),
o = i (2.25)
where the scalar quantity, , is the conductivity ratio between the two domains.
Substituting equation (2.25) into equation (2.24) and dening the diusion tensor,
D = i(=m(1 + )), the monodomain equation is,
@V
@t
= r DrV   Iion
C
(2.26)
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2.4.5 Numerical methods
2.4.5.1 The forward Euler method
The forward Euler method is a numerical integration technique for the solution
of ordinary dierential equations (ODEs), e.g. the dynamics of the membrane
potential in a cardiac cell. In an initial value ODE problem,
dy
dt
= f(t; y); y(t0) = y0 (2.27)
the solution at y(t+t) can be obtained using the Taylor seriesy expansion,
y(t+t) = y(t) + t
dy
dt
+
t2
2
d2y
dt2
+ ::: (2.28)
However, for small values of t, the higher powers t2, t3, etc., become negli-
gible,
y(t+t)  y(t) + tdy
dt
= y(t) + t  f(t; y) (2.29)
and it follows that,
yn+1 = yn +t  f(tn; yn) (2.30)
Thus, solving ODEs numerically given the previous state is relatively trivial com-
putationally using equation (2.30) and with a suciently small t, provides a
reasonably accurate approximation (Kreyzig 1999; Riley et al. 2002).
It should be noted that an important limitation of the forward Euler method
when integrating across a spatial grid of cardiac tissue, is the numerical stability
criterion:
t  x
2
2dD
(2.31)
where, t is the time step, x is the space step, D is the diusion coecient, and
d is the number of dimensions. Numerical artefacts can arise in computational
simulations if this condition is not met, potentially yielding invalid results.
2.4.5.2 The nite dierence method
The nite dierence method is a technique for the solution of partial dieren-
tial equations (PDEs), e.g. the bidomain and monodomain equations, (2.24) and
yn.b. The Taylor series is a representation of a continuous and dierentiable function as an
innite sum about a point (see Riley et al. 2002, pp. 139{144).
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(2.26) respectively, in spatially extended problems set on a regular Cartesian grid
with spacing qi, where i = f1; 2; 3g and qi are orthogonal co-ordinates (e.g. x,
y, z). Using central dierence approximations of derivatives (Riley et al. 2002,
pp. 1179{1192), if i = 1, the second-order derivative of a function, (q1; q2; q3)
can be expressed as,
@2
@q21
=
(q1 +q1; q2; q3)  2(q1; q2; q3) + (q1  q1; q2; q3)
q1
2 (2.32)
Similarly, the rst derivative can be expressed as,
@
@q1
 (q1 +q1; q2; q3)  (q1  q1; q2; q3)
2q1
(2.33)
and the cross-derivative, for i = f1; 2g as,
@2
@q1@q2
=
[(q1 +q1; q2 +q2; q3)  (q1 +q1; q2  q2; q3)]
2q12q2
  [(q1  q1; q2 +q2; q3)  (q1  q1; q2  q2; q3)]
2q12q2
(2.34)
Similar expressions can also be derived for other directions and combinations
thereof (Clayton & Panlov 2008).
2.4.5.3 The Rush{Larson method
The method of Rush & Larsen (1978) is a computationally ecient technique for
the solution of Hodgkin{Huxley type gating variables,
dyi
dt
= yi(1  yi)  yiyi (2.35)
where the rate constants,  and  are voltage dependent. By considering  and
 to be constant and rewriting equation (2.35) as,
dyi
dt
= yi(yi   yi) = yi (2.36)
the steady state solution is constant and dyi=dt = 0, with,
yi(1) = yi
yi + yi
(2.37)
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The solution to the homogeneous portion is,
yi = Kexp

  t
i

(2.38)
where, K satises the initial condition, yi = yi(t = 0) and the time constant,
i = 1=(yi + yi). With  and  assumed to be constant over a small time
increment, t, the solution of equation (2.36) is thus,
yi = yi(1)  [yi(1)  yi(0)]exp

 t
i

(2.39)
or in an iterative scheme,
yi(t+t) = yi(1)  [yi(1)  yi(t)]exp

 t
i

(2.40)
2.5 Selected existing models
In the almost 60 years after Hodgkin & Huxley (1952) published their seminal
paper on a quantitative description of the ionic currents in the giant squid axon,
followed a decade later by Noble (1962), who applied their description to cardiac
cells, a plethora of models covering a diverse range of species and cardiac tissues
have been developed (see Boyett et al. 2005, table 1). A selection of models
pertinent to this body of work is herein briey introduced.
2.5.1 DiFrancesco{Noble Purkinje bre model
The DiFrancesco & Noble (1985) model of the mammalian PF cell was the rst
detailed model capable of describing ionic currents and concentration changes.
Iion = If + IK + IK1 + Ito + Ib;Na + Ib;Ca + Ip + INaCa + INa + ICa;f + ICa;s (2.41)
Their model of Iion, given in equation (2.41), introduced an inward pacemaker
current, If , and ion concentration changes, involving the Na
+/K+ pump, Ip,
the Na+/Ca2+ exchanger, INaCa and Ca
2+ handling in the SR, including Ca2+-
induced Ca2+ release. Perhaps testament to its quality and its ability to reproduce
spontaneous, experimentally agreeable APs, but also due to a shift in emphasis
towards development of dierent cardiac tissues, it has remained the de facto
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ionic model of the PF cell for nearly a quarter of a century.
2.5.2 Luo{Rudy guinea pig ventricular model
The guinea pig ventricular model of Luo & Rudy (1991, 1994a,b) and subsequent
extension by Zeng et al. (1995) to include two components of the delayed rectier
K+ current, IKr and IKs has become one of the most extensively used cardiac
ventricular cell model (Winslow et al. 2000).
Iion = INa + IK1 + IKr + IKs + ICa;L + ICa;T + INaCa
+INaK + Ip;Ca + Ins;Ca + IK;p + INa;b + ICa;b
(2.42)
Their formulations of the components of Iion in equation (2.42) and the predictions
of the model have been extensively validated against experimental data (Winslow
et al. 2000) making the model a good choice when investigating new phenomena.
2.5.3 ten Tusscher et al. human ventricular model
The human ventricular model of ten Tusscher et al. (2004) for endocardial, mid-
myocardial and epicardial cell types, later updated to include improved Ca2+
dynamics (ten Tusscher & Panlov 2006), is based entirely on recent human
data.
Iion = INa + IK1 + Ito + IKr + IKs + ICa;L + INaCa
+INaK + Ip;Ca + Ip;K + Ib;Ca + Ib;Na
(2.43)
Aside from the calcium dynamics, the components of Iion in equation (2.43) are
Hodgkin{Huxley type and therefore the model has an advantage over more com-
plicated models (e.g. Iyer et al. 2004) in terms of computational eciency, hence
its application to multicellular tissue simulations.
2.5.4 Benson et al. canine ventricular model
A model of the canine endocardial, midmyocardial and epicardial ventricular cell
types was developed by Benson et al. (2008) based on available experimental
canine data.
Iion = INa + INa;L + IK1 + Ito;1 + Ito;2 + IKr + IKs + ICa;L
+INaK + INaCa + Ip;Ca + IK;p + ICa;b + ICl;b
(2.44)
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Their description of Iion in equation (2.44) notably includes the late Na
+ current,
INa;L, which is thought to have a substantial contribution to sodium loading
during each cardiac cycle (Noble & Noble 2006).
Chapter 3
A model of the human Purkinje
bre cell
3.1 Introduction
Purkinje bre (PF) cells are tertiary pacemakers of the heart, normally suppressed
by the primary pacemaker, the sino-atrial (SA) node (Vassalle 1970, 1977). The
PF network is an important part of the cardiac conduction system, responsible
for ensuring the synchronized timing and sequencing of ventricular contraction
(Fozzard et al. 1991). It can also be a major source for generating life threaten-
ing ventricular arrhythmias (Asano et al. 1997; Berenfeld & Jalife 1998; Nattel
& Quantz 1988; Nibley & Wharton 1995). Under normal conditions, the PF net-
work serves as a fast conduction pathway to conduct electrical excitation waves
originating from the SA node, into the ventricles. In some abnormal conditions,
the PF network may produce a series of ectopic focal activities which rapidly
drives the surrounding ventricular tissue, leading to ventricular tachycardia and
brillation (Arnar et al. 1997; Arnar & Martins 2002; Arnar et al. 2001; Chung
et al. 1997; Maruyama et al. 2010; Pogwizd & Corr 1992; Pogwizd et al. 1998).
Conduction block in either the left or right bundle branches of the PFs can
lead to uncoordinated ventricular excitation and contraction (Fantoni et al. 2005;
Imanishi et al. 2006; Niu et al. 2006). Additionally, under some circumstances
a localized temporal functional conduction block in the PF network can gener-
ate re-entrant excitation waves giving rise to ventricular brillation (Arnar et al.
1997, 2001; Xing & Martins 2004).
n.b. Portions of this chapter appear in Stewart et al. (2009).
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The PF network is a distinctive tissue of the heart with intrinsic electrical
properties remarkably dierent from other cardiac tissues including that of the
ventricle (Cordeiro et al. 1998; Dumaine & Cordeiro 2007; Han et al. 2001a,
2002; Tseng & Boyden 1989; Yu et al. 1995). In many species, the PF cell action
potentials (APs) have unique features, including a larger upstroke velocity, lower
plateau and longer AP duration (Balati et al. 1998; Burashnikov & Antzelevitch
1999; Lu et al. 2005; Schram et al. 2002). Importantly, PF cells can present
automaticity due to slow spontaneous diastolic depolarization (Balati et al. 1998;
Yu et al. 1995). Such dierences in electrical APs are associated with dierent
kinetics and current densities in a number of major ion channels (Dumaine &
Cordeiro 2007; Han et al. 2001a). Considering both the important role of the PF
system in ensuring normal ventricular excitation and generating life threatening
ventricular arrhythmias, and their distinctive properties in ion channel kinetics,
it is necessary to develop a biophysically detailed model for the electrical APs of
PF cells that can be incorporated into a realistic model of the human heart.
3.1.1 Half a century of progress
The seminal work by Hodgkin & Huxley (1952) in which they derived a quan-
titative description of the ionic currents and hence the AP of the giant squid
axon, began what is now more than half a century of development in mathe-
matical models describing the electrophysiology of biological excitable cells. A
decade later, Noble (1962) pioneered the application of the work of Hodgkin &
Huxley (1952) to cardiac myocytes, proposing modications which would result
in a simple ionic model of a mammalian PF cell, reproducing the much longer
action potential duration (APD) and pacemaker potential of the PF. The model
retained a single fast sodium current but split the potassium current into two
components, IK1 (note IK1 here diers to the inward rectier potassium current
referred later) and IK2 with the conductance of IK1, gK1, instantaneously depen-
dent on membrane potential, and gK2, the conductance of IK2, rising slowly as
the membrane depolarizes.
The advent of the rst successful voltage clamp measurements by Deck &
Trautwein (1964), discoveries of the cardiac calcium current by Reuter (1967)
and multiple components of the potassium current, IK, by Noble & Tsien (1969),
resulted in a need for a successor to the Noble (1962) model. In response to the
growing wealth of experimental data (Noble & Tsien 1968, 1969) and knowledge
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at the time, McAllister et al. (1975) developed a model to reproduce the AP of
the cardiac PF using nine ionic currents. Their model added a new secondary
inward calcium current, ICa, a transient outward chloride current, ICl, and fast
and slow potassium currents, Ix1, and Ix2. The resultant model could reproduce
a much wider range of experimental observations known at the time, some with
a high degree of accuracy.
The model of McAllister et al. (1975) was superseded by the DiFrancesco &
Noble (1985) PF cell model. DiFrancesco (1981) had already shown that what
was previously called IK2, was actually an inward, hyperpolarization activated
pacemaker current, If , as opposed to an outward, depolarization activated cur-
rent, as described by McAllister et al. (1975) in their model. In addition to the
incorporation of If , the model of DiFrancesco & Noble (1985) included dynamic
changes of intracellular and extracellular ion concentrations, ionic pumps and
exchangers that are necessary to restore and maintain the transmembrane ion
concentration gradients, and a description of the Ca2+ handling in the sarcoplas-
mic reticulum (SR). The depletion of potassium ions in the extracellular spaces
made the inclusion of the sodium-potassium (INaK) pump a necessity, otherwise
If would not resemble a potassium current. As a consequence of introducing the
Na+/K+ pump and hence changes in the potassium concentration, it also became
necessary to include concentration changes for sodium and calcium, leading to the
introduction of the sodium-calcium exchanger (INaCa) and a description of cal-
cium release from the SR, including calcium induced calcium release, described
by Fabiato & Fabiato (1975). The DiFrancesco & Noble (1985) model had thus
become the rst electrophysiologically detailed model capable of describing both
ionic currents and concentration changes.
Building on the successes of these models, development shifted towards dif-
ferent cardiac tissues across a variety of species, notably including the guinea pig
ventricular models of Luo & Rudy (1991, 1994a,b) and the human models for
atrial (Courtemanche et al. 1998; Nygren et al. 1998) and ventricular cells (Iyer
et al. 2004; ten Tusscher et al. 2004; ten Tusscher & Panlov 2006). During this
time, the development of further PF models has largely been neglected (Boyett
et al. 2005).
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3.1.2 The virtual human heart
We are fast approaching the ultimate goal of constructing a virtual human heart
with detailed ionic models of all distinctive regions of the cardiac conduction
system already available, including the atria (Courtemanche et al. 1998; Nygren
et al. 1998) and the ventricles (Iyer et al. 2004; ten Tusscher et al. 2004; ten
Tusscher & Panlov 2006). A simple caricature model for the human SA node
has been developed (Seemann et al. 2006) as has detailed anatomical geometry
of the whole human heart (Sachse et al. 2000). The human PF cell is one of
the remaining missing models for the human cardiac conduction system. Minor
modications to the maximum conductance of IKs and INa in the ten Tusscher
& Panlov (2006) human ventricle model, were proposed by ten Tusscher &
Panlov (2008) which would result in a simple human PF model and allow them to
simulate the cardiac conduction system in the ventricles. However, the resultant
AP lacks many of the characteristics observed experimentally in human PF cells
(Dangman et al. 1982; Lee et al. 2004). It is therefore desirable to develop a
biophysically detailed model of the human PF cell AP to full the impending
requirement to build a virtual human heart.
3.2 Methods
The dynamics of the membrane potential in a cardiac cell are described by the
dierential equation (3.1), where Cm is the membrane capacitance, V is the mem-
brane potential, t is time, Iion is the sum of the transmembrane ionic currents
and Istim is an externally applied stimulus current (Hodgkin & Huxley 1952).
Numerous biophysically detailed descriptions of Iion have already been developed
for many dierent cardiac tissue types, in a variety of species.
Cm
dV
dt
=  (Iion + Istim) (3.1)
3.2.1 Human Purkinje bre model
A description of Iion for the human PF cell is developed based on the model of
the human endocardial cell by ten Tusscher & Panlov (2006). Their model is
modied based on the newly available experimental data of Han et al. (2002)
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describing the properties of potassium currents in human PF cells. The descrip-
tion of Iion requires the addition of two currents: a hyperpolarization activated
current, If , and a sustained potassium current, Isus, resulting in a total of 14
ionic currents, as given in equation (3.2). In addition to the introduction of the
new currents, the descriptions for the inward rectier current, IK1, and the tran-
sient outward current, Ito, are reformulated, and the maximum conductance of
the rapid and slow delayed rectier potassium currents, IKr and IKs, and the fast
sodium current, INa, altered because these channels are distinctively dierent in
channel kinetics and current densities between PF and ventricle cells.
Iion = IKr + IKs + IK1 + Ito + Isus + INa + Ib;Na + ICa;L
+Ib;Ca + INaK + INaCa + Ip;Ca + Ip;K + If
(3.2)
A detailed listing of all equations and parameters for the developed human
PF cell action potential can be found in Appendix A.1 and A.2 respectively. The
model is available online from the CellML repository (http://www.cellml.org/)
and was developed with Cellular Open Resource (Garny et al. 2003). The
following describes details of modications to the ten Tusscher & Panlov (2006)
model of endocardial cells for each individual current necessary to describe PF
cells.
3.2.1.1 Transient outward current, Ito, and sustained current, Isus
The transient outward potassium current, Ito, and the sustained potassium cur-
rent, Isus, are both present in human PF and ventricular cells, however, their
channel properties (i.e. channel kinetics and current densities) are dierent be-
tween the two cell types (Han et al. 2002). In the PF cells it has been observed
that Ito is signicantly smaller in current density and slower in inactivation and re-
covery, but Isus current density is substantially larger (Han et al. 2002). The clear
dierence between the PF and ventricular cells in their sensitivities to potassium
channel blocks (e.g. 4AP and tetraethylammonium) may be due to a dierent
molecular basis forming the Ito and Isus channels in the two cell types as seen in
canines (Han et al. 2000, 2001b).
To reect the fundamental dierences in the Ito and Isus channel properties,
the equations of the ten Tusscher et al. (2004) model for the steady state acti-
vation variable, r1, and inactivation variable, s1, of Ito, are reformulated based
on the experimental data of Han et al. (2002) on human PF cells. This results
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Figure 3.1: Modelling Ito and Isus. (a) Steady-state activation (lled circles) and
inactivation (open circles) curves for Ito. (b) Time constants, r (lled circles) and
s (open circles) for Ito. (c) Current{voltage relationship for Ito. (d) Current{
voltage relationship for Isus. (e) Resultant current traces for Ito + Isus during
voltage clamp. In all cases, solid lines represent the simulated values and circles
represent the experimental data.
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in an increase in slope factor of r1 and s1 from 6mV and 5mV respectively, to
13mV, and an additional shift in the half-inactivation (gure 3.1a) by  1mV.
Equations for the activation and inactivation time constants, r and s, are also
reformulated to t the experimental data of Han et al. (2002). The resultant r
and s are signicantly larger than in the ventricle model (a maximal increase by
72 per cent and 1300 per cent for r and s respectively) (gure 3.1b). Maximum
conductance, Gto, is determined by tting the current{voltage (I{V ) relationship
(gure 3.1c) to the experimental data of Han et al. (2002), resulting in an increase
of 12 per cent with respect to the endocardial model of ten Tusscher et al. (2004).
In the original ten Tusscher et al. (2004) and ten Tusscher & Panlov (2006)
model, there is no formulation for the sustained potassium current, Isus. Experi-
mental data from both animal and human studies suggested the presence of the
current in PF cells, which is distinctively dierent in molecular basis to its ven-
tricular counterpart (Han et al. 2001a, 2000, 2001b). Based on the experimental
data of Han et al. (2002), Isus is introduced with a single instantaneous activation
variable, a, described by a single exponential sigmoid function. To determine
the maximum conductance, Gsus, the simulated I{V relationship (gure 3.1d)
obtained using the same voltage-clamp protocol used experimentally is t to the
experimental data of Han et al. (2002). Model parameters and equations are
validated by the consistency of the resulting simulated current traces of Ito+ Isus
(gure 3.1e) and the I{V relationship with those observed experimentally (Han
et al. 2002).
3.2.1.2 Hyperpolarization activated current, If
The hyperpolarization activated current, If , is believed to play an important role
in producing spontaneous diastolic depolarization leading to automaticity in some
cardiac tissues, such as the SA node and PF cells (DiFrancesco 2006). If has been
recorded from both animal and human PF cells (Callewaert et al. 1984; Cerbai
et al. 1997; Han et al. 2002; Shi et al. 1999). In the absence of a description
of If in the ten Tusscher & Panlov (2006) model, If is introduced based on the
model of Zhang et al. (2000) for the rabbit SA node. The model equations for the
steady state activation variable, y1, and the voltage-dependent time constant of
activation, y, are reformulated based on the experimental data on the channel
kinetics of human PF If (Han et al. 2002). The maximal channel conductance,
Gf , is determined by tting the simulated I{V relationship to the experimental
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Figure 3.2: Modelling If and IK1. (a) Resultant current traces and (b) current{
voltage relationship for If obtained during voltage clamp for the model (solid line)
and experimentally (open circles). (c) Simulated (solid line) and experimental
(open circles) current{voltage relationship for IK1.
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data (Han et al. 2002). The model equations and parameters are validated by the
agreement of the simulated If current traces (gure 3.2a) and I{V relationship
(gure 3.2b) during voltage-clamp with experimental data (Han et al. 2002).
3.2.1.3 Inward rectier current, IK1
Experimental data suggests a dierent IK1 current density between the PF and
ventricular cells (Han et al. 2002). In rabbit hearts, it has been shown the mea-
sured IK1 density is much smaller than in ventricular myocytes (Cordeiro et al.
1998). Based on the experimental data of human PF cells (Han et al. 2002), the
endocardial description (ten Tusscher et al. 2004) of the time-independent inward
rectication factor, xK11, of IK1, is reformulated. The maximum conductance,
GK1, is determined by tting the simulated I{V relationship (gure 3.2c) to the
experimental data (Han et al. 2002).
3.2.2 All-or-nothing repolarization
Following the methods of Vassalle (1966) and McAllister et al. (1975), the phe-
nomenon of all-or-nothing repolarization (Weidmann 1951) can be reproduced
in a model as a method of validating qualitatively the behaviour of the action
potential model. APs are elicited by a suprathreshold stimulus at a time interval
of 1 s and remain unperturbed during the resultant AP. During the 10th AP, at
times of 40, 60 and 80ms after the AP is elicited, the membrane potential, V , is
clamped for 20ms to a holding potential, Vhold, and then released. The response
to varying Vhold is determined by whether the AP repolarizes earlier than a nor-
mal AP. If Vhold is above a threshold value, the membrane will depolarize and the
AP will repolarize later than normal. If Vhold is at or below the threshold, the
membrane will repolarize earlier than usual.
3.2.3 Overdrive suppression
Rapid stimulation of PF cells can result in a phenomenon called overdrive suppres-
sion (Boyett & Fedida 1984; Valenzuela & Vassalle 1983; Vassalle 1970), where
the pacemaker activity of the PF cells is suppressed for a period of time follow-
ing high frequency stimulation after which it restarts again. Under normal sinus
rhythm in the heart, the pacemaking of the PF cells is usually suppressed by the
SA node. Overdrive suppression is simulated using the following protocol: no
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external stimulus is applied for the rst 100 s, after which the cell is paced by a
series of periodic suprathreshold stimuli (with amplitude of  52 pApF 1 and du-
ration of 1ms) at frequencies of 1.5, 2.0 or 2:5Hz, before the external stimulation
is terminated 10min later.
3.3 Results
3.3.1 Simulated action potential of human PF cells
The simulated time course of the autorhythmic human PF APs (gure 3.3a),
major underlying ionic channel currents (gure 3.3b-j) and the transient of intra-
cellular Ca2+ concentration (gure 3.3k) are shown in gure 3.3. The simulated
AP begins with a rapid phase-0 depolarization upstroke, accompanied by the ac-
tivation of INa (gure 3.3b). Following the rapid depolarization, there is a rapid
phase-1 repolarization caused by the activated Ito (gure 3.3d), producing a sharp
spike and notch. The phase-2 plateau is maintained by the activation of ICaL (g-
ure 3.3c), which is followed by the phase-3 repolarization as a consequence of an
integral action of IKr, IKs and IK1 (gure 3.3e-g). Activation of If (gure 3.3h)
produces a phase-4 diastolic depolarization leading to automaticity. During the
time course of APs, activation of INaK (gure 3.3i) and INaCa (gure 3.3j) con-
tributes to dynamic changes of ion concentrations and also to the morphology
of the APs. The reconstructed sharp spike/notch and the phase-4 diastolic de-
polarization leading to automaticity are features of PF cells that are distinctive
compared to ventricular myocytes.
The simulated AP has characteristics comparable to the experimental data of
human PF cells. Experimentally measured maximal diastolic potential (MDP)
of PF APs is between  79 and  85mV (Dangman et al. 1982; Lee et al. 2004).
In simulations, the computed MDP is  75:53mV. The experimentally measured
amplitude of APs (APA, measured from the MDP to the overshoot of the AP) for
human PF cells is between 107 and 114mV (Dangman et al. 1982; Lee et al. 2004).
In the model, the computed APA is 123:13mV. PF cells have a larger upstroke
velocity than ventricular myocytes. The measured maximal upstroke velocity
from human PF cells is from 207 to 387V s 1 (Dangman et al. 1982; Lee et al.
2004). In the model, the computed maximal upstroke velocity is 327:42V s 1,
which was achieved by increasing the maximum conductance of INa, GNa by a
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Figure 3.3: (a) Simulated autorhythmic APs. Inset: comparison between APs
evoked by an external stimulus from uncorrected (black) and corrected (grey)
parameters for heart failure-induced electrical remodelling. Dashed line identi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0mV. (b  j) Time traces for major ionic currents and (k) calcium transient.
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factor of 8.8. The experimentally measured APD90 is about 319  23ms (Lee
et al. 2004), whilst the computed value is about 293ms. The measured slope
of the diastolic potential from paced PF cells is about 3:7  1:0mV s 1 (Lee
et al. 2004). In automatic cells, it is expected there will be a larger slope of
the diastolic potential. Simulated APs are automatic with a slope of diastolic
potential of 10mV s 1 and the cycle length for spontaneous APs is about 1:1 s,
close to the experimental observed range of 1.3{3:0 s (Lee et al. 2004; Schmidt &
Thews 1993).
3.3.2 All-or-nothing repolarization and overdrive suppres-
sion
Figure 3.4a, b shows the simulated all-or-nothing repolarization results obtained
using the model. In gure 3.4a, time courses of repolarized APs with the model
being clamped to various potentials for 20ms at 80ms after the stimulus evok-
ing the AP are shown. When the clamp-potential is above  25mV, the model
response is a secondary depolarization that extends the AP repolarization dura-
tion and increases the APD. However, when the clamp potential is at or below
 25mV, the model response results in successive repolarization that abbrevi-
ates the AP repolarization duration. Thus the model presents the existence of a
threshold ( 25mV) at which repolarization can be accelerated. Figure 3.4b shows
the computed threshold for all-or-nothing repolarization at 40, 60 and 80ms after
the AP was elicited. The computed threshold is dynamical, which shifts towards
the plateau potential with time. The simulated all-or-nothing repolarization and
dynamical shift of the determined threshold for forcing repolarization with var-
ied refractory timing are consistent with experimental observations on PF tissues
(Vassalle 1966; Weidmann 1951).
Rapid stimulation of PF cells can result in overdrive suppression (Boyett &
Fedida 1984; Valenzuela & Vassalle 1983; Vassalle 1970), a phenomenon which
is reproduced by the model (gure 3.4c). During the rst 100 s period, the PF
cell model is stably autorhythmic. In the following 10min period, the PF model
is stimulated by a series of rapid stimuli at 2:5Hz, each of which evokes an AP.
When the external stimulus is switched o, there is a period of quiescence before
stable automaticity resumes (gure 3.4c(i)). The characteristics of the simulated
overdrive suppression are similar to the experimental observations by Boyett et al.
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Figure 3.4: Reproduction of experimental phenomena. All-or-nothing repolariza-
tion: (a) 80ms after the AP is elicited, the membrane is clamped to a holding
potential for 20ms and then released, resulting in either successive depolarization
and a prolongation of the APD or repolarization and a shortening of the APD.
(b) The threshold for repolarization approaches the plateau potential as the time
after the AP is elicited, at which the membrane is clamped, increases. (c) Over-
drive suppression of the pacemaker after a period of rapid stimulation. (i) The
cell is autorhythmic before rapid stimulation at 90, 120 or 150 beats per minute
for 10min, after which a period of quiescence occurs, the pacemaker recovers and
eventually resumes spontaneous activity. Slow rises in both (ii) [Na+]i and (iii)
INaK occur during rapid pacing, returning to normal levels shortly after auto-
maticity resumes. (d) Removal of INaK from equation (3.2) while retaining the
Na+/K+ pump function resulted in no period of quiescence after rapid pacing.
(e) Eect of pacing frequency, f , on period of quiescence, Tq.
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(1987b).
To investigate possible mechanisms underlying the genesis of overdrive sup-
pression, time courses of intracellular Na+ concentration and the Na+/K+ pump
current are considered (gure 3.4c(ii-iii)). During the period of rapid stimula-
tion, the intracellular Na+ concentration rises slowly towards an asymptotic level,
approximately 4mM higher than the initial value. Associated with the increased
intracellular Na+ concentration is a monotonic increase in the Na+/K+ pump
current. This increase in Na+/K+ pump current suppresses the spontaneous
pacemaking activity when the external stimulus is switched o, leaving the cell
model in a quiescent state. During the quiescent period, intracellular Na+ falls
comparatively quickly to the initial value (gure 3.4c(ii)) resulting in decreased
Na+/K+ pump current. When the Na+/K+ pump current decreases to a critical
amplitude, comparable to the amplitude of INaK during the diastolic phase of the
AP before rapid stimulation, the spontaneous pacemaking activity of the PF cell
model resumes.
An increase in intracellular Na+ during rapid pacing has been observed exper-
imentally (Boyett et al. 1987b) and is believed to be responsible for suppression
of automaticity following prolonged periods of rapid stimulation (Valenzuela &
Vassalle 1983) as it produces a rate dependent increase in the Na+/K+ pump
activity (Boyett & Fedida 1984; Kline & Kupersmith 1982). The simulations
presented support this hypothesis (gure 3.4c). The link between overdrive sup-
pression and the rate-dependent increase in the Na+/K+ pump current due to
intracellular Na+ overload, can be further studied by removing the contribution
of INaK to cell membrane potential (i.e. it is removed from equation (3.2)) whilst
retaining the Na+/K+ pump function in sustaining the homoeostasis of Na+ and
K+ ions. The removal of the Na+/K+ pump current from equation (3.2) results
in a relatively small intracellular Na+ overload and negligible increase in Na+/K+
pump current, and as a result abolishes the period of quiescence after the rapid
stimulation (gure 3.4d). This provides further support for the hypothesis that
the overloading of intracellular Na+ concentration is responsible for the genesis
of overdrive suppression (Vassalle 1970).
Boyett & Fedida (1984) demonstrated that overdrive suppression is rate de-
pendent and the period of quiescence, Tq, is longer at higher stimulation frequen-
cies. Such a rate dependent prolongation of the suppression period is reproduced
by the model for stimulation frequencies greater than 1:5Hz. The model is paced
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at 1.5, 2 and 2:5Hz (corresponding to pacing rates of 90, 120 and 150 beats per
minute respectively) and with the increasing frequency, the measured Tq increases
from 50 to 83 s (gure 3.4e).
3.3.3 Ionic mechanisms underlying human PF cells
Simulations are performed to elucidate the role of each major individual ionic
current in generating autorhythmic human PF APs (gure 3.5), especially the
genesis of diastolic depolarization leading to automaticity.
3.3.3.1 Eect of INa on the action potential
The role of INa is investigated by blocking INa either partially or completely (gure
3.5a). Blocking INa by 50 per cent slows down the automatic activity. Compared
to the control condition, the measured cycle length increases from 1.1 to 2:6 s,
whilst the overshoot is decreased from 30 to 18mV, as is the maximal upstroke
velocity, which decreases to 24V s 1. There is no noticeable change in the MDP
or the APD. Blocking INa by 100 per cent, results in the abolition of automaticity
with the membrane potential resting at  66:5mV.
3.3.3.2 Eect of ICaL on the action potential
The role of ICaL is determined by blocking ICaL either partially or completely
(gure 3.5b). Blocking ICaL by 50 per cent results in a slowing of the automaticity,
increasing the cycle length to 1:4 s. Additionally, it decreases the overshoot,
abbreviates APD and also decreases the plateau potential of the APs. There
is no noticeable change in the MDP. However, blocking ICaL further to 100 per
cent accelerates, rather than decelerates the automaticity. In this condition,
the measured CL decreases to 0:9 s. The accelerated automaticity is due to an
abbreviation of the APD as a consequence of the loss of the AP plateau, similar to
previous experimental observations in peripheral rabbit SA node cells, in which
the application of nidipine, a inhibiter of ICaL, abbreviated the rabbit SA node
APD and accelerated its pacemaking activity (Kodama et al. 1997b).
3.3.3.3 Eect of IKr on the action potential
Blocking IKr by 50 or 100 per cent produces a prolonged APD and a reduction
in the rate of automaticity (gure 3.5c). However, it has negligible eect on the
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Figure 3.5: Eects of blocked ionic current on autorhythmic APs. (a) ICaL blocked
by (i) 50% and (ii) 100%, (b) INa blocked by (i) 50% and (ii) 100%, (c) IKr blocked
by (i) 50% and (ii) 100%, (d) IKs blocked by (i) 50% and (ii) 100%, (e) Ito blocked
by (i) 50% and (ii) 100% and (f) If blocked by (i) 30% and (ii) 100%. In all
cases, the grey trace is the control AP and the black trace is the eect of the
block. Dashed line identies 0mV.
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overshoot and MDP. The slowing down in the automaticity can be attributed to
the prolonged APD as observed in rabbit SA node cells (Kodama et al. 1997b).
3.3.3.4 Eect of IKs on the action potential
Blocking IKs by 50 or 100 per cent produces negligible eects on the overshoot,
MDP, maximal upstroke velocity and the automaticity of the APs (gure 3.5d).
It does however prolong the measured APD50 from 231 to 309ms with a 100 per
cent block.
3.3.3.5 Eect of Ito on the action potential
Blocking Ito by 50 or 100 per cent produces negligible eects on the overshoot,
MDP, maximal upstroke velocity and the automaticity of APs (gure 3.5e). How-
ever, it has remarkable eects on the phase-1 repolarization. Blocking Ito slows
down the phase-1 repolarization producing an elevated plateau potential and a
less marked phase-1 spike/notch. By blocking Ito by 100 per cent, the unique
feature of the phase-1 notch of the PF cell AP disappears.
3.3.3.6 Eect of If on the action potential
Blocking If has the most dramatic eect on the automaticity of the PF cell model,
though its eect on the overshoot, MDP, maximal upstroke velocity and APD
is negligible (gure 3.5f). Blocking If by 30 per cent, increases the measured
cycle length of APs to 1.7 from 1:1 s under the control condition. Blocking If by
100 per cent, abolishes the automaticity with the membrane potential resting at
 75:5mV, close to the MDP. However, the cell model remains excitable and with
an external suprathreshold stimulus, a full action potential can be evoked.
3.4 Discussion
In this study a biophysically detailed model for the electrical AP of the hu-
man PF cell has been developed based on modications to the ten Tusscher &
Panlov (2006) model of human ventricular myocytes which incorporate extant
voltage clamp data recorded from human PF cells (Han et al. 2002). Conduc-
tance, steady-state activation and inactivation curves and time constants for Ito,
IKr, IKs and IK1 have been updated, and two additional currents introduced: a
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hyperpolarization activated pacemaking current, If , and a sustained potassium
current, Isus, absent in the ventricle cell models but present in PF cells, which are
tted to the experimental data of (Han et al. 2002). The resultant model repro-
duces the PF cell AP with characteristics consistent with experimental recordings
(Dangman et al. 1982; Lee et al. 2004). Inclusion of If in the model produces
autorhythmic APs with a cycle length of approximately 1:1 s, which is consistent
with experimental data (Lee et al. 2004; Schmidt & Thews 1993). The model is
also validated by its ability to reproduce the all-or-nothing repolarization phe-
nomenon observed in PF tissues (Vassalle 1966; Weidmann 1951), and the well
known physiological phenomenon of overdrive suppression (Boyett & Fedida 1984;
Valenzuela & Vassalle 1983; Vassalle 1970). Using the model, the functional role
of several major ionic currents (INa, ICaL, Ito, IKr, IKs and If) on producing the
unique features of human PF APs is computed, especially the fast phase-1 repo-
larization, the phase-4 diastolic depolarization and the automaticity. It is shown
that whilst Ito plays an important role in producing the phase-1 notch, INa, ICaL
and If all play an important role in controlling the automaticity of PF cells.
3.4.1 Adjustment of model parameters due to heart fail-
ure induced ionic channel remodelling
The experimental data of Han et al. (2002) on properties of potassium currents
of human PF cells was obtained from explanted failing human hearts. It is well
known that heart failure induces changes in channel properties of several major
ion channels (i.e. ionic channel remodelling) responsible for electrical APs in both
PF and ventricular cells (Han et al. 2001a; Priebe & Beuckelmann 1998). Exper-
imental data also suggests that heart failure induced ionic channel remodelling
is comparable between PF and ventricular cells (Han et al. 2001a). In human
ventricular cells, it has been shown that the AP is prolonged in patients with
heart failure (Priebe & Beuckelmann 1998). Associated with the change in the
AP is the down-regulation of IK1 (Beuckelmann et al. 1993; Koumi et al. 1995)
and Ito (Beuckelmann et al. 1993; Nabauer et al. 1993). There is no evidence for
heart failure induced remodelling on other potassium channels, such as IKr and
IKs, nor on the fast sodium current INa (Han et al. 2001a; Priebe & Beuckelmann
1998). However, there is evidence that the current densities and kinetics of ICa are
unaltered (Beuckelmann et al. 1993; Mewes & Ravens 1994; Ouadid et al. 1995),
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though Ca2+ handling is altered and the activity of the Na+/Ca2+ exchanger
enhanced (Beuckelmann et al. 1992; Flesch et al. 1996; Gwathmey et al. 1987;
Reinecke et al. 1996) in the failing hearts. Data obtained from canine studies
suggests that congestive heart failure (CHF) produces compatible ionic channel
remodelling between PF and ventricular myocytes, with the main changes in-
volving down-regulation of both IK1 and Ito densities and slowed inactivation of
ICaL, but no change in other currents such as IKs, IKr, INaCa and ICaT (Han et al.
2001a, 2002; Priebe & Beuckelmann 1998; Tomaselli & Marban 1999).
The present PF cell model is based on the experimental data of Han et al.
(2002) obtained from failing human hearts. Some major ion channels, including
IK1 and Ito may be aected by heart failure induced ion channel remodelling.
Thus it is necessary to adjust some channel parameters in order to model a
normal human PF cell. To this end, heart failure induced ion channel remodelling
is assumed to be consistent across PF and ventricular myocytes and the approach
of Priebe & Beuckelmann (1998) followed. Namely, heart failure would produce
a 36 per cent reduction in Ito and a 20 per cent reduction in IK1 current densities.
Therefore, in the normal PF cell model, Gto and GK1 are increased by 36 and 20
per cent respectively. As equations and parameters for INaCa and Ca
2+ handling,
are inherited from the original ten Tusscher & Panlov (2006), it is assumed they
are for healthy cells and therefore do not require adjustment. It is also assumed
that changes to ion channel kinetics are not induced by heart failure, only changes
in conductances. This is therefore an important limitation of the heart failure
adjustment.
In the model with adjusted parameters to compensate for heart failure induced
ion channel remodelling of Ito and IK1, the simulated PF APs (the grey line in
the inset of gure 3.3a) evoked by an external stimulus are similar to those of
the uncorrected model, except for a more marked phase-1 repolarization. This is
consistent with the experimental observation of Han et al. (2001a) on canine PF
cells: the characteristics of canine PF cells are very close between normal hearts
and hearts with CHF, except a less marked phase-1 repolarization and higher
plateau voltage in CHF. There were no signicant dierences observed in resting
potential, AP amplitude or APD between control and CHF cells.
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3.4.2 Limitations
The model is constructed based on the experimental data of Han et al. (2002) on
properties of potassium currents in human PF cells isolated from failing hearts,
which were treated by a variety of medications. As both disease and medication
can change the kinetics and current density of ion channels (Han et al. 2001a), it is
possible the Han et al. (2002) data may not truly reect the electrical properties
of healthy human PF cells. These are well recognized limitations for virtually
all electrophysiological studies of human cardiac cells in the literature, based on
which all other models for human cardiac cells were developed. Though the model
has been adjusted for possible electrical remodelling induced by heart failure for
Ito and IK1 based on experimental studies in canine and humans (Han et al. 2001a;
Priebe & Beuckelmann 1998), the adjustment for parameters may be incomplete,
as other channels, such as IKr and IKs may also be remodelled by heart failure.
In the absence of detailed experimental data, a number of major currents
including INa and ICaL, and intracellular Ca
2+ handling, are inherited from the ten
Tusscher et al. (2004) and ten Tusscher & Panlov (2006) models. It is possible
that these inherited descriptions - notably the Ca2+ handling mechanisms - are
dierent between PF and ventricular cells (e.g. due to a lack of t-tubules in PF
cells (Boyden et al. 2000; Sommer & Johnson 1968)). These limitations must
be addressed in the future when more experimental data is available and can be
used to improve the validity of the current model. The present model is quiescent
following rapid stimulation at pacing rates over 90 beats per minute (i.e. stimulus
frequency higher than 1:5Hz), faster than an average adult human heart rate at
normal physiological conditions, potentially due to the inheritance of ventricle
data.
Additionally, recent studies identify a number of currents absent in the model
which are believed to play an important role in AP morphology of PF cells,
notably IK(ACh), ICaT and INaL (Dun & Boyden 2008; Gaborit et al. 2007). Though
identied in human PF cells, a lack of experimental data on IK(ACh) and INaL
prevents their inclusion in the current model, while the presence of ICaT in human
PF cells has yet to be observed (Dun & Boyden 2008). The role of INaL and ICaT
has been studied in more detail in canine PF cells (Aslanidi et al. 2009), which
reveal that ICaT and IK(ACh) play a minor role, whereas the eect of INaL on
the AP duration was much more prominent. Future models of human PF cells
should incorporate eects of the latter, subject to availability of experimental
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data. The developed model can however reproduce the typical features of APs in
human PF cells, such as the marked phase-1 notch, automaticity, all-or-nothing
repolarization and overdrive suppression, thus it can be used to simulate the
conduction system of PF network in the whole heart model.
3.4.3 Role of If in pacemaking activity of PF cells
Controversy still surrounds the mechanism underlying the genesis of automaticity
in cardiac pacemaking cells including the SA node and PF cells. Blocking If in the
present model abolishes the automaticity of the PF cells (gure 3.5f), providing
evidence to support the hypothesis that If is the primary factor responsible for
generating pacemaking activity (DiFrancesco 1981, 2006). However, experimen-
tal studies have also suggested an alternative hypothesis that reverse excitation
contraction (EC) coupling (Boyden et al. 2000; Dangman & Miura 1987; Lakatta
et al. 2003; ter Keurs & Boyden 2007) may play a critical role underlying cardiac
automaticity. The present model is not sucient to investigate the possible role
of the major mechanisms of reverse EC coupling - Ca2+ sparks and waves - in
initiating PF cell automaticity since the model lacks consideration of spatially
extended features of Ca2+ handling and Ca2+ diusion (Tao et al. 2008). Such
an approach would involve considering spatio-temporal dynamics of sub-cellular
variables, which is beyond the scope of the present work.
Chapter 4
A model of the canine Purkinje
bre cell
4.1 Introduction
The electrical properties of Purkinje bre (PF) cells are species dependent (Lu
et al. 2001). Experimental data indicates dramatic dierences in the morphology
of human and canine PF action potentials (APs). Primarily, canine PF cells have
a much lower AP plateau and more predominant notch (Dumaine & Cordeiro
2007) than human PF cells (Lee et al. 2004). It is possible that such dierences
in their APs are due to dierent properties of ion channels in the two species. In
Chapter 3, a model of the human PF cell was described, reproducing experimen-
tally observed AP characteristics (Dangman et al. 1982; Lee et al. 2004). The
canine heart is similar to that of the human, sharing many similar features and as
a result is often used for simulations (Benson et al. 2008) owing to the increased
availability of data. Here, the family of canine cell models is extended with a
model for the canine PF cell developed to reproduce the dierent AP morphol-
ogy of the canine PF and investigate the ionic dierences between human and
canine PF cells.
n.b. Portions of this chapter appear in Aslanidi et al. (2009); Stewart et al. (2009).
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4.2 Methods
The dynamics of the membrane potential in a cardiac cell are described by the
dierential equation (4.1), where Cm is the membrane capacitance, V is the mem-
brane potential, t is time, Iion is the sum of the transmembrane ionic currents
and Istim is an externally applied stimulus current (Hodgkin & Huxley 1952).
Numerous biophysically detailed descriptions of Iion have already been developed
for many dierent cardiac tissue types, in a variety of species.
Cm
dV
dt
=  (Iion + Istim) (4.1)
4.2.1 Canine Purkinje bre model
A detailed description of Iion, and hence a single cell AP for canine PF cells is
developed by modifying the existing canine endocardial cell model (Benson et al.
2008) based on experimental data for the kinetics of several major ionic currents
in canine PFs (Han et al. 2001a). A total of 17 ionic currents are summated to
describe Iion, as given in equation (4.2). These include the L-type and T-type
Ca2+ currents, ICa;L and ICa;T, the transient outward current, Ito, the fast and
slow delayed rectier currents, IK;r and IK;s, and the inward rectier K
+ current,
IK;1. Conductances and kinetics of each of the currents in the canine endocardial
cell model (Benson et al. 2008) are modied to simulate their correct current{
voltage (I{V ) relationships and time courses, as recorded experimentally from
canine PF cells (Han et al. 2001a).
Iion = INa + INa;L + ICa;L + ICa;T + Ito;1 + Ito;2 + IK;r + IK;s + IK;1
+INaCa + INaK + INa;b + IK;b + ICa;b + ICl;b + ICa;p + IK;p
(4.2)
Detailed equations and parameters for the newly developed canine PF cell
model are provided in Appendix B.1 and B.2 respectively. The code for the model
is available online from the CellML repository (http://www.cellml.org/). The
following details the modications made for each individual current.
4.2.1.1 Fast sodium current, INa
Changes to the fast sodium current aect the upstroke of the AP. Maximum
conductance, gNa, and the time constant for the slow component of inactivation,
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j, in the PF cell model are reduced to 97 per cent and 10 per cent, with respect
to the values for the endocardial cell model (Benson et al. 2008) to result in
an AP upstroke velocity comparable to experimental data (table 4.1). Relative
contributions of the fast, h, and slow, j, components of inactivation are adjusted
to 80 per cent and 20 per cent, respectively.
4.2.1.2 Late sodium current, INa;L
The late sodium current has a greater eect on the AP duration in PF cells than in
ventricular cells (Coraboeuf et al. 1979; Iacono & Vassalle 1990). Characteristics
of INa;L recorded from canine PFs (Vassalle et al. 2007) are used to modify the de-
scription in the canine endocardial cell model (Benson et al. 2008). This includes
a  22mV shift in the steady-state inactivation curve, hL;1, and reformulation of
the inactivation time constant, hL , as a variable. Maximum conductance, gNa;L,
is rescaled based on the measured I{V relationship for INa;L (Vassalle et al. 2007).
The value of gNa;L in the PF cell model is vefold larger compared to that in the
endocardial cell model. Experimentally validated characteristics of this current
are presented in gure 4.1. As a result of the modication of INa;L, the AP dura-
tion in the PF is signicantly increased in comparison to that in ventricular cells,
in agreement with experimental data (Dumaine & Cordeiro 2007).
4.2.1.3 L-type calcium current, ICa;L
Kinetics of fast and slow voltage-dependent inactivation variables, f and f2, are
ret to experimental data (Han et al. 2001a): sigmoidal steady-state inactivation
curves and time constants are modied based on experimentally measured values
of their half-inactivation and slope factors (gure 4.2). The maximum conduc-
tance, gCa;L, is determined by tting the simulated I{V relationship for ICa;L to
experimental data (Han et al. 2001a), resulting in a 66 per cent reduction in
gCa;L compared to the respective value in the endorcardial cell model (Benson
et al. 2008). Consequently, the AP duration in the PF is signicantly increased
and the AP plateau lowered in comparison to ventricular cells and in line with
experimental observations (Dumaine & Cordeiro 2007).
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Figure 4.1: Model of the late Na+ current, INa;L. (a) Steady-state inactivation
curve. (b) Inactivation time constants. (c) I{V relationship using 500ms voltage-
clamp pulses over  70 to 30mV from a holding potential of  80mV.. In all cases,
and throughout the gures, solid lines represent simulated values, circles represent
experimental data.
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Figure 4.2: Model of the L-type Ca2+ current, ICa;L compared with experimental
data. (a) Steady-state activation and inactivation curves. (b) Fast and slow
voltage-dependent inactivation time constants, 1 and 2. (c) ICa;L during 200ms
voltage-clamp pulses over  40 to 50mV from a holding potential of  50mV. (d)
I{V relationship.
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Figure 4.3: Model of the T-type Ca2+ current, ICa;T compared with experimental
data. (a) Steady-state activation and inactivation curves. (b) ICa;T during 200ms
voltage-clamp pulses over  70 to 40mV from a holding potential of  90mV. (d)
I{V relationship.
CHAPTER 4. A MODEL OF THE CANINE PURKINJE FIBRE CELL 68
4.2.1.4 T-type calcium current, ICa;T
The T-type calcium current is absent in the ventricular cell model (Benson et al.
2008), but is recorded in canine PF cells (Han et al. 2001a). Hence, ICa;T is incor-
porated into the PF cell model (gure 4.3). Sigmoidal expressions for steady-state
activation, b, and inactivation, g, are derived from the experimental data (Han
et al. 2001a). Expressions for the time constants of activation and inactivation
are adopted from the rabbit sino-atrial model of Zhang et al. (2000). The resul-
tant equations and parameters used (e.g. maximum channel conductance, gCa;T)
are validated by matching the simulated I{V relationship for ICa;T to the experi-
mental data (Han et al. 2001a), as illustrated in gure 4.3c. The introduction of
ICa;T contributes to the experimentally observed increase in AP duration in PF
cells with respect to ventricular cells (Dumaine & Cordeiro 2007).
4.2.1.5 Transient outward potassium current, Ito;1
The expression for the steady-state activation variable, a1, is tted to experi-
mental data (Han et al. 2001a), requiring a  36mV shift in the half-activation
compared to the respective expression in the endocardial cell model (Benson
et al. 2008). In addition, the expression for the activation time constant, a, is
also shifted by  36mV. Both fast and slow inactivation variables, i and i2, are
retted to the experimental data (Han et al. 2001a) by modifying their respective
half-inactivation, slope factors and time constants (gure 4.4). Relative contri-
butions of the inactivation components, i and i2 are set to 80 per cent and 20
per cent respectively. Maximum conductance, gto;1, is determined by tting the
simulated I{V relationship for Ito;1 to the experimental data (Han et al. 2001a).
The resultant value of gto;1 in the PF cell model is 49 per cent larger than in
the endocardial cell model. Modications to Ito;1 change the morphology of the
AP notch, making it more pronounced, and the plateau of the PF cell, providing
better correspondence with experimental data (Dumaine & Cordeiro 2007).
4.2.1.6 Inward rectier potassium current, IK;1
The steady-state I{V relationship for IK;1 is t to experimental data (Han et al.
2001a) by rescaling the maximum conductance, gK;1 and through the addition of
a small constant component to the steady-state activation (see equation (B.83)
in Appendix B.1). The resultant value of gK;1 in the PF cell model is 50 per cent
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Figure 4.4: Model of the transient outward K+ current, Ito;1 compared with
experimental data. (a) Steady-state activation and inactivation curves. (b) Fast
and slow voltage-dependent inactivation time constants, fast and slow. (c) Ito;1
during 100ms voltage-clamp pulses over  40 to 70mV from a holding potential
of  70mV. (d) I{V relationship. Note that (d) shows the pure 4AP-sensitive
current, Ito;1, whereas (c) presents the sum of Ito;1 and the steady-state component
of the outward K+ current, Ito;2.
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of the respective value in the endocardial model (Benson et al. 2008).
4.2.1.7 Rapid delayed rectier potassium current, IK;r
Equations describing IK;r are modied based on experimental data (Han et al.
2001a). The steady-state activation curve, xr;1, is shifted by  10mV and its
slope factor increased by 288 per cent; the steady-state inactivation curve, rr;1,
is shifted by  15:4mV and its slope factor increased by 132 per cent (gure 4.5);
activation and inactivation time constants, xr and rr , are reformulated based
on Hodgkin{Huxley formalism. The maximum conductance, gK;r, is determined
from the measured current density of IK;r (Han et al. 2001a). The resultant value
of gK;r is approximately 163 per cent larger in the PF cell model compared to the
endocardial cell. Model equations and parameters are validated by matching the
simulated I{V relationship for IK;r to the experimental data (Han et al. 2001a)
for both the step and tail currents.
4.2.1.8 Slow delayed rectier potassium current, IK;s
The steady-state activation curve, xs;1, is shifted by 1:5mV and its slope factor
decreased to 55 per cent of the endocardial value (gure 4.6). The maximum
conductance, gK;s, is determined by tting the simulated I{V relationship for
IK;s to the experimental data (Han et al. 2001a). The resultant value of gK;s
is 135 per cent larger than in the endocardial cell model (Benson et al. 2008).
Changes in IK;1, IK;r and IK;s contribute to the reproduction of morphology of
the AP in the repolarization stages (Dumaine & Cordeiro 2007).
4.3 Results
The ability of the canine PF model to reproduce a wide variety of AP charac-
teristics is summarised in gures 4.7; 4.8; 4.9. In gure 4.7 dierences in current
densities are illustrated between the canine PF and the three ventricular cell types
- endocardial, midmyocardial and epicardial cells. Major dierences are observed
in INa;L (gure 4.7a), IK;r (gure 4.7e), and IK;1 (gure 4.7c), which contribute to
large dierences in AP plateau, duration and repolarization properties between
these cell types (gure 4.8).
Dynamic dierences in the APs and underlying ionic currents are illustrated
in gure 4.8 between the canine PF and ventricular cell models. In the simulated
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Figure 4.5: Model of the rapid delayed rectier K+ current, IK;r. (a) IK;r simulated
during 1000ms voltage-clamp pulses over  40 to 50mV from a holding potential
of  50mV and followed by a repolarizing 1000ms pulse to  30mV. Simulated
I{V relationships for (b) the step and (c) tail currents compared to experimental
data.
Han et al. Dumaine & Cordeiro Kondo et al.
Simulation
(2001a) (2007) (1999)
RP (mV)  80  83  85  83
APA (mV) 112 120 115 124
PP (mV) 3  10    7
APD (ms) 373   378 375
_Vmax (V s
 1)     250 262
Table 4.1: Action potential properties in a canine PF cell: model versus ex-
periment. RP, resting potential; APA, action potential amplitude; PP, plateau
potential; APD, action potential duration; _Vmax, maximum upstroke velocity. In
both the model and experiments, APD was measured at 90 per cent repolarization
after periodic pacing at 1Hz.
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Figure 4.6: Model of the slow delayed rectier K+ current, IK;s. (a) IK;s simulated
during 5000ms voltage-clamp pulses over  40 to 60mV from a holding potential
of  60mV and followed by a repolarizing 500ms pulse to  40mV. Simulated
I{V relationships for (b) the step and (c) tail currents compared to experimental
data.
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Figure 4.7: Dierences in ionic currents densities between the canine PF and
ventricular cell. Current densities in the model indicated by grey vertical bars.
Circles denote experimentally measure values of current densities.
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Figure 4.8: Dierences in the dynamics of APs and ionic currents between the
canine PF and ventricular cell models. Simulated AP morphologies and ionic cur-
rent traces in the PF and endocardial, midmyocardial and epicardial ventricular
cell models are shown. Inset: experimental AP recording from a canine PF cell
for comparison. Dashed line identies 0mV.
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AP of the PF, rapid phase-0 depolarization of the cell is accompanied by acti-
vation of INa. Subsequently, a rapid phase-1 repolarization, characteristic of PF
cells, is caused by the activated Ito;1, resulting in a pronounced spike and notch.
The long plateau in phase-2 is sustained primarily by the activation of INa;L and
additionally contributions from the activation of ICa;L and ICa;T. Repolarization
in phase-3 occurs as a result of sustained contributions from IK;r, IK;s and IK;1.
Illustrated in gure 4.9 is validation of the resultant AP morphology and rate
dependence in the canine PF cell model. Key quantiers including resting poten-
tial, RP; action potential amplitude, APA; plateau potential, PP; action potential
duration at 90 per cent repolarization, APD90; and maximum upstroke velocity,
_Vmax, all compare well with experimental data (Dumaine & Cordeiro 2007; Han
et al. 2001a; Kondo et al. 1999). The AP shape and duration, as well as the full
APD restitution curve, are in good agreement with experimental data (Dumaine
& Cordeiro 2007; Kondo et al. 1999), thus validating the model equations and
parameters used. A full comparison of the AP characteristics in the PF cells
between the simulations and experimental data is provided in table 4.1.
4.3.1 Comparison between human and canine PF cell AP
models
Using the model developed here for canine PF cells and the human PF model de-
veloped in Chapter 3, Ito is identied as the main factor contributing to dierences
between human and canine PF APs. There is experimental data suggesting that
the current density of Ito measured at 20mV from canine PF cells is signicantly
larger than from human PF cells (gure 4.10a). Blocking Ito in the canine PF
cell model produces APs with substantially changed morphology (gure 4.10b):
an elevated plateau and less marked notch as seen in human PF cells (Han et al.
2002). It is therefore implied that the large dierences in the AP plateau potential
and notch between the canine and human PF cells seen experimentally (Dumaine
& Cordeiro 2007; Lee et al. 2004) can be explained by signicant dierences in
the transient outward current between the two species (Han et al. 2001a, 2002).
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Figure 4.9: AP properties in the PF cell model. (a) Morphology compared with
experimental AP data. (b) Restitution curve for APD90 compared with experi-
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Figure 4.10: (a) Ito current density measured at 20mV in human and canine PF
cells. (b) Eect of blocking Ito in the canine PF cell model (grey) produced a
human PF cell-like AP (black). Dashed line identies 0mV.
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4.4 Discussion
A new electrophysiologically detailed model describing AP properties in a canine
PF cell has been developed based on modications of the canine ventricular cell
model (Benson et al. 2008). This species-specic mathematical model incorpo-
rates extensive experimental data on ionic channel properties (Han et al. 2001a;
Vassalle et al. 2007) and reproduces experimentally validated AP morphologies
(Dumaine & Cordeiro 2007) and rate dependence (Kondo et al. 1999) for a mam-
malian (primarily canine) PF cell.
Early development of single cell cardiac models, such as the iconic DiFrancesco
& Noble (1985) model, which integrates electrophysiological descriptions of ionic
channels with a description of the ionic pump and sequestering process, provided
a very general description for a mammalian PF cell. In the past two decades,
the emphasis has shifted from such general models to species-specic models
developed for a variety of human or animal cardiac tissue types, including the
sino-atrial node, atria, and ventricles, whereas PFs have been largely neglected.
However, achieving the ultimate goal of creating a virtual heart will require de-
tailed models of all parts of the cardiac conduction system, including the PF.
The developed PF cell model is validated by its ability to reproduce experi-
mental data for the kinetics of several major ionic currents recorded from a single
species (Han et al. 2001a; Vassalle et al. 2007), which included INa;L, ICa;L, ICa;T,
Ito;1, IK;r, IK;s, and IK;1 from canine PF cells. Kinetic variables, time courses, and
I{V relationships for each of these currents are tted to the experimental data
(gures 4.1{4.6). The PF cell model equations and parameters used are also vali-
dated by the simulated AP characteristics matching experimental data (Dumaine
& Cordeiro 2007; Han et al. 2001a; Kondo et al. 1999) in the resting potential, AP
overshoot, maximum upstroke velocity, low AP plateau, and long AP duration.
Of primary importance, the model is able to reproduce experimental data on the
AP rate dependence (Kondo et al. 1999) in a canine PF cell (gure 4.9). Large
dierences in ionic currents such as INa;L, IK;r, and IK;1 between the canine PF
and ventricular cells (gures 4.7 and 4.8) contribute to major dierences in the
AP morphologies observed experimentally between these two cardiac cell types
(Dumaine & Cordeiro 2007).
It is also demonstrated that the marked dierences in the morphology of PF
APs between the human and canine hearts can be explained by the dierent Ito
densities of PF cells measured in the two species, as observed experimentally (Han
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et al. 2001a, 2002). In contrast to many other species including canine (Dumaine
& Cordeiro 2007), rabbit (Dumaine & Cordeiro 2007) and sheep (Boyett 1981),
the human PF AP lacks a number of the characteristics, such as a longer APD,
lower plateau potential and less marked phase-1 notch than its ventricular coun-
terpart. The human PF AP is in fact, more ventricular-like than other species
(Dangman et al. 1982; Lee et al. 2004).
4.4.1 Limitations
Limitations of cardiac cell and tissue models are well documented (Benson et al.
2008; Zipes & Jalife 2004). In the single PF cell model development, modications
are made to the equations for all major ionic currents (INa, INa;L, ICa;L, ICa;T, Ito;1,
IK;1, IK;r, and IK;s) in the ventricular cell model (Benson et al. 2008) based on
available experimental data (Han et al. 2001a; Vassalle et al. 2007). However,
the hyperpolarization-activated pacemaking current, If , has not been introduced
in the PF model, as no experimental data on its properties in canine PF cells
are presently available. Note that under physiological conditions, canine PFs
have not yet been observed displaying pacemaking activity. Besides, for pump
and exchanger currents, as well as intracellular Ca2+ handling, due to the lack of
experimental data concerning dierences between the PF and ventricular cells,
equations and parameters from the original ventricular model (Benson et al. 2008)
are implemented and no dierence between the two cell types is assumed.
4.4.2 Late sodium current
Due to a lack of experimental data, the formulation for INa;L is based on a single
data source (Vassalle et al. 2007), which may limit the validity of the model
properties related to this current. The quality of the experimental data (Vassalle
et al. 2007) is also arguable, as Na+ currents were measured without blockade of
K+ currents; the eective patch pipette resistance was large (5{8M
) and the
recording temperature was not specied. However, in the absence of other data
sources for canine PFs, it is reasonable to use the data (Vassalle et al. 2007) as
the basis for INa;L formulation based on the following:
1. Although K+ currents were not blocked, pharmacological evidence from the
same study (Vassalle et al. 2007) shows that the total current was almost
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completely blocked by tetrodotoxin (TTX) or lignocaine and hence were
predominantly Na+ current.
2. In a more recent study from the same group (Bocchi & Vassalle 2008), which
showed similar results, the recording temperature was explicitly specied
as 37 C.
3. Large pipette resistance, R  5{8M
, could present a major problem in
measurements of a very large fast Na+ current, INa, but for the much smaller
late sodium current, INa;L, which reaches a maximum amplitude of approxi-
mately I = 300 pA at  20mV, such a resistance would result in a maximum
error in voltage measurement of approximately IR = 300 pA  8M
 =
2:4mV.
In addition, recordings from PF strands (Carmeliet 1987) have recorded INa;L
with a density of the same magnitude (approximately 5 pApF 1), which is sev-
eral times higher than the respective current density in canine ventricular cells
(Maltsev et al. 2008; Zygmunt et al. 2001). These arguments justify the use of
the experimental data (Vassalle et al. 2007) for INa;L in the canine PF cell model.
There is experimental evidence for a prominent role of high INa;L in PFs.
The APD in PFs is much longer than in ventricular myocytes: this dierence
is related to INa;L, as TTX shortens the AP of PFs much more than that of
ventricular myocytes (Coraboeuf et al. 1979; Iacono & Vassalle 1990); the study
of Iacono & Vassalle (1990) also shows that TTX decreases intracellular sodium
activity much more in PF than in ventricular myocytes. Dose dependence of INa;L
on TTX shows that the current is blocked by approximately 50 per cent at TTX
concentrations of approximately 10 6M; such concentrations have been used in
experiments (Coraboeuf et al. 1979), producing a remarkable decrease of the APD
in PFs. In the model, a similar 50 per cent block of INa;L results in a twofold
APD decrease, matching the experimental data (Coraboeuf et al. 1979). However,
a 50 per cent block of INa;L in the ventricular cell models results in a much
smaller APD decrease, which is also consistent with experimental observations
(Coraboeuf et al. 1979; Zygmunt et al. 2001). This provides additional validation
for the INa;L characteristics used in the model.
Chapter 5
Mechanistic insights into the
Bowditch eect and the tension
staircase of the heart
5.1 Introduction
An important ability of the heart is that it can adapt to changes in rate and
rhythm (e.g. during exercise) of electrical stimulation by the heart's natural pace-
maker, the sino-atrial (SA) node. Changes in heart rate are known to arise from
and result in a wide range of eects in the electrical behaviour of the heart (see
Boyett & Jewell 1980; Carmeliet 1977, for an overview). These changes have
physiologically important consequences (as the pumping function of the heart is
triggered primarily by electrical impulses), yet the precise mechanisms underlying
them are not fully understood.
Bowditch (1871) was the rst to show that the force of contraction of the heart
depends on the rate and rhythm of stimulation (Langer 1971; Whalen 1958). To-
day, this well known physiological response is referred to as the Bowditch eect
or alternatively the staircase or treppe phenomenon (`treppe' is the German word
for staircase). Sustained repetitive stimulation at high frequencies results in a
slow progressive rise in contractile force akin to a force or tension staircase mor-
phology (Boyett et al. 1987b; Chapman & Niedergerke 1970a,b; Fedida et al.
1987; Miura et al. 1992; Noble 1984; Noble & Shimoni 1981a,b) from which the
phenomenon derives its name. At higher heart rates, cardiac output is known to
increase (Miura et al. 1994; Miyazaki et al. 1990; Vatner & Boettcher 1978), an
80
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important physiological consequence of the Bowditch eect as an increase in heart
rate could result, for example, from an increased demand for oxygen whilst ex-
ercising. Blood concentration of epinephrine (adrenaline) increases with exercise
(Koh et al. 2007) and as a result, heart rate increases (Anrep & De Burgh Daly
1925; Cannon et al. 1929) and cardiac output follows because of the Bowditch
eect, thereby increasing oxygen supply.
The widely known restitution property of the healthy heart is that the du-
ration of the cardiac action potential is abbreviated at high heart rates (Boyett
& Fedida 1984; Carmeliet 1955; Hausworth et al. 1972; Homan & Craneeld
1960; Homan & Suckling 1954; Liu & Antzelevitch 1995; Liu et al. 1993; Rudy
2007; Trautwein & Dudel 1954), manifested as a shortening of the QT interval
of the ECG (Nagatomo et al. 2002). The relationship between action potential
duration (APD) and stimulation time interval is non-linear and is typically rep-
resented by an electrical or APD restitution (APDr) curve (Bass 1975; Boyett &
Jewell 1978). APD restitution is believed to play an important role in the dynam-
ics of arrhythmia (Decker et al. 2009) and measurements of the steepness of the
slope of the APDr curve provide an indication of the susceptibility to arrhythmia
(Franz 2003; Garnkel et al. 2000; Karma 1994; Koller et al. 2005; Weiss et al.
2005) with steeper slopes indicating a higher susceptibility (Narayan et al. 2007;
Selvaraj et al. 2007).
The rate dependence of the action potential is physiologically important for
a number of reasons. The eective refractory period (ERP) of an elicited action
potential in the normal heart is determined by the duration of the plateau phase
of the action potential. Encroachment on this ERP without a rate dependent
shortening of the action potential would result in a lower achievable maximum
heart rate (Homan & Craneeld 1960). Purkinje bre action potentials are in
general signicantly longer than those of the ventricle over a wide range of stim-
ulation intervals and it is thought that the cardiac conduction system therefore
acts as a protective mechanism against premature excitation of the myocardium
at high heart rates (Moore et al. 1965). High heart rates compromise the time
available during diastole for the heart to ll. However, the rate dependent abbre-
viation of the action potential shortens the duration of systole since contraction
duration is linked to APD (Antoni et al. 1969; Morad & Trautwein 1968). As a
result, the time for diastole is increased ensuring adequate lling of the ventricles
(Boyett & Fedida 1984; Boyett & Jewell 1980; Warren et al. 2010).
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The contraction of heart muscle is activated through the elevation of intra-
cellular Ca2+ concentration (Marban et al. 1980), with the strength of the con-
traction dependent on the [Ca2+]i transient (Chapman & Niedergerke 1970a).
Underlying the treppe phenomenon, the progressive increase in contractile force
is accompanied by a slow progressive rise in peak [Ca2+]i resulting in a similar
staircase morphology and illustrating the Ca2+ dependence of the phenomenon
(Boyett et al. 1987b; Noble 1984; Noble & Shimoni 1981a; Peineau et al. 1992;
Pieske et al. 1995).
During the course of an action potential, Ca2+ inux occurs primarily through
the L-type Ca2+ channel, ICaL, and eux via the Na
+/Ca2+ exchanger (neglecting
release from, and uptake to, the SR, which approximately balance each other out
over the course of an AP (Levick 2003, pp. 37{40)). At high heart rates, Ca2+
enters into the cytoplasmic space through the repetitive opening of the L-type
Ca2+ channels, however incomplete removal of Ca2+ through the exchanger occurs
between successive stimuli, resulting in an accumulation of [Ca2+]i as rapid pacing
persists (Boyett & Jewell 1978; Chapman & Niedergerke 1970b; Shimoni 1981)
and consequently the treppe phenomenon arises as successive loading of Ca2+
through ICaL occurs (Boyett et al. 1987b). Incomplete reactivation of ICaL can
become a limiting factor in the supply of Ca2+ for the production of tension
(Shimoni 1981) and a plateau in [Ca2+]i and tension is reached if rapid pacing
persists further.
Intracellular Ca2+ is also of primary importance in determining the rate de-
pendent shortening of the action potential at high heart rates (Boyett 1978).
Changes in APD are primarily attributed to changes in the plateau phase of the
action potential (Boyett & Jewell 1980). The inux of Ca2+ through the L-type
Ca2+ channel, ICaL, determines the dynamics of the plateau phase, thereby indi-
cating ICaL possesses a critical role in APD accommodation (Decker et al. 2009).
At high pacing rates, an initial rapid decrease in APD is observed, followed by
a slow progressive decrease as pacing is maintained (Williams et al. 1999). The
rapidity of pacing determines whether inactivated Ca2+ channels from the pre-
vious stimulation have sucient time to reactivate. High pacing rates result in
incomplete reactivation and therefore Ca2+ inux is limited and APD is conse-
quently reduced, especially at pacing rates greater than f = 100min 1 (Boyett
& Jewell 1978; Shimoni 1981). Additionally, it is noteworthy that inactivation of
L-type Ca2+ channels is both voltage and [Ca2+]i dependent (Brown et al. 1981;
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Kass & Sanguinetti 1984; Lee et al. 1985) and thereby as [Ca2+]i accumulates,
ICaL progressively inactivates and hence APD decreases.
In addition to the slow progressive rise in [Ca2+]i observed in the treppe phe-
nomenon, a similarly slow increase in [Na+]i is also well documented (Boyett &
Fedida 1988; Boyett et al. 1987a,b; Cohen et al. 1982; Mills et al. 2007; Wang
et al. 1988). It has previously been demonstrated in the squid axon that Ca2+
inux is greatly increased with high concentrations of [Na+]i (Baker et al. 1969)
and it is widely known that the mechanism through which [Na+]i can exert in-
uence on [Ca2+]i is the Na
+/Ca2+ exchanger (Decker et al. 2009; Eisner et al.
1981; Vila Petro et al. 2003).
Activation of the fast Na+ channel, INa, causes a rapid inux of Na
+ and re-
sults in the depolarization of the cell as [Na+]i increases. The primary mechanism
for the reduction of [Na+]i is the Na
+/K+ pump, INaK, which actively pumps three
Na+ ions out of the cell for every two K+ ions pumped in. It has been suggested
by Langer (1971) that a Na+/K+ pump response `lag' could result in an increase
in intracellular Na+ activity, aiNa, at high stimulation rates. The rapid inux of
Na+ through INa and subsequent relatively slow reduction through the Na
+/K+
pump can result in Na+ loading and [Na+]i accumulation during high frequency
repetitive activity (Boyett et al. 1987a,b).
The Na+/Ca2+ exchanger, INaCa, exchanges three Na
+ ions with a single Ca2+
ion. In contrast to the Na+/K+ pump, the exchanger is reversible and can operate
in either of two directions depending on ionic concentration gradients. In cardiac
myocytes, the exchanger normally operates in the `forward' mode, extruding Ca2+
ions and facilitating Na+ ion entry (Bassani et al. 1994; Bers et al. 1989; Blaustein
& Lederer 1999). However, during the course of an action potential, the exchanger
may also operate in the `reverse' mode, in which Na+ ions are extruded and Ca2+
ions enter the cell (Bers 2001; Blaustein & Lederer 1999; Pieske et al. 2002).
An elevation of [Na+]i, such as that observed in the treppe phenomenon,
favours the reverse operation of the exchanger and limits the forward mode. With
increased [Na+]i, either a reduction in Ca
2+ eux through the exchanger operat-
ing in the forward mode, or an increase in Ca2+ inux through the exchanger in
the reverse mode will result in an elevation of [Ca2+]i (Vila Petro et al. 2003).
A potential consequence of increased Ca2+ inux through the reverse operation
of the exchanger is an increase in the sarcoplasmic reticulum (SR) Ca2+ content,
[Ca2+]SR, and an enhancement of SR Ca
2+ release in co-operation with Ca2+
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entry through the L-type Ca2+ channels (Litwin et al. 1998).
In the opposite direction, [Na+]i accumulation can occur as a result of Ca
2+
inux through the L-type Ca2+ channel and the resultant Na+ inux through
the forward mode of the Na+/Ca2+ exchanger. Decker et al. (2009) identify ICaL
as having a critical role in APD accommodation and APDr rate dependence.
They demonstrate that at fast stimulation rates, Ca2+ entry through ICaL drives
increased Ca2+ extrusion via the Na+/Ca2+ exchanger and hence increased Na+
entry which subsequently leads to increased Na+ extrusion through the Na+/K+
pump, from which APD accommodation arises. An impairment of the Ca2+-
dependent inactivation of the L-type Ca2+ channel, fCa, would increase Ca
2+
inux through ICaL and consequently increase Na
+ inux through the exchanger
further, enhancing APD accommodation and rate dependence further.
The Bowditch phenomenon and APD restitution are two correlated rate de-
pendent behaviours with complex underlying mechanisms. Despite the numerous
mechanisms proposed to explain [Na+]i and [Ca
2+]i accumulation at high heart
rates, it remains unclear which, if indeed any, is the primary mechanism ulti-
mately responsible for APD restitution and increases of contractile force in the
Bowditch eect. Hence, using the unique ability of computer modelling to isolate
potential mechanisms (that may be impossible experimentally), this study will
attempt to elucidate this debate. The role of [Na+]i accumulation, and its eect
on [Ca2+]i will be considered, in addition to the role of the L-type Ca
2+ chan-
nel; the Na+/K+ pump; and the Na+/Ca2+ exchanger; all of which aect [Na+]i
directly or indirectly.
5.2 Materials and methods
The dynamics of the membrane potential of a cardiac cell are described by equa-
tion (5.1), where Cm is the membrane capacitance, V is the membrane potential,
t is time, Iion is the sum of the transmembrane ionic currents and Istim is an
externally applied stimulus current (Hodgkin & Huxley 1952).
Cm
dV
dt
=  (Iion + Istim) (5.1)
A large number of biophysically detailed descriptions of Iion for ventricular
tissue have already been developed for a variety of species, including guinea pig
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(Luo & Rudy 1991, 1994a,b; Noble & Noble 2001), canine (Benson et al. 2008;
Hund & Rudy 2004) and human (Iyer et al. 2004; ten Tusscher et al. 2004).
It should be noted that even biophysically accurate descriptions of complex
physiological processes (e.g. the dynamics of the cardiac cell membrane poten-
tial) introduce the possibility that a simulated outcome obtained from the model
(i.e. a theoretically derived outcome with no experimental verication) could be
inherent of a particular model and not an accurate depiction of a physiological
process. The wealth of ventricular models already developed to date provides
an opportunity to mitigate this potential problem and obtain results which are
model independent. Consequently, all ventricular simulations are performed us-
ing four models covering three species: guinea pig (Luo & Rudy 1994b; Noble &
Noble 2001), canine (Benson et al. 2008) and human (ten Tusscher & Panlov
2006), however for convenience, only data from a single model will be presented
for each result (although each result has been veried in all the models).
A common stimulation protocol is implemented, comprising 4min of rest,
followed by 4min of pacing and subsequent rest for the cell to recover. The cell is
paced with a supra-threshold stimulus, amplitude 80 pApF 1 and duration 1ms,
applied at a frequency, f , in the range 0:33  f  2:5Hz.
APDr curves are obtained using an S1-S2 stimulation protocol (Boyett et al.
1987b; Cherry & Fenton 2004; Decker et al. 2009; Taggart et al. 1996) in which
4min of successive stimuli are applied separated by an interval, S1, after which a
further stimulus is applied following an interval, S2, which is varied. The action
potential duration at 90 per cent repolarization (APD90) of the action potential
evoked by the range of S2 stimuli is recorded. APDr curves for a range of S1
intervals are obtained and the points where S1 = S2 provide the dynamic APDr
curve.
The solution of equation (5.1) is obtained numerically using the explicit for-
ward Euler method with time step t = 0:01ms, suciently small to produce
stable numerical solutions. Gating variables of the individual ionic currents are
integrated following the methods of Rush & Larsen (1978). Descriptions of the
ionic models can be found in their original papers (Benson et al. 2008; Luo &
Rudy 1994b; Noble & Noble 2001; ten Tusscher & Panlov 2006).
The roles of INaK and INaCa can be established using the cell models through
the removal of their contribution to the membrane potential (in equation (5.1),
INaK and INaCa are components of Iion). The underlying processes however (i.e.
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Na+/K+ pump and Na+/Ca2+ exchanger) must be retained to maintain the bal-
ance of ionic concentrations.
The eects of a high concentration of tetrodotoxin (TTX), a selective blocker
of INa commonly used in electrophysiological experiments, can be simulated by
reducing the conductance of INa to zero. A consequence of such a complete
block of INa is the inability to depolarize the cell using a stimulus current. The
pacing protocol is subsequently modied to hold the cell at 40mV for 5ms before
allowing the cell to repolarize.
Following the approach of Shiferaw et al. (2003) and Fox et al. (2002a), the
Ca2+-dependent inactivation of the L-type Ca2+ channel, fCa can be reformulated
as in equation (5.2), where [Ca2+]i in the intracellular Ca
2+ concentration, km;Ca
is the half-saturation concentration of the Ca2+ channel, and  is an exponent
controlling the dependence on Ca2+-induced inactivation.
fCa =
1
1 +
 
[Ca2+]i
km;Ca
! (5.2)
Experimental results were obtained previously by Prof. Mark R. Boyett. De-
tails of the experimental methods, preparations and solutions used to obtain the
results can be found in previous publications (see Boyett 1978; Boyett & Fedida
1984; Boyett et al. 1987b; Harrison et al. 1992). It is noteworthy that a variety
of animal preparations were used in the experiments including sheep, rat and
cat tissue for which none of the models used here simulate and consequently
quantitative discrepancies are likely when comparing simulation to experiments.
5.3 Results
5.3.1 Physiological eects of rapid pacing
The eects of 4min pacing at 2Hz in the Noble & Noble (2001) guinea pig
model on membrane potential, APD90 and the transients of intracellular Na
+
and Ca2+ concentration are presented in gure 5.1a. During rapid pacing, a
small reduction in AP amplitude from 160 to 154mV is observed (gure 5.1a(i))
similar to that observed experimentally (gure 5.1b(ii)). Over the same period,
APD90 is reduced by 115ms from 260 to 145ms (gure 5.1a(ii)), comparable to a
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Figure 5.1: Physiological eects of rapidly pacing a ventricular cell. (a): Variation
in (i) membrane potential, (ii) APD90, (iii) [Na
+]i and (iv) [Ca
2+]i during 4min
of pacing in the Noble & Noble (2001) model at 2Hz. (v) Plot of APD90 vs
peak [Ca2+]i for each AP in the pacing period. (b): Experimental recordings of
(i) peak tension, (ii) membrane potential, (iii) APD90, (iv) cell length and (v)
intracellular Na+ activity. (vi) Plot of APD80 vs peak tension for each AP in the
pacing period (n.b. numbers indicate position of AP in train).
CHAPTER 5. BOWDITCH AND THE TENSION STAIRCASE 88
drop of around 125ms observed in experiments (gure 5.1b(iii)). Experimentally,
intracellular Na+ concentration rises by 2mM during the period of rapid pacing
before recovering over an approximately equal time period (gure 5.1b(v)). In
the simulations, an increase in intracellular Na+ of 3:4mM is observed, with a
similarly slow (4min) recovery to the pre-pacing level of 5:6mM (gure 5.1a(iii)).
Intracellular Ca2+ was not directly measured experimentally, however, peak
tension (gure 5.1b(i)) and cell length (gure 5.1b(iv)), both indirectly related
to [Ca2+]i (see Allen & Blinks 1978), were measured, providing a mechanism for
qualitative comparison with simulation results (gure 5.1a(iv)). In the model,
peak intracellular Ca2+ rises slowly from 0:45M, towards a maximum of almost
1:4M over the course of the 4min rapid pacing (gure 5.1a(iv)). Experimentally,
peak tension also increases slowly towards a maximum of 0:5 gm greater than
at the start of rapid pacing (gure 5.1b(i)). Cell length decreases with greater
intracellular Ca2+ concentration and experimentally, a progressive shortening of
the cell is observed over the course of rapid pacing (gure 5.1b(iv)). Plotting
APD90 verses peak intracellular Ca
2+ or peak tension, an approximately linear,
inverse relationship is obtained both experimentally (gure 5.1b(vi)) and in the
model (gure 5.1a(v)). As peak intracellular Ca2+ increases, APD90 decreases,
with ever smaller intervals at each successive AP.
5.3.2 Abbreviation of the action potential and associated
changes in ionic currents
Action potentials resultant from stimuli delivered following a period of 4min
rest to allow the cell to reach an equilibrium state are presented in gure 5.2 at
both the onset and cessation of the rapid pacing period from both experimental
recordings (gure 5.2a) and simulations of the Luo & Rudy (1994b) guinea pig
ventricle model paced at 2Hz (gure 5.2b(i)). Simulated current traces for the
Na+/K+ pump, INaK (gure 5.2b(ii)), the Na
+/Ca2+ exchanger, INaCa (gure
5.2b(iii)), and the L-type Ca2+ current, ICaL (gure 5.2b(iv)), are also presented.
Substantial abbreviation of the second AP with respect to the rst is observed
in the model, with APD90 reduced from 181 to 161ms (gure 5.2b(i)). Subsequent
APs are abbreviated less severely than the preceding AP and after 2min of rapid
pacing, each successive abbreviation is signicantly smaller than at the onset of
pacing with APD90 approaching 134ms. This progressive reduction in APD90
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Figure 5.2: Action potential shortening and associated changes in ionic currents.
(a): Experimental recordings of membrane potential and tension force (overlaid)
during repetitive stimulation. (b): Simulated variation in (i) membrane potential,
(ii) Na+/K+ pump current, INaK, (iii) Na
+/Ca2+ exchanger current, INaCa, and
(iv) L-type Ca2+ current, ICaL, in the Luo & Rudy (1994b) model paced at 2Hz.
Colour denotes AP number in the 4min pacing protocol.
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abbreviation is clearly illustrated in gure 5.1a(ii) in which APD90 is plotted as
a function of time. Immediately after the onset of pacing, the steep prole of
the APD90 curve illustrates the marked abbreviation of successive APs. As time
progresses, the curve becomes increasingly shallow, illustrating the progressive
reduction in APD90 abbreviation. This behaviour is also observed experimentally
in gure 5.2a: successive AP traces are abbreviated less than the previous AP
(right to left).
Underlying the AP abbreviation, the simulated behaviour of the Na+/K+
pump, the Na+/Ca2+ exchanger and the L-type Ca2+ current, ICaL, are pre-
sented in gure 5.2b(ii   iv). An increase in pump current, INaK, of 22 per cent
is observed between the initial and penultimate AP (gure 5.2b(ii)), both during
the AP transient and between APs, as a consequence of the increased intracel-
lular Na+ concentration. In addition to an increase in Na+ concentration within
the cell, there is also an accumulation of Ca2+ ions. Consequently, the exchanger
current, INaCa, increases in magnitude as rapid stimulation is maintained (gure
5.2b(iii)). In contrast to the behaviour of INaK and INaCa, both of which pro-
gressively increase in magnitude as pacing is maintained, ICaL initially increases
signicantly in magnitude by 25 per cent. However, as the period of rapid pacing
approaches the end, the magnitude of ICaL has recovered to end with only a 2 per
cent increase with respect to the initial AP (gure 5.2b(iv)) due to an enhance-
ment of Ca2+-dependent inactivation with increased [Ca2+]i (gure 5.1a(iv)).
5.3.3 Rate dependence - APD restitution and the depen-
dence on intracellular sodium
APDr curves obtained both experimentally and simulated using the Luo & Rudy
(1994b) guinea pig model are presented in gure 5.3. In the control case, a
decrease in the S1 interval from 3 s (f = 0:33Hz) to 0:4 s (f = 2:5Hz) results in
a depression of the APDr curve (gure 5.3a(i)), in agreement with experimental
observations (gure 5.3b), however the depression in the simulations is not as
pronounced as observed experimentally. A leftward shift (i.e. towards lower S2
test intervals) of the APDr curves is observed experimentally with increasing S1
interval, however this is not observed in the simulated results. These discrepancies
could be due to inter-species dierences between the model (guinea pig) and
experiment (canine).
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Figure 5.3: Rate dependence of APD90 - APD restitution and the dependence on
[Na+]i. (a): Simulated APDr curves using the Luo & Rudy (1994b) model for
(i) control and (ii) [Na+]i buered to a constant level of 12:2mM for S1 = 3, 2,
1, 0.5 and 0:4 s and S2 varied between 0.2 and 3 s. Dynamic restitution curve
(S1 = S2) shown in red. (b): Experimental APDr curve obtained for S1 = 10,
3, 1, 0.6 and 0:3 s and S2 varied between 0.2 and 10 s. Circled points lie on the
dynamic restitution curve.
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The accumulation of intracellular Na+ observed under rapid pacing both ex-
perimentally (gure 5.1b(v)) and in the simulations (gure 5.1a(iii)), can be
articially prevented in the model by buering [Na+]i to a constant level, thereby
indicating the eects of intracellular Na+ accumulation on APDr. A dramatic
reduction in the depression of the APDr curves with decreasing S1 interval is
observed with the buering of [Na+]i (gure 5.3a(ii)) indicating that [Na
+]i is an
important factor determining the rate dependence of APD90. The abolition of
the depression of the restitution curves results in an increase in steepness of the
dynamic restitution curve (red lines in gure 5.3a). It has been suggested (Franz
2003; Garnkel et al. 2000; Karma 1994; Koller et al. 2005; Weiss et al. 2005)
that slope of the restitution curve is indicative of susceptibility to arrhythmia.
5.3.4 Potential underlying mechanisms
5.3.4.1 Intracellular sodium concentration accumulation
The importance of [Na+]i is further explored in gure 5.4b with the Luo & Rudy
(1994b) guinea pig model paced at 2Hz. The slow, progressive shortening of
APD90 observed in the control simulation (gure 5.4a(ii)) as rapid pacing persists
is abolished when [Na+]i is buered to a constant level of 12:2mM and instead,
following the initial rapid abbreviation, APD90 remains constant throughout the
pacing period, at 147ms (gure 5.4b(ii)) - signicantly larger than the APD90 of
the control cell, which approaches 133ms towards the end of 4min pacing. In the
control case, [Ca2+]i rises progressively as pacing persists, resulting in a `tension
staircase' morphology, i.e. the Bowditch eect (gure 5.4a(iv)). When [Na+]i is
buered, it is evident from gure 5.4b(iv) that consequently the progressive rise
of [Ca2+]i and thereby tension does not occur.
5.3.4.2 Calcium-dependent inactivation of the L-type calcium channel
The removal of the Ca2+-dependent inactivation of the L-type Ca2+ channel, fCa,
increases Na+ inux though the Na+/Ca2+ exchanger as a result of an increase
in [Ca2+]i. In the simulations, both [Na
+]i (gure 5.4c(iii)) and [Ca
2+]i (gure
5.4c(iv)) levels signicantly exceed their control levels (gure 5.4a(iii) and (iv)
respectively) as expected. Similar to the control simulation, a slow progressive
decrease in in APD90 is observed, although the reduction in APD90 following the
initial rapid decrease is not as pronounced: 8ms (gure 5.4c(ii)) compared to
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Figure 5.4: Potential underlying mechanisms. Recordings of (i) membrane po-
tential, (ii) APD90, (iii) [Na
+]i and (iv) [Ca
2+]i obtained from simulations of ve
test cases using the Luo & Rudy (1994b) model paced at 2Hz. (a): Control.
(b): [Na+]i buered to constant level. (c): Removal of Ca
2+-dependent inactiva-
tion of the L-type Ca2+ channel, fCa. (d): Removal of the contribution of INaK
to the membrane potential (function of Na+/K+ pump retained). (e): Removal
of the contribution of INaCa to the membrane potential (function of Na
+/Ca2+
exchanger retained).
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20ms in control (gure 5.4a(ii)).
5.3.4.3 Role of the pump and exchanger
Both the Na+/K+ pump and the Na+/Ca2+ exchanger directly aect [Na+]i
through their active transport of Na+ across the cell membrane. The model
allows us to make either non-electrogenic (i.e. remove their contribution to the
electrical potential across the cell membrane) whilst retaining their function to
maintain an action potential and examine their eects during repetitive activity.
The removal of either INaK or INaCa has little eect on either the slow decrease
in APD90 (gure 5.4d(ii) and e(ii)), or the progressive rise in [Ca
2+]i (gure
5.4d(iv) and e(iv)), thereby indicating no mechanistic dependence of APD90 rate
dependence, nor the Bowditch eect on either process.
5.3.5 Role of the fast sodium channel
The application of TTX to a cardiac cell prevents the activation of the fast
Na+ channel, INa. As a result, the large Na
+ inux in phase 0 of the action
potential and consequently the large accumulation of [Na+]i during rapid pacing,
is prevented. It has been demonstrated in gure 5.4b that the slow decrease in
APD90 and progressive increase of [Ca
2+]i is abolished when [Na
+]i is buered.
The application of TTX to the Benson et al. (2008) canine model paced at 2:5Hz
reduces the slow rise of [Na+]i (gure 5.5b(iii)) to 25 per cent of the control rise
(gure 5.5a(iii)), with an increase of 0:5mM compared to 2mM. The reduction
in [Na+]i leads to a reduction in the slow decrease of APD90 (gure 5.5b(ii)) and
a dramatic attenuation of the slow progressive rise in [Ca2+]i (gure 5.5b(iv)).
Experimentally, strong agreement with the model simulations is obtained. Prior
to the application of TTX, intracellular Na+ activity, aiNa, (gure 5.5c(ii)) and
active force (gure 5.5c(iii)) rise progressively by 1mM and 50g respectively.
Following the application of TTX, both rises are signicantly decreased, with aiNa
increasing 0:2mM (gure 5.5d(i)) and active force increasing 5g (gure 5.5d(ii)).
5.3.6 Response to a step change in membrane potential
The response of the Benson et al. (2008) model to a step change in membrane
potential is illustrated in gure 5.6. Step changes in membrane potential isolate
membrane ionic and capacitive currents because (aside from the instant at which
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Figure 5.5: Eects of tetrodotoxin (TTX). Comparison of (i) membrane potential,
(ii) APD90, (iii) [Na
+]i and (iv) [Ca
2+]i for (a) control and (b) with a TTX
block of INa simulated with the Benson et al. (2008) model paced at 2:5Hz. (c):
Experimental recordings of (i) membrane potential, (ii) intracellular Na+ activity
and (iii) active force without application of TTX. (d): Experimental recordings
of (i) intracellular Na+ activity and (ii) active force with application of TTX.
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the step transition occurs) the rate of change of membrane potential, dV=dt is
zero, as therefore is the capacitive current (see equation (5.1)) and only ionic cur-
rent remains (Hille 2001, pp. 35). A succession of square wave pulses of duration
200ms with voltage step from  80 to 10mV are delivered at 2:5Hz for a duration
of 4min. The time course of the membrane potential illustrating the protocol for
a single pulse is illustrated in gure 5.6a(i). Control simulations indicate that
the Na+/K+ pump current, INaK, increases gradually in magnitude and becomes
increasingly outward as pacing persists - over the course of the pacing period,
pump current increases in magnitude by around 10 per cent (gure 5.6a(ii)). It
does not however change in morphology - closely following the membrane po-
tential. In contrast, with [Na+]i buered, the pump current remains constant in
both magnitude and morphology through the pacing period (gure 5.6b(ii)), as
the activity of the pump depends on both [Na+]i and [K
+]o, both of which remain
constant if [Na+]i is buered.
The behaviour of the Na+/Ca2+ exchanger current, INaCa, unveils the com-
plex dynamics of the exchanger as a result of the interplay between [Na+]i and
[Ca2+]i. The exchanger current switches instantaneously from an inward to an
outward current when the cell membrane is depolarized and reaches a maximum,
INaCa;max(p), for the pulse. However, it reduces in amplitude over the following
40ms until [Ca2+]i has risen suciently (primarily through the inux of Ca
2+
through ICaL), for the Na
+/Ca2+ exchanger to increase in function and transport
Ca2+ out of the cell. As a result, the exchanger current becoming increasingly
outward once again (gure 5.6a(iii)).
Subsequent pulses only increase the complexity of the behaviour - in particular
they alter the time course of the exchanger current during the pulse as the pacing
period progresses. Following the initial pulse, the second results in a relatively
modest decrease in INaCa after INaCa;max(p) before a similarly modest increase to
nish approximately 20 per cent higher than the initial pulse. As pacing contin-
ues, the decrease following INaCa;max(p) progressively becomes more pronounced,
approaching the decrease of the initial pulse, but the subsequent increase as the
end of each pulse approaches, progressively increases, eventually reaching an ap-
proximately 50 per cent increase compared to the initial pulse. This is a result
of the progressive increase of [Ca2+]i caused by the rapid pacing (gure 5.1a(iv))
which leads to an increase in exchanger pump activity.
Buering [Na+]i has already been shown to remove the progressive increase
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in [Ca2+]i (gure 5.4b(iv)), otherwise observed in rapidly paced cells (gure
5.4a(iv)). As a result, there is no overall increase in the exchanger current be-
tween the initial and nal pulse if [Na+]i is buered (gure 5.6b(iii)). However,
although [Na+]i is buered, [Ca
2+]i is not, and therefore consequently, the dynam-
ics of INaCa during the pulse do change with respect to the unbuered results.
In particular, the morphologies of the current traces remain similar, with a fast
decrease in current followed by slow rise to the end of the pulse, however the lat-
ter pulses have a more pronounced depression from INaCa;max(p) and subsequently
a slightly increased rate of increase in exchanger current to the cessation of the
pulse.
The L-type Ca2+ current, ICaL, activates rapidly upon depolarization of the
cell membrane and is responsible for a large inux of Ca2+ for a short period of
time (approximately 1ms), after which a small persistent inward current remains
throughout the duration of the square wave pulse (gure 5.6a(iv)). Subsequent
pulses result in a similar morphological response, although their magnitude is
markedly reduced (> 50 per cent reduction) as a result of the increased net
[Ca2+]i caused by rapid pacing. In contrast to INaK and INaCa, buering [Na
+]i
results in a negligible eect, if any at all, on both the magnitude and morphology
of ICaL (gure 5.6b(iv)).
5.3.7 Dependence of APD shortening on fCa
The dependence of APD shortening on the Ca2+-dependent inactivation of the L-
type Ca2+ channel, fCa, is illustrated in gure 5.7, based on simulations performed
using the Luo & Rudy (1994b) model paced at 2Hz and fCa reformulated as in
equation (5.2). The exponent controlling the dependence of fCa on [Ca
2+]i, , is
varied between 1:0 and 0:1, with  = 1:0 equivalent to the control model. From
equation (5.2), as  is decreased from 1:0 to 0:1, Ca2+-dependent inactivation
weakens and therefore ICaL becomes larger. The results in gure 5.7a are identical
to those in gure 5.4a and will not therefore be described here (see instead x5.3.4).
Decreasing  progressively from 1:0 to 0:1 (n.b. only  = 1:0 and  = 0:1 are
shown) results in a progressive reduction in APD90 shortening from APD90 =
48ms ( = 1:0: gure 5.7a(ii)) to APD90 = 36ms ( = 0:1: gure 5.7b(ii)).
Accompanying this reduction in APD90 shortening however, in contrast to either
the use of TTX (gure 5.5b), or the buering of [Na+]i (gure 5.4b), both of which
result in reductions of APD90 shortening, a reduction in  results in an increase
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in both [Na+]i (gure 5.7b(iii)) and [Ca
2+]i (gure 5.7b(iv)).
5.4 Discussion
5.4.1 Intracellular sodium accumulation is responsible for
slow changes in APD and contractility
It is clear when comparing gure 5.3a(i) with 5.3a(ii) and additionally gure
5.4a(ii) with 5.4b(ii), that the accumulation of intracellular Na+ during sustained
high frequency pacing has a marked eect on APD. Buering [Na+]i to a constant
level (gure 5.3a(ii)) restricts the downward displacement of the APD restitution
curves with increasing S1 stimulus frequency, a phenomenon normally observed
in the control case (gure 5.3a(i)), suggesting that the accumulation of [Na+]i
is responsible for the downward displacement, a nding supported by Boyett
& Jewell (1978). Sustained high frequency stimulation over a period of 4min
normally results in a slow progressive accumulation of [Na+]i accompanied by a
slow progressive decrease in APD (gure 5.4a). If [Na+]i is buered, the slow
decrease in APD is eliminated (gure 5.4b), although the initial sudden decrease
in APD observed in the control case and experimentally (Williams et al. 1999) is
still observed.
In addition to the slow decrease observed in APD, a similarly slow increase
in [Ca2+]i occurs with rapid pacing, observed physiologically as a slow increase
in tension force. Indeed, it is clear from gure 5.1a(v) that APD and [Ca2+]i
are approximately inversely proportional to each other, suggesting a common
underlying mechanism. The slow increase in [Ca2+]i can also be eradicated if
[Na+]i is buered to a constant (gure 5.4b(iv)). However, although it is not
clear in gure 5.4b(iv), an initial sudden increase in [Ca2+]i can still be observed
in conjunction with the initial rapid decrease in APD.
It has been proposed by Vila Petro et al. (2003) that a dissociation of [Na+]i
is responsible for the two phases of the positive inotropic eect observed in rapid
stimulation - one [Na+]i dependent process governing the slow progressive rise in
contractility; another responsible for the initial rapid contraction often observed.
The continuing presence of the initial rapid increase of [Ca2+]i and decrease in
APD following the buering of [Na+]i appears to support their conclusion of a
dual process mechanism.
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Incomplete Na+ extrusion occurs at high heart rates leading to the accumu-
lation of [Na+]i as rapid stimulation persists. The single greatest contribution
to [Na+]i is sourced through the fast Na
+ current, INa, through which a rapid
inux of Na+ occurs when the cell is depolarized. A complete block of INa signif-
icantly reduces the accumulation of [Na+]i by approximately 75 per cent (gure
5.5b(iii)) and as a consequence, the slow decrease of APD shortening is restricted
(gure 5.5b(ii)) and the treppe phenomenon observed in [Ca2+]i is almost en-
tirely prevented (gure 5.5b(iv)). It is noted that a complete block of INa is not
sucient to completely inhibit [Na+]i accumulation and therefore either entry of
Na+ through the reverse mode of the Na+/Ca2+ exchanger, or a reduction in Na+
extrusion via the forward mode of the exchanger, or extrusion via the Na+/K+
pump, must also contribute. Blocking either the exchanger (gure 5.4e) or the
pump (gure 5.4d) results in only minor changes to the increases in [Ca2+]i in
the treppe phenomenon and the slow decrease in APD. These results support the
ndings of Vila Petro et al. (2003) that neither the reverse nor forward mode of
the exchanger contributes signicantly to the increase in contractility.
5.4.2 Correspondence of modelling with experiment
It is essential that the models are capable of reproducing the observed physiolog-
ical responses reported experimentally in the treppe phenomenon if they are to
provide a sound basis for the underlying mechanisms of the phenomenon to be
uncovered through simulation based experiments. It should be remembered that
a number of the experimental preparations are not from guinea pig, canine or
human (see x5.2) and therefore quantitative (but not qualitative) discrepancies
between the models and experimental data are to be expected.
A variety of changes in action potential characteristics are known to occur
during high frequency repetitive activity (see Boyett & Jewell 1980, for a detailed
review). One such change observed experimentally is an asymptotic reduction in
the maximum membrane potential, Vmax, attained over the duration of an evoked
action potential (gure 5.1b(ii)). All the models reproduce this reduction in Vmax
over the range of frequencies tested (gures 5.1a(i), 5.4a(i) and 5.5a(i)).
A further change, and certainly the most prominent observed in the action
potential during repetitive activity, occurs with the APD. As pacing persists,
APD continually decreases with each successive stimulation (gure 5.2a). The
decrease in APD is nonlinear, with greater decreases observed in the early stages
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of pacing and much smaller successive decreases in APD as pacing persists (g-
ure 5.1b(iii)). The models all reproduce the nonlinear decrease in APD (gures
5.1a(ii), 5.4a(ii) and 5.5a(ii)), although the total reduction in APD over identical
time periods of pacing periods varies between models.
APD is known to be rate dependent (Boyett & Fedida 1984; Boyett & Jewell
1978). Experimentally, faster pacing rates cause a depression and `leftwards' shift
of the restitution curve (gure 5.3b). The models reproduce the depression of the
restitution curve, however they fail to reproduce the shift of the curve to the left
(gure 5.3a(i)).
Increased frequency of sustained repetitive activity is known to result in an
increase in [Na+]i (Boyett et al. 1987b; Harrison & Boyett 1995; Harrison et al.
1992). Accumulation of [Na+]i has already been demonstrated by Faber & Rudy
(2000) to play an important role in APD shortening at high heart rates and it
is therefore an important phenomenon the models should be able to reproduce
(n.b. it should be noted that the Luo & Rudy (1994b) guinea pig model was used
by Faber & Rudy (2000) in their investigation and therefore [Na+]i accumulation
in that model has already been documented). The models all conrmed a slow
accumulation of [Na+]i at high pacing rates, with increases of approximately
2 4mM over 4min of sustained activity (gures 5.1a(iii), 5.4a(iii) and 5.5a(iii)).
A commonly observed experimental phenomenon - described as the negative
inotropic eect of activation by Blinks & Koch-Weser (1961) - is an abrupt de-
crease in the force recorded for the second stimulation with respect to the initial
one following a period of rest, or in the rst stimulation following an increase in
stimulation rate (e.g. Boyett et al. 1987b; Boyett & Jewell 1978). The models all
reproduce this behaviour to some extent, with the canine ventricular model of
Benson et al. (2008) illustrating the phenomenon most clearly in gure 5.5a(iv).
A quantication of the underlying decrease in [Ca2+]i recorded in the Noble &
Noble (2001) guinea pig ventricular model in gure 5.1a(v) demonstrates an ap-
proximately 0:1M decrease in [Ca2+]i between the rst and second stimulation,
signicantly greater than any subsequent changes in [Ca2+]i between stimulations.
In addition to the negative inotropic eect of activation, Blinks & Koch-Weser
(1961) dened the positive inotropic eect of activation as a progressive increase
in force following an increase in rate, i.e. a tension staircase - a phenomenon which
is well documented experimentally (Boyett et al. 1987b; Chapman & Niedergerke
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1970a,b; Fedida et al. 1987). Although none of the models are capable of simu-
lating tension without rst extending them, Allen & Blinks (1978) have demon-
strated that changes in peak tension follow the underlying [Ca2+]i transient and
can thereby serve as an indirect indicator of each other (Boyett 1978). In all the
models, a slow progressive rise in [Ca2+]i during rapid pacing is observed over
the course of 4min, asymptotically approaching a concentration approximately
double that recorded in the initial stages of pacing (gures 5.1a(iv), 5.4a(iv) and
5.5a(iv)) and in agreement with experimental observations of peak tension (gure
5.1b(i)). Furthermore, an inverse linear relationship between APD and peak ten-
sion is observed experimentally (gure 5.1b(vi)) - a relationship which is closely
mirrored in the models between APD and peak [Ca2+]i (gure 5.1a(v)).
The reproduction of a wide variety of observed experimental phenomena re-
ported during repetitive activity by the range of models chosen ensures a sucient
level of condence in the models that they form a sound basis for subsequent sim-
ulations carried out using them.
5.4.3 Accumulation of intracellular sodium and the sup-
pression of pacemaker activity
In addition to the primary pacemaker - the SA node - the heart has subsidiary
pacemakers, namely the atrio-ventricular (AV) node and the Purkinje bres,
whose activity is normally suppressed by the higher frequency sinus rhythm of
the SA node. The function of the subsidiary pacemakers is to assume the role of
pacemaker in an eort to maintain the rhythmic contraction of the heart during
abnormal circumstances in which the primary pacemaker fails to initiate periodic
APs. The SA node has a higher frequency sinus rhythm than the subsidiary
pacemakers and initiates AP propagation through the cardiac conduction system
before the subsidiary pacemakers depolarize naturally. However, the cessation of
the primary pacemaker does not result in an instantaneous assumption of pace-
maker by one of the subsidiaries. A period of quiescence is instead maintained be-
fore the subsidiary pacemaker begins to discharge automatically - a phenomenon
known as overdrive suppression (Boyett & Fedida 1984; Valenzuela & Vassalle
1983; Vassalle 1970, 1977). The physiological importance of overdrive suppres-
sion is that it acts as a protective mechanism against `accidental' spontaneous
activity of the subsidiary pacemakers, which could otherwise result in chaotic,
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Figure 5.8: Overdrive suppression in cardiac Purkinje bres. (a): Experimen-
tal recordings of membrane potential in an autorhythmic Purkinje bre, rapidly
paced at 150 beats per minute for 180 s and then left unperturbed. (b): Simulated
recordings of (i) membrane potential, (ii) [Na+]i and (iii) [Ca
2+]i using the same
protocol in the newly developed human Purkinje bre model.
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discordant cardiac activity and impairment of cardiac function.
It was proposed by Vassalle (1970) that an elevation of intracellular Na+ ac-
tivity, aiNa, is responsible for the hyperpolarization of the membrane potential and
suppression of pacemaker activity following repetitive stimulation. The duration
of the quiescent period is determined by the `overdrive' pacing frequency - higher
frequency stimulation is shown to increase the period of quiescence (Boyett &
Fedida 1984). Using the recently developed model of the human Purkinje bre
cell (Chapter 3; Stewart et al. 2009), it is possible to investigate the mechanisms
underlying overdrive suppression. Imitating an experimental protocol, follow-
ing a 100 s period in which no external stimulus is applied, a series of periodic
suprathreshold stimuli of amplitude  52 pApF 1 and duration 1ms are applied
at a frequency of 2:5Hz for 10min, after which no further external stimulus is
applied. Following the cessation of overdrive pacing, a period of quiescence occurs
before automaticity resumes in both the experiment (gure 5.8a) and the model
(gure 5.8b(i)). It has already been shown that an slow increase in [Na+]i occurs
during rapid stimulation and indeed an approximately 4mM increase in [Na+]i is
observed in the model over the pacing period (gure 5.8b(ii)), as is a slow pro-
gressive rise in [Ca2+]i (gure 5.8b(iii)). In support of the hypothesis of Vassalle
(1970), the suppression of the pacemaker activity continues post-stimulation until
[Na+]i has reduced suciently back to its base level for automaticity to resume
(gure 5.8b(ii)).
Chapter 6
Optimal velocity and safety of
discontinuous conduction
through the heterogeneous
Purkinje-ventricular junction
6.1 Introduction
The propagation of electrical excitation waves, i.e. action potentials (APs), is the
basis for rapid signal transmission which triggers the synchronized contraction
of the heart (Tyson & Keener 1988; Zipes & Jalife 2004). In the maintenance
of normal cardiac function, APs must be rapidly and safely conducted through
the whole conduction pathway of the heart, consisting of both simple cable-like
structures and complex heterogeneous tissues that are often formed by cells with
varying morphology, electrical excitability, and intercellular coupling. AP con-
duction velocity is determined primarily by the latter two factors (Shaw & Rudy
1997), but is also inuenced by the presence of structural heterogeneities within
the tissue (Cole et al. 1988; Goldstein & Rall 1974; Joyner et al. 1984; Kucera et al.
1998; Kucera & Rudy 2001). Structural heterogeneities can create a local electri-
cal source-to-load mismatch (Xie et al. 2010) - an imbalance between the current
provided by a smaller mass of tissue (source) and the current necessary to bring to
threshold an adjacent larger mass of tissue (load). Source-to-load mismatch can
n.b. Portions of this chapter appear in Aslanidi et al. (2009, 2010b).
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induce a local slowing of conduction, or even conduction failure (Cole et al. 1988;
Goldstein & Rall 1974; Joyner et al. 1984; Kucera et al. 1998; Kucera & Rudy
2001; Mendez et al. 1970; Overholt et al. 1984; Veenstra et al. 1984; Wiedmann
et al. 1996). Hence, along with reduced excitability and reduced intercellular
coupling, source-to-load mismatch at junctions between dierent cardiac tissues
can contribute to slow, discontinuous, and potentially unsafe AP conduction in
the heart.
The Purkinje-ventricular junction (PVJ) is a typical cardiac junction with
structural and electrophysiological heterogeneities, where source-to-load mismatch
and discontinuous conduction can occur. Ordinarily, APs conducted from the
thin Purkinje bres (PFs) into the large mass of the ventricles determine the
electrical activation and contraction sequence in the heart. However, slow and
discontinuous conduction through the heterogeneous PVJ can be arrhythmogenic.
Primarily, discontinuities in the AP conduction velocity, commonly manifested
experimentally as conduction time delays at the PVJ (Gilmour &Watanabe 1994;
Mendez et al. 1970; Overholt et al. 1984; Tranum-Jensen et al. 1991; Veenstra
et al. 1984; Wiedmann et al. 1996), have long been considered indicative of unsafe
conduction leading to possible conduction blocks (Mendez et al. 1970; Overholt
et al. 1984; Veenstra et al. 1984; Wiedmann et al. 1996) or re-entry (Gilmour &
Watanabe 1994). Slow AP conduction and associated time delays have also been
linked as arrhythmogenic substrates in other (healthy or infarcted) cardiac tissues
(de Bakker et al. 1993; Dillon et al. 1988; Fox et al. 2002b; Kucera et al. 1998).
However, other experimental studies have provided evidence for greater safety
with slow conduction (Spach et al. 1981) - under certain conditions, the safety
factor may increase with slow conduction instead of decreasing. A modelling
study with one-dimensional cardiac tissue (Shaw & Rudy 1997) has suggested
that the dependence of the safety factor on conduction velocity can be bipha-
sic within the same system, where safety sharply decreases only at very slow
velocities. However, precise relationships between tissue heterogeneities (both
structural and functional), the AP conduction velocity, and measures of the risks
of conduction failure remain unclear.
The aim of this study is therefore to determine such relationships using a de-
tailed computer model of AP conduction through the PVJ that accounts for both
electrophysiological and morphological dierences between PFs and the ventricles.
A two-dimensional (2D) tissue model of the canine PVJ is developed based on
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a simplication of an earlier diusion-tensor magnetic resonance imaging (MRI)
reconstruction (Benson et al. 2008), which incorporates details of the transmural
AP heterogeneity and tissue geometry of the canine left ventricular free wall. The
ventricular wedge is completed with a single PF entering from the endocardium.
The resultant model is used to study the relationships between the tissue hetero-
geneity, the AP conduction velocity, and the safety factor (Shaw & Rudy 1997)
at the PVJ.
6.2 Methods
The dynamics of electrical waves in cardiac tissue can be described by the reaction-
diusion-type non-linear partial dierential equation (6.1), where V [mV] is the
transmembrane potential, t [s] is time, andr is a spatial gradient operator dened
within the tissue geometry. D [mm2ms 1] is a diusion coecient characterizing
electrotonic intercellular spread of voltage via gap junctional coupling, Cm [pF] is
the cell membrane capacitance, and Iion [pA] is the total membrane ionic current
(Benson et al. 2008; Panlov & Keener 1995).
@V
@t
= Dr2V   Iion
Cm
(6.1)
A biophysically detailed model has been developed previously to describe the
voltage and time dependent current Iion, and hence cell-specic AP properties,
in the canine ventricle (Benson et al. 2008). In chapter 4, a model of the canine
Purkinje bre is described (see also Aslanidi et al. 2009) to complement the
ventricular model of Benson et al. (2008).
6.2.1 2D slice model
A simple 2D model of the PVJ is also developed, with a PF strand connected to
a 2D caricature of a transmural slice of ventricular tissue incorporating realistic
dimensions and couplings. Note that such a model provides a feasible description
for the transmural AP propagation (Benson et al. 2008). Geometry of the 2D
model is illustrated in gure 6.1a. Dimensions of the tissue are varied along the
horizontal spatial coordinate, x, with the vertical width of the PF, d1, smaller than
the width of the ventricular slab, d2 (Overholt et al. 1984; Tranum-Jensen et al.
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Figure 6.1: Properties of the two-dimensional slice model of the PVJ. (a) Geome-
try of the PVJ: a single PF (left) runs perpendicular to, and enters the endocardial
surface a slab of ventricular tissue (right) composed of endocardial, midmyocar-
dial and epicardial layers. The width of the PF, d1, is much smaller than the
width of the ventricular slab, d2. Insets: AP morphologies of the PF (left) and
ventricular cells (right). Horizontal arrow denotes direction of AP propagation
from free running end of PF. (b) AP conduction time delay, T , at the PVJ (solid
line), overlaid with the non-uniform diusion coecient, D, (dashed line) along
the horizontal spatial co-ordinate, x. As in experiments, T is measured over
a distance of 2mm along the x-direction. (c) Time delay between APs recorded
from the PF and ventricular tissues 2mm apart across the PVJ.
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1991). The thickness of the ventricular tissue is 17:5mm, with endocardial, mid-
myocardial and epicardial regions occupying one third each (Benson et al. 2008).
The diusion coecient, D, is also dened as a spatially non-uniform function of
x (gure 6.1b), with a greater value in the PF than in ventricular tissue, D1 > D2
(Joyner & Overholt 1985). In control simulations, parameter values are set at
d1 = 0:7mm, d2 = 17:5mm, D1 = 0:8mm
2ms 1, and D2 = 0:2mm2ms 1. The
control model produces AP conduction velocities of 1:8m s 1 and 0:5m s 1 in
the PF and ventricular tissues, respectively, as observed experimentally (Joyner
& Overholt 1985; Kanter et al. 1993). As the coupling decreases and the tis-
sue dimension increases between the PF and the ventricle, the AP conduction
through the PVJ becomes discontinuous, with a time delay, T , of up to ap-
proximately 7:5ms (gure 6.1c), as observed in experiments (Joyner & Overholt
1985; Overholt et al. 1984). It is important to note that the discontinuity is due
to the natural non-uniformity of the PVJ and does not require a specic resistive
barrier (Joyner et al. 1984; Tranum-Jensen et al. 1991).
The model was integrated using the forward Euler method, with spatial reso-
lution of 0:175mm and time step 0:01ms. For computational simplicity, no-ux
boundary conditions were implemented at the tissue edges.
6.2.2 Safety factor
Safety factor (SF) is a simple, putative index of the robustness of conduction in
cardiac tissues (Delgado et al. 1990; Romero et al. 2005; Shaw & Rudy 1997). It
is dened as the ratio of charge generated to charge consumed by a cell during
its excitation. Successful conduction is indicated if SF > 1, with the fraction > 1
representing the margin of safety. When SF is close to 1, conduction in critical,
and when SF < 1, propagation is likely to fail. Following Romero et al. (2005),
equation (6.2) is used to calculate SF at any given point in the tissue.
SF =
R
A
Icdt+
R
A
IoutdtR
A
Iindt
;A j t 2 [t1%; tVmax ] (6.2)
Here, Ic is the capacitive current of the cell, Iout is the intercellular current
that ows from the cell to its downstream neighbour, and Iin is the intercellular
current that ows into the cell from its upstream neighbour. The domain of
integration, A, is dened as the period elapsed from the time at which _V at the
AP wave-front reaches 1 per cent of its maximum, to the time at which V reaches
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its maximum, Vmax (Romero et al. 2005). Note that Ic = @V=@t, Iin =  DrV ,
and Iout =  DrV+ (with all currents normalized by the membrane capacitance,
Cm). Note also that the surface to volume term which precedes D has been
omitted from these generalizations.
6.3 Results
Simulations with the 2D slice model are carried to establish relationships be-
tween parameters of the tissue heterogeneity (specically dimensions, d, and the
diusion coecient, D) and the AP conduction velocity and safety factor at the
PVJ.
6.3.1 2D slice simulations
As described previously, parameters d1 < d2 and D1 > D2 are adjusted to experi-
mentally validated values, which reproduce experimentally observed AP conduc-
tion velocities in the PF and ventricular tissues. Under such physiological condi-
tions, AP conduction through the morphologically and electrically non-uniform
PVJ is discontinuous, with a sharp increase in the conduction time delay, T ,
measured over 2mm along the x-direction. When both morphological and inter-
cellular coupling heterogeneities are considered, the maximum measured T is
approximately 7:5ms at the PVJ (gure 6.1b), consistent with experimental mea-
surements of 3{10ms (Gilmour & Watanabe 1994; Mendez et al. 1970; Overholt
et al. 1984; Tranum-Jensen et al. 1991; Veenstra et al. 1984; Wiedmann et al.
1996). If heterogeneity in the tissue dimensions is considered alone (d1 < d2,
D1 = D2), the maximum time delay, T , at the PVJ is approximately 4ms (g-
ure 6.2a). When heterogeneity in the intercellular coupling is considered alone
(d1 = d2, D1 > D2), T is approximately 4:5ms (gure 6.2a). Without non-
uniformities in the tissue dimensions or coupling, AP conduction is continuous
(i.e. no signicant time delay is observed), even though the electrophysiological
properties of the PF and ventricular cells are dierent.
As T increases, the AP conduction velocity at the PVJ, v, decreases from ap-
proximately 1:3m s 1 in the uniform tissue (d1 = d2, D1 > D2) to approximately
0:2m s 1 in the tissue with non-uniformity in both d and D (gure 6.2b). Note
that local velocity decreases at non-uniform tissue junctions has been explained
by mismatches between the electrical current source and load (Cole et al. 1988;
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Figure 6.2: Discontinuous AP conduction through the PVJ, represented by (a)
conduction time delay, T , and (b) conduction velocity, v. Plots illustrate proles
of T and v along the horizontal spatial co-ordinate, x. Four cases are illustrated:
the PVJ with non-uniformities in both tissue geometry and diusion coecient
(d1 < d2; D1 > D2); tissue with a non-uniform diusion coecient (d1 = d2; D1 >
D2).; tissue with a non-uniform geometry (d1 < d2; D1 = D2); and tissue where
both geometry and diusion coecient are uniform (d1 = d2; D1 = D2).
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Goldstein & Rall 1974; Joyner et al. 1984; Kucera et al. 1998; Kucera & Rudy
2001), and are generally considered pro-arrhythmogenic (Gilmour & Watanabe
1994; Kucera et al. 1998; Mendez et al. 1970; Overholt et al. 1984; Veenstra
et al. 1984; Wiedmann et al. 1996), although precise relationships between the
conduction velocity and safety have not yet been established.
The AP conduction through the PVJ and the associated SF are shown in
gure 6.3. Under physiological conditions (as dened previously), the conduction
delay results in a local increase in the SF around the PVJ, which can be explained
by an accumulation of charge at the PVJ due to the source-to-load mismatch.
Qualitative relationships between the SF and the conduction velocity through the
PVJ, v, arising under variations of the tissue heterogeneity parameters are herein
described.
Changes in velocity, v, can be achieved by varying either the width, d1, or the
diusion coecient D1 of the PF strand (gure 6.4). Paradoxically, variations
(primarily decreases) in d1, which decrease v at the same time, can increase SF,
suggesting that slower conduction through the PVJ corresponds to higher safety
(gure 6.4a). However, SF does not increase monotonically: as d1 is decreased
to less than approximately 1mm, SF begins to decrease, until it eventually drops
below 1 and the AP conduction through the PVJ fails. Hence, the dependence
of SF on d1 has a maximum at d1 = d

1  1mm, where d1 can be considered
as an optimal width of the PF for the conditions chosen. Note that PF bundles
dissected from canine hearts can be 0.5{2:0mm in diameter (Christini et al. 2006;
Vassalle & Lee 1984). As v monotonically increases with d1, the dependence of
SF on v also has a maximum at v = v  0:3m s 1 (gure 6.4c), where v can
be considered to be an optimal velocity providing maximum safety of conduction
through the PVJ.
The dependence of SF on D1 also exhibits a clear maximum at D1 = D

1 
0:6mm2ms 1 (gure 6.4b), and the respective dependence of SF on v in this case
has a maximum at v = v  0:3m s 1 (gure 6.4c). Note that v in the simulation
is measured at the PVJ and as such is dependent on the gradient between D1
and D2, rather than on either of the two diusion coecients. Therefore, the
simple relationship v  pD (Tyson & Keener 1988) valid for a uniform diusion
coecient, D, does not apply in this case, and v decreases as D1 is increased
(gure 6.4b). Note also that the dependence of SF on v has a maximum in the
tissue with only one non-uniform parameter (d1 = d2, D1 > D2), at the optimal
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Figure 6.3: AP conduction in the 2D model of the PVJ, showing (a) spatial
distribution of the transmembrane potential, V , during successful AP conduction
from the PF into the ventricular tissue, and (b) the resultant distribution of SF.
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Figure 6.4: Relationships between non-uniformities of the PVJ, the AP conduc-
tion velocity, v, and the safety factor, SF. Dependence of SF and v on (a) width
of the PF, d1, and (b) the diusion coecient of the PF, D1. Both v and SF are
measured at the PVJ, where v reaches a local minimum. (c) Relationships be-
tween v and SF at the PVJ. Three cases are illustrated: v is changed by varying
d1; v is changed by varying D1 at the PVJ (d1 < d2); and v is changed by varying
D1 in a geometrically uniform tissue (d1 = d2). In all three cases, the dependence
of SF on v has a maximum.
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velocity v = v  0:45m s 1 (gure 6.4c). These results demonstrate that both
very fast and very slow conduction can be unsafe, whereas there is an optimal
conduction velocity that produces the maximum SF. Noteworthy that optimal
velocities of conduction through the PVJ, v, lie within the physiological range of
observed AP conduction velocities (Joyner & Overholt 1985; Kanter et al. 1993).
6.4 Discussion
A morphologically and electrophysiologically detailed model of the PVJ has been
developed to determine relationships between its heterogeneity parameters and
the velocity and safety of AP conduction through it. Simulations with the model
have demonstrated that when the tissue dimensions and the intercellular electri-
cal coupling at the PVJ are varied, neither very fast, nor very slow conduction
is safe, and there exists an optimal velocity which provides the maximum safety
factor for conduction through the junction. The respective conduction time delay
across the PVJ occurs as a natural consequence of the electrophysiological and
morphological dierences between the PF and ventricular tissue. Primarily, the
much larger ventricle imposes a large electrical load on the PF, which in combi-
nation with the disparity in electrotonic intercellular coupling leads to delays in
conduction through the junction. The conclusions which can be drawn from this
study and the ndings of Shaw & Rudy (1997) are:
1. A maximum SF in a uniform tissue (or a uniform continuous tissue model)
is not feasible.
2. Cardiac tissue is not intrinsically uniform, and hence, potentially always
has an optimal SF and an optimal conduction velocity.
3. The specic value of the optimal conduction velocity is dened by the nature
and scale of the underlying tissue heterogeneity.
6.4.1 Conduction time delay
The simulations, in line with results of earlier theoretical and experimental stud-
ies (Cole et al. 1988; Goldstein & Rall 1974; Joyner et al. 1984; Kucera et al.
1998; Kucera & Rudy 2001), show that the AP conduction time delay across the
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PVJ occurs as a natural consequence of the electrophysiological and morpholog-
ical dierences between the PF and ventricular tissue. At the ionic level, the
delay allows the cell to accumulate a large amount of charge, provided by the
membrane currents, before passing it through the PVJ for successful excitation
of the ventricular tissue. At the same time, the time delay enhances the source-
to-load mismatch at the PVJ over time. However, at optimal velocities, such
enhancement should be minimal, allowing safer conduction.
In accordance with equation (6.2), successful conduction requires that the
sum of integral currents produced (Iout) and stored (Ic) by a cell must equal or
exceed the current received from other cells (Iin). Structural non-uniformity, such
as changes in tissue dimensions or heterogeneities in gap junctional coupling, can
create an electrical imbalance between these currents and, hence, inuence the
conduction safety. Thus, an abrupt increase of the tissue dimensions at the PVJ
(d1 < d2) implies that a larger load imposed by the mass of ventricular tissue
decreases the current density of Iout in comparison to Iin. On the other hand, a
decrease in the intercellular coupling (D1 > D2) reduces electrical loading at the
PVJ and as a result, less current leaks into the ventricular tissue at any given
moment, and a larger fraction of the charge provided by the ionic current (Iion) is
stored by the cell. Long conduction time delays (gure 6.2a) allow more charge
to be stored and then passed through the PVJ over time. Hence, when both
non-uniformities are combined (d1 < d2, D1 > D2), source-to-load mismatch at
the PVJ coexists with an increase of the total stored/passed currents due to long
conduction time delays. The balance between these two processes determines
whether the SF increases or decreases when d1 or D1 are varied.
In a similar way, when the conduction velocity, v, at the PVJ is too low, the
resultant time delay is long enough for a substantial amount of capacitive charge
to be stored, but also long enough to enhance the mismatch between Iin and Iout
at the PVJ over time. When v is too high and the time delay is short, imbalance
between Iin and Iout is not enhanced, but cells at the PVJ cannot accumulate
sucient charge at their capacity. Thus, in both cases the conduction is unsafe,
and there must be an optimal conduction velocity and an optimal time delay
sucient for the tissue to accumulate and pass through the PVJ substantial
charge, but not long enough to let the mismatch between Iin and Iout at the
junction to be substantially enhanced over time.
Note that the L-type Ca2+ current, ICa;L, has been identied as the major
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inward current sustaining discontinuous AP conduction (Joyner et al. 1996; Rohr
& Kucera 1997; Shaw & Rudy 1997; Wagner et al. 2000). Hence, the conduction
time delay, T , may be essential in providing enough time for ICa;L to become
activated. At the same time, ICa;L produces signicant eects in the membrane
potential and the intracellular Ca2+ concentration (Wagner et al. 2000) and hence
may alter AP conduction properties, primarily T , at the PVJ. Finding detailed
ionic mechanisms of the feedback between ICa;L and T at the PVJ presents an
interesting challenge for a separate study, but is beyond the scope of this work.
6.4.2 Optimal velocity
The simulations show the existence of an optimal velocity which provides the max-
imum conduction safety through the heterogeneous PVJ (gure 6.4). Simulations
with a uniform one-dimensional cardiac tissue (Shaw & Rudy 1997) suggest that
the dependence of SF on the conduction velocity can also have a maximum at very
slow velocities. Primarily, SF monotonically increases when a uniform diusion
coecient, D, in a one-dimensional tissue is decreased to very low values, and
drops abruptly only as D approaches zero and the conduction velocity, v  pD,
reaches a unphysiologically low value of approximately 0:02m s 1 (Shaw & Rudy
1997). However, the following simple theoretical analysis demonstrates that such
a maximum in a uniform tissue (not necessarily cardiac) is not feasible, and hence
can represent an artefact of numerical approximation.
If, over the range of values of D used in the simulations, action potential
amplitude (calculated from the capacitive current during the upstroke) is assumed
to be approximately constant, as Ic = @V=@t, Iin =  DrV  and Iout =  DrV+
(where rV  and rV+ are voltage gradients between a cell and its upstream
and downstream neighbours, respectively, and all currents are normalized by the
membrane capacitance, Cm), equation (6.2) can be rewritten as:
SF =
R
A
dV  D R
A
rV+dt
 D R
A
rV V dt (6.3)
=
a+ bD
cD
(6.4)
where a > 0 corresponds to the positive AP amplitude, b > 0 and c > 0 are
positive integrals at the wave-front, where V   V  V+, and both gradients,
rV   (V   V )=x and rV+  (V+   V )=x, are always negative. From
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equation (6.4), it is clear that SF ! 1 when D ! 0, and the derivative
@SF=@D =  a=cD2 < 0 is negative for all values D > 0; hence, SF(D) is a
monotonically decreasing function. Only at a singular point, D = 0, cells in the
tissue are not connected to each other, AP conduction fails (v = 0 and SF < 1).
Thus, SF(D) in a uniform tissue cannot have a maximum at small, but non-
zero, values of D (and hence, v  pD). The present simulations of a uniform
one-dimensional ventricular strand corroborate this: the maximum in the SF(D)
dependence progressively shifts towards innity when the space step of numerical
integration, x, is decreased, and completely disappears for x < 0:003mm;
SF(D) calculated with smaller x is monotonic (not shown).
6.4.3 Limitations
Limitations of cardiac cell and tissue models are well documented (Benson et al.
2008; Zipes & Jalife 2004). Note that idealistically, in the 2D tissue model, the PF
is considered to run perpendicular to the endocardial surface of the left ventricular
wall, whereas spatial interactions between PFs and ventricular tissue in vivo can
be complex (Tranum-Jensen et al. 1991).
Continuous models are not the best idealization of cardiac tissue, as discrep-
ancies between continuous models and more accurate discontinuous models (e.g.
in the AP conduction velocity and maximum upstroke velocity) at weak inter-
cellular coupling can be substantial (Henriquez & Plonsey 1987; Keener 1990;
Rudy & Quan 1987). However, at normal or even moderately low values of the
intercellular coupling, the macroscopic behaviour of the discontinuous cardiac
tissue can be described using the continuous cable approximation (Henriquez &
Plonsey 1987; Rudy & Quan 1987). Hence, although models that account for
subcellular heterogeneities - such as the one-dimensional strand model used by
Shaw & Rudy (1997) - provide a high degree of biological accuracy for a wide
range of the intercellular coupling values, larger scale multi-dimensional simula-
tions of cardiac tissue often rely on uniform reaction-diusion mono- or bidomain
models (Benson et al. 2008; Vigmond et al. 2009) in order to remain computa-
tionally ecient. Importantly, macro-scale heterogeneities and anisotropy can
be incorporated into such models. Thus, to maintain a balance between biolog-
ical accuracy and computational eciency a macroscopically heterogeneous and
anisotropic reaction-diusion model is used for the two-dimensional ventricular
sheet.
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6.4.4 Application to other tissues
Equation (6.1) belongs to a broad class of non-linear reaction-diusion equations
that describe wave propagation in many excitable biological systems (Tyson &
Keener 1988), where phenomena similar to those described in this study can
exist. For example, discontinuous propagation through non-uniform junctions
has been demonstrated in branching bres of the atrioventricular node (Kucera
et al. 1998), infarcted ventricular tissues (de Bakker et al. 1993; Dillon et al. 1988),
and neural dendritic trees (Vetter et al. 2001), and has also been associated with
breakdown of propagating wave-fronts during the development of atrial brillation
(Ong et al. 1995). Finding simple phenomenological relationships between the
wave velocity and conduction safety indicators can provide new theoretical and
practical insights into optimal conditions for wave propagation in such complex
heterogeneous systems.
Chapter 7
Pharmacological eects at the
Purkinje-ventricular junction
7.1 Introduction
Fast action potential (AP) conduction through the Purkinje bres (PFs) en-
sures the synchronized contraction of the ventricles. However, discontinuous AP
conduction through the morphologically disparate Purkinje-ventricular junction
(PVJ) is potentially unsafe (Chapter 6; Aslanidi et al. 2009) and could lead to
conduction block (Mendez et al. 1970; Overholt et al. 1984; Veenstra et al. 1984;
Wiedmann et al. 1996) or re-entry (Gilmour &Watanabe 1994). In addition, ionic
heterogeneities between the PFs and ventricular tissue (Chapter 3, 4; Aslanidi
et al. 2009; Stewart et al. 2009) provide a substrate for non-uniform repolariza-
tion of the tissue with potentially pro-arrhythmic consequences (Benson et al.
2008). Non-uniform prolongation of the AP by pharmacological action can fur-
ther enhance the dispersion of repolarization (Zhang et al. 2009), which could lead
to conduction block of the following excitation wave-front (primarily, at narrow
junctions such as the PVJ) and the cessation of normal synchronized ventricular
contraction (Tyson & Keener 1988; Zipes & Jalife 2004).
Signicant regional dispersion in action potential duration (APD) and repolar-
ization are also known to enhance the vulnerability of cardiac tissue to re-entrant
arrhythmias (Antzelevitch et al. 1999b; Kirchhof et al. 1996). Such naturally
occurring APD dispersion through the ventricular wall is well documented (Akar
et al. 2002; Nabauer et al. 1996), with signicant dierences in APD recorded
n.b. Portions of this chapter appear in Aslanidi et al. (2009).
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between endocardial, midmyocardial and epicardial cell types. Electrophysio-
logically, the primary eect of class III anti-arrhythmic drugs (e.g. amiodarone;
d-sotalol) is a prolongation of the action potential (Weirich & Antoni 1998). A
number of studies have demonstrated that some class III anti-arrhythmic drugs
(e.g. d-sotalol) enhance APD dispersion in ventricular tissue (Akar et al. 2002;
Hohnloser & Singh 1995; Huikuri et al. 2001; Lazzara 1989; Nguyen et al. 1986)
and could therefore also have a pro-arrhythmic eect. In contrast, amiodarone
decreases APD dispersion (Drouin et al. 1998; Sicouri et al. 1997) and would there-
fore pose a lesser risk of complications from pro-arrhythmic side-eects. Simula-
tion studies by Benson et al. (2008) demonstrate that the application of d-sotalol
increases the vulnerable window of the tissue to unidirectional conduction block,
which may lead to the initiation of re-entry through extrasystole or rapid pacing
(Qu et al. 2006). Furthermore, they demonstrate a decrease in the vulnerable
window in the tissue with the application of amiodarone. However, simulation of
the eects of pharmacological agents on safety of conduction into the ventricles
through the PVJ has hitherto not been studied and could provide further insights
into the potentially pro-arrhythmic side-eects of class III anti-arrhythmic drugs.
Here, a three-dimensional (3D) wedge model of the canine PVJ is developed
based on an earlier diusion tensor magnetic resonance imaging (MRI) recon-
struction (Benson et al. 2008), which incorporates details of the transmural AP
heterogeneity, tissue geometry, and bre orientation of the canine left ventricular
free wall. The ventricular wedge is completed with a single PF entering from the
endocardium. Complementary relationships between D1, the diusion coecient
in the PF; v, the conduction velocity through the PVJ; and SF, the safety factor
of conduction are established and compared to the 2D relationships previously
established in Chapter 6. Pharmacological eects on conduction through the
PVJ are studied including the class III anti-arrhythmic drugs, amiodarone and
d-sotalol, and putative drugs selectively blocking inward (ICa;L and INa;L) and
repolarizing (IKr and IKs) currents.
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7.2 Methods
The dynamics of electrical waves in cardiac tissue can be described by the reaction-
diusion-type non-linear partial dierential equation:
@V
@t
= r DrV   Iion
Cm
(7.1)
where V [mV] is the transmembrane potential, t [s] is time, and r is a spatial
gradient operator dened within the tissue geometry. D [mm2ms 1] is a tensor
of diusion coecients characterizing electrotonic intercellular spread of voltage
via gap junctional coupling, Cm [pF] is the cell membrane capacitance, and Iion
[pA] is the total membrane ionic current (Benson et al. 2008; Panlov & Keener
1995).
7.2.1 3D wedge model
Ventricular (Benson et al. 2008) and PF (Chapter 4; Aslanidi et al. 2009) sin-
gle cell models are incorporated into a 3D tissue model describing the detailed
anatomical structure of the canine ventricles (Benson et al. 2008). The 3D ven-
tricular wedge geometry is dened by a regular Cartesian grid of 50  50  50
`cells' with a spatial resolution of 0:35mm. Each `cell' carries an identication
ag indicating whether it belongs to the endocardial, midmyocardial, or epicar-
dial layer (Benson et al. 2008). A caricature of a single PF strand with a length
of 50 `cells' enters the wedge perpendicular to the endocardial surface. Values of
the diusion coecient characterizing electrotonic coupling along and transverse
to ventricular bres, Dk = 0:60mm2ms 1 and D? = 0:15mm2ms 1, are cho-
sen to reproduce experimentally observed anisotropic AP conduction velocities
in the canine ventricle (Benson et al. 2008). The value of the diusion coecient
characterizing electrotonic coupling along the quasi-one-dimensional PF strand
is chosen to produce an experimentally observed conduction velocity of approxi-
mately 1:8m s 1 (Joyner & Overholt 1985). Combinations of the bre orientation
vectors and diusion coecients determine the components of the tensor D at
each grid point (Panlov & Keener 1995).
Equation (7.1) is solved on the geometry grid using a nite-dierence partial
dierential equation (PDE) solver based on the explicit Euler method, with time
and space steps, t = 0:01ms and x = 0:35mm, respectively. Note that
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Figure 7.1: Pharmacological induced changes to the action potential. Plots of
membrane potential [mV] in PF, endocardial, midmyocardial and epicardial cells
recorded for the tenth AP in a train of APs elicited every 800ms. Changes
induced by the class III anti-arrhythmic drugs, amiodarone and d-sotalol, and
putative drugs blocking 50 per cent of IKr, IKs, ICa;L and INa;L (black lines) are
compared to the control APs (black lines in top row and underlaid grey lines
elsewhere). Dashed line identies 0mV.
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the space step of 0:35mm corresponds to the spatial resolution of the diusion
tensor magnetic resonance imaging (MRI) data on which the canine ventricular
geometry has been based; the geometry has been successfully used previously to
simulate transmural propagation in the canine ventricles (Benson et al. 2008).
However, to test for possible eects of spatial resolution on simulation results,
the space step has also been reduced to 0:175mm through the introduction of
intermediate points between the existing grid points and linearly interpolating the
respective bre orientations. The tests nd that the results of simulations with
the rened model are in agreement with those using the original space step. The
computer code implementing the PDE solver has been parallelized using MPI and
executed on the Horace supercomputer (Manchester, UK). A single simulation
of 1 s of activity on eight processors required approximately 45min. This high-
resolution model incorporating detailed tissue anatomy, bre orientation, and
electrical heterogeneity within the canine PVJ can therefore be used to investigate
behaviour at the junction in a reasonable time-frame.
7.2.2 Calculation of the electrocardiogram
An electrocardiogram (ECG) provides valuable information for the diagnosis and
treatment of cardiac electrophysiological disorders and resulting arrhythmias (No-
ble 1979, pp. 1{10). Signicant eort to establish mechanistic relationships be-
tween the ECG and underlying cellular processes has been undertaken to enable
the diagnosis of electrophysiological disorders using characteristics of the ECG
(e.g. Antzelevitch et al. 1999a; Gima & Rudy 2002; Shimizu & Antzelevitch 1999;
Yan & Antzelevitch 1998; Yan et al. 1998).
In the model, the ventricular component of the ECG (pseudo-ECG) is com-
puted at an electrode 2 cm from the epicardial surface of the wedge using:
 =
a2i
4e
Z
( rV ) 

r1
r

dxdydz (7.2)
where  is the unipolar potential recorded at the electrode, a is the radius of the
cell, i and e are the intra- and extra-cellular conductivities, V is the membrane
potential, and r = [(x   x0)2 + (y   y0)2 + (z   z0)2]1=2 is the distance from the
electrode (x0; y0; z0) to a source point (x; y; z) in the tissue (Plonsey & Barr 2007).
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7.2.3 Simulation of pharmacological agents
The electrophysiological eects of the class III anti-arrhythmic drugs, amiodarone
and d-sotalol, are simulated by altering the maximal conductance of specic chan-
nels, extending the methods of Benson et al. (2008) in order to reproduce the
reported changes in canine action potential characteristics. The resultant sin-
gle cell APs for the PF, endocardial, midmyocardial and epicardial cell types are
illustrated in gure 7.1 with control APs compared to `drugged' APs and are con-
sistent with experimental observations on the AP eects of the drugs (Gallagher
et al. 1989; Kodama et al. 1997a; Sicouri et al. 1997; Varro et al. 2000, 1988).
Specically, the application of 100M d-sotalol is modelled by scaling the control
maximal conductance of IKr to 20 per cent in PF cells, 50 per cent in endocar-
dial cells, 30 per cent in midmyocardial cells, and 80 per cent in epicardial cells.
Amiodarone applied at a dosage of 30{40mg kg 1 day 1 is modelled by scaling
the control maximal conductance of INa;L to 75 per cent in PF cells and 20 per
cent in midmyocardial cells and that of IKs to 20 per cent in endocardial cells and
70 per cent in epicardial cells. Additionally, putative pharmacological eects are
investigated with a 50 per cent block applied in turn to either IKr, IKs, ICa;L or
INa;L, all of which are known to aect the duration of the action potential. These
blocks are ideologically applied uniformly across cell types.
7.3 Results
Initially, simulations are carried out with the 3D model to establish `normal'
relationships with respect to conduction velocity and safety through the PVJ and
additionally the relationships are compared and contrasted to the 2D counterparts
in Chapter 6. Subsequently, simulations are carried out to ascertain the eects of
both putative and class III anti-arrhythmic drugs, on conduction velocity, safety,
APD90, APD dispersion and the ECG.
7.3.1 Safety of conduction in a 3D wedge
Stimulation applied to the free-running end of the PF bre results in AP con-
duction through the PVJ into the ventricular tissue (gure 7.2). As with the
2D slice model (Chapter 6), under physiological conditions (i.e. physiologically
relevant cellular AP properties and parameters d1 < d2; D1 > D2, adjusted to
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Figure 7.2: Propagation through the PVJ. Time series visualization of AP prop-
agation at 5ms intervals. Stimulation applied to the free-running end of the PF
results in AP conduction along the PF, through the PVJ and into the ventricular
tissue. Membrane potential is denoted by colour (see legend below sequence).
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Figure 7.3: AP conduction velocity and safety through the PVJ. (a) Spatial
distribution of the time delay, T , during successful AP conduction from the
PF into the ventricular wedge. (b) Resultant distribution of the SF. Spatial
distributions are colour coded according to the accompanying legends. Note
that the visible discontinuity of the 3D patterns is due to the anisotropy of the
ventricular tissue. (c) Dependence of v and SF on the diusion coecient of
the PF, D1. Both v and SF are measured at the PVJ, where v reaches a local
minimum. (d) Relationship between v and SF at the PVJ, showing that the
dependence of SF on v has a maximum.
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experimentally validated values, which reproduce experimentally observed AP
conduction velocities in the PF and ventricular tissues), conduction through the
PVJ is slowed, demonstrating a signicant time delay (gure 7.3a), a local de-
crease of the conduction velocity, v, and an increase of the SF at the PVJ (gure
7.3b). With variation of the diusion coecient of the PF strand, the relation-
ships between v and SF demonstrate similarity with those observed in 2D slices
(gure 6.4). Note that the varied parameter, D1, can be altered experimen-
tally, for example, through the application of gap junction blockers to the PF.
The dependence of SF on D1 is found to have a maximum at approximately
1:5mm2ms 1 (gure 7.3c), which is larger than in 2D slices due to the increased
electrical load imposed by the 3D mass of ventricular tissue. The corresponding
dependence of SF on v has a maximum at approximately 0:6m s 1 (gure 7.3d),
which also ts well into the range of experimentally observed AP conduction ve-
locities (Joyner & Overholt 1985; Kanter et al. 1993). Hence, results obtained
with the simple 2D slice model have been qualitatively validated and re-evaluated
using the morphologically detailed 3D model.
Note that the quantitative dierences between the 2D and 3D simulations
(gures 6.4 and 7.3 respectively) are due to dierent source-to-sink relations in
the two models, as the same set of parameters are used for both cases. Adding
a third dimension increases the mass of ventricular tissue - the sink - much more
substantially than the mass of the PF - the source - which leads to quantitative
(but not qualitative) dierences. Thus, an optimal conduction velocity exists
in both 2D and 3D, assuming values of approximately 0:3m s 1 and 0:6m s 1,
respectively. Both values are in the same order of magnitude and fall within the
experimentally reported range of conduction velocities through the PVJ (Joyner
& Overholt 1985; Kanter et al. 1993). The higher optimal velocity in 3D may be
explained by the fact that conduction into a large 3D mass of ventricular tissue
requires faster transfer of charge though the PVJ to maintain the same level of
safety as that in 2D slices.
7.3.2 Eects of class III anti-arrhythmic drugs
7.3.2.1 Amiodarone
The application of amiodarone to cardiac cells has a varied eect on APD de-
pending on the cell type: in PF and midmyocardial cells, APD is abbreviated,
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Figure 7.4: Eects of class III anti-arrhythmic drugs on (a) conduction velocity,
v, through the PVJ, (b) safety of conduction, SF, at the PVJ, (c) APD90 at
the PVJ, (d) QT interval of the ECG, (e) APD90 dispersion, APD90, along
the central axis of the PF through to the epicardial surface and (f) amplitude
of the T wave of the ECG. Bar height denotes measurements for control (ctrl),
amiodarone (amio) and d-sotalol (d-sot) simulations.
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however in endocardial and epicardial cells the converse is true, APD is prolonged
(gure 7.1), consistent with experimental observations with the drug (Gallagher
et al. 1989; Kodama et al. 1997a; Sicouri et al. 1997; Varro et al. 2000, 1988). In
the 3D model, APD90 at the PVJ increases from 276:4ms in control conditions
to 283:4ms when amiodarone is applied (gure 7.4c). Note that the increase
in APD observed at the junction is likely due to a prolongation of APD in the
substantially larger mass of the endocardium masking any abbreviation of APD
in PF cells. Complementing the increase in APD, a small increase in the QT
interval of the ECG is observed (gure 7.4d) from 251.2 to 252:8ms. The disper-
sion of the APD through the centre of the PF to the epicardial surface, APD90,
increases slightly in the presence of amiodarone (gure 7.4e), from 77 to 82ms,
leading to an increase of 22 per cent in the amplitude of the T wave in the ECG
(gure 7.4f). Amiodarone causes a slight slowing of conduction through the PVJ,
with v dropping from 0.4972 to 0:4955m s 1 (gure 7.4a), in addition to a small
decrease in safety of conduction at the junction, SF, from 1.055 to 1.038 (gure
7.4b). Note however, that since SF > 1 still holds, the conduction through the
junction is still considered `safe'.
7.3.2.2 d-sotalol
In contrast to amiodarone, the application of d-sotalol prolongs APD (albeit with
varying severity) in all four cell types (gure 7.1), somewhat unsurprisingly given
that d-sotalol inhibits IKr, one of the main repolarizing currents. At the junction,
in contrast to amiodarone, APD90 increases dramatically with the application of
d-sotalol (gure 7.4c), with an APD90 of 324:9ms, up from 276:4ms in control.
Consequently, a dramatic prolongation of the QT interval occurs (gure 7.4d),
increasing from 251.2 to 283:4ms. Similarly, a large increase in APD dispersion
occurs (gure 7.4e), with APD90 increasing from 77 to 102ms, resulting in an
increase of 61 percent in the ECG T wave amplitude (gure 7.4f). Conduction
velocity through the PVJ however, remains unchanged at 0:4972m s 1 (gure
7.4a) and SF increases only slightly from 1.055 to 1.058 (gure 7.4b).
7.3.3 Eects of putative outward current blockers
Inhibition of the outward, repolarization currents, IKr and IKs, causes a prolonga-
tion of the APD (gure 7.1). Indeed, inhibition of IKr by 50 per cent results in a
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Figure 7.5: Eects of putative drugs inhibiting outward, repolarization currents
on (a) conduction velocity, v, through the PVJ, (b) safety of conduction, SF, at the
PVJ, (c) APD90 at the PVJ, (d) QT interval of the ECG, (e) APD90 dispersion,
APD90, along the central axis of the PF through to the epicardial surface and
(f) amplitude of the T wave of the ECG. Bar height denotes measurements for
control (ctrl), 50 per cent IKr block (IKr) and 50 per cent IKs block (IKs).
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similar response to the application of d-sotalol, which also inhibits IKr, although
the inhibition is heterogeneous across cell types. In the 3D model, blocking either
IKr or IKs by 50 per cent results in a prolongation of APD90 at the PVJ from
276:4ms in the control case, to a substantially greater 327:9ms for the IKr block
and a less dramatic 292:9ms for the IKs block (gure 7.5c). The QT interval nat-
urally follows the increases in APD90 (gure 7.5d), with a substantial lengthening
from 251.2 to 297:3ms for the IKr block and a lesser increase to 265:3ms for the
IKs block. The dispersion of APD again increases in both cases to varying extents
(gure 7.5e), with APD90 increasing from 77 to 86ms for the IKr block and to
80:5ms for the IKs block, resulting in T wave amplitude increases of 22 and 11 per
cent respectively (gure 7.5f). Conduction velocity, v, (gure 7.5a) and safety,
SF, (gure 7.5b) at the PVJ remain approximately unchanged at 0:4972m s 1
and 1.055 respectively for the IKs block, however, for the IKr block, both increase
to 0:5058m s 1 and 1.057 for v and SF respectively.
7.3.4 Eects of putative inward current blockers
Inhibition of the inward currents, ICa;L and INa;L, aects the plateau phase of the
AP, and in general, causes an abbreviation of the APD and changes to the plateau
potential (gure 7.1). Inhibition of INa;L in PF and midmyocardial cells also
occurs as a consequence of the application of amiodarone and a similar response
is observed in these cell types. In the 3D simulations, a 50 per cent block of
ICa;L results in a negligible variation in the APD90 at the PVJ from 276:4ms in
the control case (gure 7.6c). A 50 per cent block of INa;L however, results in a
decrease in APD90 to 263:9ms. In terms of the QT interval, the changes in APD90
translate into negligible variation with the ICa;L block from 252:1ms in the control
case, and a decrease to 241:6ms with the INa;L block (gure 7.6d). Similarly, APD
dispersion changes negligibly with the ICa;L block from 77ms in the control case
and decreases to 70ms with the INa;L block (gure 7.6e). However, in both cases,
the amplitude of the T wave decreases (gure 7.6f) to 96 and 89 per cent of
the control case amplitude for the ICa;L and INa;L blocks respectively. Note that
although a negligible change in APD dispersion wouldn't be expected to lead to
a change in T wave amplitude, the ICa;L block decreases the T wave amplitude
due to a decrease in APD dispersion in the larger volume ventricle (not shown)
which contribute signicantly more to the morphology and amplitude of the T
wave than the PF. Decreases in conduction velocity (gure 7.6a) and conduction
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Figure 7.6: Eects of putative drugs inhibiting inward currents on (a) conduction
velocity, v, through the PVJ, (b) safety of conduction, SF, at the PVJ, (c) APD90
at the PVJ, (d) QT interval of the ECG, (e) APD90 dispersion, APD90, along
the central axis of the PF through to the epicardial surface and (f) amplitude of
the T wave of the ECG. Bar height denotes measurements for control (ctrl), 50
per cent ICa;L block (ICa;L) and 50 per cent INa;L block (INa;L).
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safety (gure 7.6b) are also observed, with v decreasing from 0:4972m s 1 in the
control case, to 0:4955m s 1 with the ICa;L block and to 0:4939m s 1 with the
INa;L block. At the same time, SF decreases from 1.055 in the control case, to
1.050 with the ICa;L block and 1.025 with the INa;L block.
7.4 Discussion
A detailed 3D model of the PVJ has been developed incorporating a single PF
entering the endocardium perpendicular to the endocardial surface, with details
of electrical heterogeneities, tissue geometry and bre orientation of the canine
left ventricular free wall (Benson et al. 2008). The addition of a third dimension
to the 2D PVJ model in Chapter 4 signicantly increases the electrical load of
the ventricular tissue on the PF and hence quantitative dierences arise in the
optimal conduction velocity, although the qualitative relationships remain with
optimal velocities occurring in both the 2D and 3D models of the PVJ. Intro-
ducing the eects of class III anti-arrhythmic drugs and putative ionic channel
current blockers causes heterogeneous changes to the electrophysiology of the dif-
ferent cell types in the model, which result in changes to AP repolarization and
safety of conduction through the PVJ. Thus, the 3D wedge model is used to
quantify the pharmacological eects on conduction safety through the PVJ.
7.4.1 Pro-arrhythmic eects of class III drugs
The class III anti-arrhythmic drugs amiodarone and d-sotalol have diering ef-
fects on the APs of PF, endocardial, midmyocardial and epicardial cell types
(gure 7.1), leading to changes in the propagation of APs through the PVJ (g-
ure 7.4) which indicate potentially pro-arrhythmic consequences. Benson et al.
(2008) previously demonstrated that d-sotalol could substantially widen the vul-
nerable window to unidirectional conduction block and that sustained re-entry
could occur. In the PVJ model, it is found that both amiodarone and d-sotalol
increases APD90 at the junction leading to an increase in the QT interval of the
ECG and furthermore, produce potentially pro-arrhythmic eects, with increases
in APD dispersion leading to an increase in the ECG T-wave amplitude (gure
7.4). However, the increases with amiodarone are substantially less than those
caused by d-sotalol, suggesting that d-sotalol is potentially more pro-arrhythmic
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than amiodarone. At the junction, conduction safety, SF, decreases with amio-
darone (although it is still `safe') but increases with d-sotalol (gure 7.4b). This
is due to the fact that d-sotalol only inhibits IKr and therefore only aects the
repolarization of the excitation wave, while amiodarone inhibits inward currents
in PF and midmyocardial cells and therefore aects the wave-front and decreases
SF which depends on the excitation of a cell (Delgado et al. 1990; Romero et al.
2005; Shaw & Rudy 1997). However, although for an individual wave SF increases
with d-sotalol, the large increase in APD90 at the junction increases the eective
refractory period and hence the likelihood of conduction block for the following
wave. Therefore, a continuous sequence of excitation would be less safe because
of highly non-uniform depolarization through the junction. In contrast, with
amiodarone only a small increase in APD dispersion and APD90 at the junction
occurs (due to IKs inhibition in endocardial and epicardial cells) and so although
an individual wave has decreased conduction safety, consecutive excitation waves
would be safer than with d-sotalol, maintaining the conclusion that d-sotalol is
potentially more pro-arrhythmic than amiodarone.
7.4.2 Comparison with putative drugs
In contrast to amiodarone and d-sotalol, modelling putative drugs permits the
dissection of the eects caused by the homogeneous inhibition of selected ion
channels, e.g. eects of drugs which block inward currents. Amiodarone is mod-
elled in PF and midmyocardial cells with a partial inhibition of INa;L, an inward
current, however in endocardial and epicardial cells, it is modelled with a par-
tial inhibition of IKs, an outward, repolarization current. Isolating inward and
outward channel inhibitors individually, further support for d-sotalol having the
potential to be more pro-arrhythmic than amiodarone is revealed: if IKs alone
is blocked by 50 per cent, a relatively small (cf. IKr) increase in APD90, QT in-
terval, APD dispersion and T wave amplitude is observed and SF is unchanged,
suggesting any pro-arrhythmic eects would be minimal. Taken together with
a 50 per cent block in INa;L, APD90, QT interval, APD dispersion and T wave
amplitude all decrease and although SF also decreases, as was discussed earlier,
successive excitation waves would be safer.
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7.4.3 Limitations
In vivo, the spatial interaction between PFs and ventricular tissue is known to be
complex (Tranum-Jensen et al. 1991), however, to study the eects of propagation
through the PVJ, as an approximation the PF is idealized to run perpendicular
to the endocardial surface. Note also that while no diusion tensor MRI data was
available for the PF, it is assumed that the bre orientation within the PF lies
parallel to the PF and hence perpendicular to the endocardial surface. This is a
reasonable approximation given the typical width of a PF bundle dissected from
a canine heart is approximately 0.5{2:0mm in diameter (Christini et al. 2006;
Vassalle & Lee 1984).
The precise electrophysiological eects of amiodarone and d-sotalol in the
model are implemented qualitatively to reproduce the relative changes of APD in
PF, endocardial, midmyocardial and epicardial tissues reported experimentally
(Gallagher et al. 1989; Kodama et al. 1997a; Sicouri et al. 1997; Varro et al. 2000,
1988). The implementation in the ventricular tissues is based on the methods
of Benson et al. (2008) since their methods successfully reproduces transmural
propagation patterns reported experimentally by Akar et al. (2002). Detailed
descriptions of any ion channel remodelling which occurs with the application
of the drugs could provide further insights into potentially lethal pro-arrhythmic
eects related to conduction through the PVJ.
Simulations were carried out using a single excitation wave due to simulation
time constraints. However, to establish the precise relationships of wave-front
and repolarization eects in a wave-train, further simulations must be carried
out.
Chapter 8
Discussion and Conclusion
The virtual heart is a powerful scientic tool with which to dissect and unravel
complex physiological phenomena in this remarkable organ, yet its construction
is ongoing as new data are continuously collected and new phenomena discovered.
The evolution of knowledge about, and the understanding of the cardiac conduc-
tion system in particular continues with this thesis which has led to a number of
interesting conclusions:
1. The intrinsic non-uniformity of cardiac tissue, both in terms of structure
and electrophysiology, dictates than an optimal conduction velocity exits
and that neither very fast, nor very slow is safe.
2. Optimal velocity is determined by the nature of the underlying hetero-
geneities, e.g. a larger electrical load requires a higher safe conduction ve-
locity.
3. The conduction time delay across the Purkinje-ventricular junction (PVJ)
occurs as a natural consequence of the electrophysiological and morpholog-
ical dierences between the Purkinje bre (PF) and ventricular tissue.
4. The conduction time delay enhances the source-to-load mismatch at the
PVJ over time, which can potentially lead to conduction failure. However,
at optimal velocities, such enhancement should be minimal, allowing safer
conduction.
5. The class III anti-arrhythmic drugs, amiodarone and d-sotalol can exhibit
pro-arrhythmic eects at heterogeneous junctions such as the PVJ, with d-
sotalol potentially more pro-arrhythmic than amiodarone, especially during
138
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a sequence of excitation due to the likelihood of conduction block caused
by the marked increase in APD90 at the junction.
6. Accumulation of [Na+]i during high frequency stimulation is the underly-
ing mechanism for both the slow progressive abbreviation of APD90 and
the slow progressive increase in contractile force (i.e. the Bowditch eect)
observed experimentally.
7. The accumulation of [Na+]i is primarily a result of a rapid inux of Na
+
through the fast Na+ current and incomplete Na+ extrusion between suc-
cessive excitation.
8. Overdrive suppression of pacemaker activity in PF cells is a result of ele-
vated [Na+]i and once it has returned to its base level, automaticity resumes.
Furthermore, two new models have been developed of the human and canine
PF cell, both hitherto sorely lacking, yet important components of whole heart
models for the two species. Without the development of these models, attempts
to simulate the whole cardiac conduction system would be incomplete and would
limit the validity of any results. Finally, the limitations of computationally e-
cient, `reduced' models has been demonstrated with the importance of intracel-
lular ion concentration changes highlighted, particularly in lengthy simulations.
8.1 Recent developments
Cardiac electrophysiology is a rapidly evolving area of research, continually ex-
tending the frontier of our understanding of the heart and its underlying mech-
anisms. New data continually becomes available, allowing novel models to be
developed, or existing ones rened and (hopefully) improved. As new modelling
techniques are developed and computing resources enhanced, the scale of prob-
lem which can be eciently simulated advances, allowing increasingly complex
behaviour to be modelled and dissected. The very nature of cutting-edge research
means that the state of the art rarely remains so indenitely. This thesis is no
exception and results from it which have already been reported to the scientic
community (Aslanidi et al. 2009, 2010b; Stewart et al. 2008, 2007, 2009) have
led to interest from a number of other groups (Boyle & Vigmond 2010; Sampson
et al. 2010; Shaw & Rudy 2010).
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Following the publication of the human (Chapter 3; Stewart et al. 2009) and
canine (Chapter 4; Aslanidi et al. 2009) PF cell models, a recent resurgence of
interest in the development of models for the PF cell has occurred (e.g. Aslanidi
et al. 2010a; Sampson et al. 2010). Based on recently acquired experimental
data for the human, Sampson et al. (2010) have developed a detailed model of
the ionic currents and hence AP of the human PF cell, including descriptions
of a number of currents (e.g. a non-inactivating, TTX-sensitive component of
the Na+ channel) for which no data was available during construction of the
model presented in Chapter 3, but which can exert an inuence on AP morphol-
ogy and duration. Additionally, their model includes Markov descriptions (cf.
Hodgkin{Huxley type descriptions used in the models in this thesis) for many of
the ionic currents to better reect the complex gating schemes of the ion channels.
However, as a consequence, their model uses approximately four times as many
state variables, increasing the computational burden signicantly. As a result,
the model presented in Chapter 3 remains relevant, particularly for multicellular
tissue simulations where computational eciency is important.
A new formulation for safety factor (SF) has recently been proposed by Boyle
& Vigmond (2010) to address a number of counter-intuitive observations result-
ing from the formulation of SF (Romero et al. 2005; Shaw & Rudy 1997) used in
Chapter 6, including a maximum in SF at the junction, despite the fact propaga-
tion is most likely to fail at that point. They apply their new formulation of SF
to a two-dimensional model of the PVJ similar to that implemented in Chapter
6 and reported in Aslanidi et al. (2009). Their results dier markedly from the
results in this thesis, namely demonstrating a decrease in SF at the junction,
however they do agree with the intuitive expectations, in particular that increas-
ing PF width increases conduction safety through an provision of more current
and therefore faster, more robust propagation through the junction. They sug-
gest that other dierences in the two sets of results may arise from dierences in
numerical methods, specically their use of the nite element method, which pre-
serves no-ux boundary conditions at corners, unlike the nite dierence method
used in Chapter 6 which can have diculties.
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8.2 Future development
Naturally, given the scope for research in this eld, there are a wide variety of
directions available for future research. The logical progression following the 3D
wedge model of the PVJ in Chapter 7 is to build a complete model the ventricles
(e.g. Benson et al. 2008, gure 1) and incorporate a PF network with which to ex-
cite them. This would rst require an appropriate PF network to be constructed.
However, an absence hitherto of detailed anatomical data, ideally including bre
orientation, prevents the immediate incorporation of an anatomically accurate
PF network. Details of the activation patterns of the ventricles (Durrer et al.
1970) could be used in the interim to assemble a caricature PF network in a sim-
ilar way to ten Tusscher & Panlov (2008). Alternatively, photographs of stained
PFs on the endocardial surface of an unfurled ventricle could be digitized and
projected onto the endocardial surface of an existing ventricular dataset. Neither
of these methods would be anatomically accurate, however they should provide
a reasonable approximation. Ultimately, the ideal scenario would be to obtain
diusion tensor magnetic resonance imaging datasets of both the ventricles and
the PFs from one heart, providing the basis for an anatomically accurate model.
In the 2D and 3D models of the PVJ (Chapter 6, 7), the PF is considered to
run perpendicular to the endocardial surface of the left ventricular wall, whereas
in vivo spatial interactions between PFs and ventricular tissue can be complex
(Tranum-Jensen et al. 1991). It is noteworthy that Tranum-Jensen et al. (1991)
identied one or two sheets of transitional cells between the PF and ventricular
mass with dierent morphological and electrophysiological characteristics than
both PF and endocardial cells. They speculate that this transitional layer and
in particular the thin connections between the transitional layer and the PF and
ventricular cells, could be sites of high-resistance coupling, enhancing the time
delay of conduction through the junction. An interesting line of research could be
to model the ultrastructure of these interactions at the junctions and investigate
the eects on AP conduction through it.
The model of the AP of the human PF presented in Chapter 3 is autorhythmic,
reecting the role of the PFs as tertiary pacemakers, normally suppressed by the
primary pacemaker, the sino-atrial (SA) node (Vassalle 1970, 1977). In a model
of the human ventricles complete with PF network, allowing the PFs to act as the
pacemaker of ventricular excitation could provide insights into the behaviour of
the heart under conditions in which the SA node fails or the conduction pathway
CHAPTER 8. DISCUSSION AND CONCLUSION 142
to the PF network is blocked. It may then be possible to investigate potential
pharmacological enhancement of their function under such conditions to prolong
the longevity of the heart.
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Appendix A
Human Purkinje bre cell model
A.1 Model equations
A.1.1 Inward rectier current, IK1
IK1 = GK1xK11((V   8)  EK) (A.1)
xK11 =
1
1 + e0:1(V+75:44)
(A.2)
A.1.2 Transient outward current, Ito
Ito = Gtors(V   EK) (A.3)
r1 =
1
1 + e(20 V )=13
(A.4)
r = 10:45e
 (V+40)2=1800 + 7:3 (A.5)
s1 =
1
1 + e(V+27)=13
(A.6)
s = 85e
 (V+25)2=320 +
5
1 + e(V 40)=5
+ 42 (A.7)
A.1.3 Sustained current, Isus
Isus = Gsusa(V   EK) (A.8)
a1 =
1
1 + e(5 V )=17
(A.9)
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A.1.4 Hyperpolarization-activated current, If
If = if;K + if;Na (A.10)
if;K = Gf;Ky(V   EK) (A.11)
if;Na = Gf;Nay(V   ENa) (A.12)
y1 =
1
1 + e(V+80:6)=6:8
(A.13)
y = e
 2:9 (0:04V ) (A.14)
y = e
3:6+(0:11V ) (A.15)
y =
4000
y + y
(A.16)
A.1.5 Fast sodium current, INa
INa = GNam
3hj(V   ENa) (A.17)
m1 =
1
[1 + e( 56:86 V )=9:03]2
(A.18)
m =
1
1 + e( 60 V )=5
(A.19)
m =
0:1
1 + e(V+35)=5
+
0:1
1 + e(V 50)=200
(A.20)
m = mm (A.21)
h1 =
1
[1 + e(V+71:55)=7:43]2
(A.22)
h =
8<:0 if V   400:057e (V+80)=6:8 otherwise (A.23)
h =
8><>:
0:77
0:13[1 + e (V+10:66)=11:1]
if V   40
2:7e0:079V + 3:1 105e0:3485V otherwise
(A.24)
h =
1
h + h
(A.25)
j1 =
1
[1 + e(V+71:55)=7:43]2
(A.26)
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j =
8><>:
0 if V   40
( 2:5428 104e0:2444V   6:948 10 6e 0:04391V )(V + 37:78)
1 + e0:311(V+79:23)
otherwise
(A.27)
j =
8><>:
0:6e0:057V
1 + e 0:1(V+32)
if V   40
0:02424e 0:01052V
1 + e 0:1378(V+40:14)
otherwise
(A.28)
j =
1
j + h
(A.29)
A.1.6 L-type calcium current, ICaL
ICaL = GCaLdff2fCass4
(V   15)F 2
RT
0:25[Ca2+]sse
2(V 15)F=RT   [Ca2+]o
e2(V 15)F=RT   1 (A.30)
d1 =
1
1 + e( 8 V )=7:5
(A.31)
d =
1:4
1 + e( 35 V )=13
+ 0:25 (A.32)
d =
1:4
1 + e(V+5)=5
(A.33)
d =
1:4
1 + e(50 V )=20
(A.34)
d = dd + d (A.35)
f1 =
1:4
1 + e(V+20)=7
(A.36)
f = 1102:5e
( (V+27)=15)2 (A.37)
f =
200
1 + e(13 V )=10
(A.38)
f =
180
1 + e(V+30)=10
+ 20 (A.39)
f = f + f + f (A.40)
f21 =
0:67
1 + e(V+35)=7
+ 0:33 (A.41)
f2 = 600e
 ((V+25)2=170) (A.42)
f2 =
31
1 + e(25 V )=10
(A.43)
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f2 =
16
1 + e(V+30)=10
(A.44)
f2 = f2 + f2 + f2 (A.45)
fCass1 =
0:6
1 +

[Ca2+]ss
0:05
2 + 0:4 (A.46)
fCass =
80
1 +

[Ca2+]ss
0:05
2 + 2 (A.47)
A.1.7 Slow delayed rectier current, IKs
IKs = GKsxs
2(V   EKs) (A.48)
xs1 =
1
1 + e( 5 V )=14
(A.49)
xs =
1400p
1 + e(5 V )=6
(A.50)
xs =
1
1 + e(V 35)=15
(A.51)
xs = xsxs + 80 (A.52)
A.1.8 Rapid delayed rectier current, IKr
IKr = GKr
r
[K+]o
5:4
xr1xr2(V   EK) (A.53)
xr11 =
1
1 + e( 26 V )=7
(A.54)
xr1 =
450
1 + e( 45 V )=10
(A.55)
xr1 =
6
1 + e(V+30)=11:5
(A.56)
xr1 = xr1xr1 (A.57)
xr21 =
1
1 + e(V+88)=24
(A.58)
xr2 =
3
1 + e( 60 V )=20
(A.59)
xr2 =
1:12
1 + e(V 60)=20
(A.60)
APPENDIX A. HUMAN PURKINJE FIBRE CELL MODEL 177
xr2 = xr2xr2 (A.61)
A.1.9 Na+=Ca2+ exchange current, INaCa
INaCa = kNaCa
eV F=RT [Na+]3i [Ca
2+]o   e( 1)V F=RT [Na+]3o[Ca2+]i
(K3mNai + [Na
+]3o)(KmCa + [Ca
2+]o)(1 + ksate( 1)V F=RT )
(A.62)
A.1.10 Na+=K+ pump current, INaK
INaK =
PNaK[K
+]o[Na
+]i
([K+]o +KmK)([Na
+]i +KmNa)(1 + 0:1245e 0:1V F=RT + 0:0353e V F=RT )
(A.63)
IpCa = GpCa
[Ca2+]i
KpCa + [Ca
2+]i
(A.64)
IpK = GpK
V   EK
1 + e(25 V )=5:98
(A.65)
A.1.11 Background current, Ib
IbNa = GbNa(V   ENa) (A.66)
IbCa = GbCa(V   ECa) (A.67)
A.1.12 Calcium dynamics
Ileak = Vleak([Ca
2+]sr   [Ca2+]i) (A.68)
Iup =
Vmaxup
1 + K2up=[Ca
2+]2i
(A.69)
Irel = VrelO([Ca
2+]sr   [Ca2+]ss) (A.70)
Ixfer = Vxfer([Ca
2+]ss   [Ca2+]i) (A.71)
O =
k1[Ca
2+]2ss R
k3 + k1[Ca
2+]2ss
(A.72)
d R
dt
=  k2[Ca2+]ss R + k4(1 + R) (A.73)
k1 =
k01
kCasr
(A.74)
k2 = k
0
2kCasr (A.75)
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kCasr = maxsr   maxsr  minsr
1 + (EC=[Ca2+]sr)2
(A.76)
[Ca2+]i Bufc =
[Ca2+]i  Bufc
[Ca2+]i KBufc
(A.77)
d[Ca2+]i total
dt
=  IbCa + IpCa   2INaCa
2VcF
+
Vsr
Vc
(Ileak   Iup) + Ixfer (A.78)
[Ca2+]sr Bufsr =
[Ca2+]sr  Bufsr
[Ca2+]sr +KBufsr
(A.79)
d[Ca2+]sr total
dt
=  Ileak + Iup   Irel (A.80)
[Ca2+]ss Bufsr =
[Ca2+]ss  Bufss
[Ca2+]ss +KBufss
(A.81)
d[Ca2+]ss total
dt
=   ICaL
2VssF
+
Vsr
Vss
Irel   Vc
Vss
Ixfer (A.82)
A.1.13 Sodium and potassium dynamics
d[Na+]i
dt
=  INa + IbNa + if;Na + 3INaK + 3INaCa
VcF
(A.83)
d[K+]i
dt
=  IK1 + Ito + IKr + IKs + if;K + Isus   2INaK + IpK + Istim
VcF
(A.84)
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A.2 Model parameters
A.2.1 Parameters
parameter value
GK1 0:065 nS pF
 1
Gto 0:08184 nS pF
 1
Gsus 0:0227 nS pF
 1
Gf;K 0:0234346 nS pF
 1
Gf;Na 0:0145654 nS pF
 1
GKr 0:0918 nS pF
 1
GKs 0:2352 nS pF
 1
GNa 130:5744 nS pF
 1
R 8:3143 JK 1mol 1
T 310K
F 96:4867Cmmol 1
Cm 2:0F cm
 2
S 0:2m 1
 162
 cm
Vc 16:404m
3
Vsr 1:094m
3
Vss 0:05468m
3
[K+]o 5:4mM
[Na+]o 140mM
[Ca2+]o 2mM
pKNa 0.03 (dimensionless)
GCaL 3:980 10 5 cmms 1 F 1
kNaCa 1000 pApF
 1
 0.35 (dimensionless)
KmCa 1:38mM
KmNai 87:5mM
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parameter value
ksat 0.1 (dimensionless)
 2.5 (dimensionless)
PNaK 2:724 pApF
 1
KmK 1mM
KmNa 40mM
GpK 0:0146 nS pF
 1
GpCa 0:1238 nS pF
 1
KpCa 0:0005mM
GbNa 0:000290 nS pF
 1
GbCa 0:000592 nS pF
 1
Vmaxup 0:006375mMms
 1
Kup 0:00025mM
Vrel 40:8mMms
 1
k01 0.15mM
 2ms 1
k02 0.045mM
 1ms 1
k3 0:060ms
 1
k4 0:000015ms
 1
EC 1:5mM
maxsr 2.5 (dimensionless)
minsr 1 (dimensionless)
Vleak 0:00036mMms
 1
Vxfer 0:0038mMms
 1
Bufc 0:2mM
KBufc 0:001mM
Bufsr 10mM
KBufsr 0:3mM
Bufss 0:4mM
KBufss 0:00025mM
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A.2.2 Initial conditions
parameter value
V  74:7890522727mV
[Na+]i 8:5447311020mM
[K+]i 136:9896086978mM
[Ca2+]i 0:0001720623mM
[Ca2+]sr 3:2830723338mM
[Ca2+]ss 0:0006146554mM
m 0.0145766758
h 0.2979720207
j 0.0692509548
xr;1 0.4663168269
xr;2 0.3657472179
xs 0.0486609588
r 0.0006830833
s 0.9717098312
d 0.0001356656
f1 0.5943228461
f2 0.8265709174
fCass 0.9767040566
R 0.8199969443
O 0.0000006152
y 0.0184308075
Appendix B
Canine Purkinje bre cell model
B.1 Model equations
B.1.1 Fast sodium current, INa
INa = gNam
3(0:8h+ 0:2j)(V   ENa) (B.1)
dm
dt
=
m1  m
m
(B.2)
m1 =
m
m + m
(B.3)
m =
1:0
m + m
(B.4)
m =
0:32(V + 47:13)
1  e 0:1(V+47:13) (B.5)
m = 0:08e
 V=11:0 (B.6)
dh
dt
=
h1   h
h
(B.7)
h1 =
h
h + h
(B.8)
h =
1:0
h + h
(B.9)
h =
8<:0:135e (V+80:0)=6:8 if V <  40mV0:0 otherwise (B.10)
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h =
8><>:
3:56e0:079V + 3:1 105e0:35V if V <  40mV
1:0
0:13(1 + e (V+10:66)=11:1)
otherwise
(B.11)
dj
dt
=
j1   j
j
(B.12)
j1 =
0:1j
j + j
(B.13)
j =
0:1
j + j
(B.14)
j =
8><>:
 (127140e0:2444V + 0:00003474e 0:04391V )(V + 37:78)
1 + e0:311(V+79:23)
if V <  40mV
0:0 otherwise
(B.15)
j =
8><>:
0:1212e 0:01052V
1 + e 0:1378(V+40:14)
if V <  40mV
0:3e 0:000000235V
1 + e 0:1(V+32)
otherwise
(B.16)
B.1.2 Late sodium current, INa;L
INa;L = gNa;Lm
3
LhL(V   ENa) (B.17)
dmL
dt
=
mL;1  mL
mL
(B.18)
mL;1 =
mL
mL + mL
(B.19)
mL =
1:0
mL + mL
(B.20)
mL =
0:32(V + 47:13)
1  e 0:1(V+47:13) (B.21)
mL = 0:08e
 V=11:0 (B.22)
dhL
dt
=
hL;1   hL
hL
(B.23)
hL;1 =
1:0
1 + e(V+69)=6:1
(B.24)
hL = 175 +
125
1 + e (V+25)=6
(B.25)
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B.1.3 L-type calcium current, ICa;L
ICa;L = gCa;Ldff2fCafCa;2iCa (B.26)
iCa = pCaz
2
Ca
(V   15)F 2
RT
Cai [Ca
2+]re
zCaF (V 15)=RT   Cao [Ca2+]o
ezCaF (V 15)=RT   1 (B.27)
dd
dt
=
d1   d
d
(B.28)
d1 =
1:0
1 + e (V 4)=6:74
(B.29)
d = 0:59 +
0:8e0:052(V+13)
1 + e0:132(V+13)
(B.30)
df
dt
=
f1   f
f
(B.31)
f1 =
1:0
1 + e(V+18)=10
(B.32)
f = 4 + 0:005(V   2:5)2 (B.33)
df2
dt
=
f2;1   f2
f2
(B.34)
f2;1 =
1:0
1 + e(V+18)=10
(B.35)
f2 = 38 + 0:07(V   18:6)2 (B.36)
dfCa
dt
=
fCa;1   fCa
fCa
(B.37)
fCa;1 =
0:3
1  ICa;L=0:05 +
0:55
1 + [Ca2+]r=0:003
+ 0:15 (B.38)
fCa = 0:5 +
10:0CaMK;act
CaMK;act + km;Ca;MK
+
1:0
1:0 + [Ca2+]r=0:003
(B.39)
dfCa;2
dt
=
fCa;2;1   fCa;2
fCa;2
(B.40)
fCa;2;1 =
1:0
1  ICa;L=0:01 (B.41)
fCa;2 = 125 +
300
1 + e (ICa;L+0:175)=0:04
(B.42)
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B.1.4 T-type calcium current, ICa;T
ICa;T = gCa;Tbg(V   ECa;T) (B.43)
db
dt
=
b1   b
b
(B.44)
b1 =
1:0
1 + e (V+33)=6:1
(B.45)
b =
1:0
b + b
(B.46)
b = 1:068e
(V+16:3)=30 (B.47)
b = 1:068e
 (V+16:3)=30 (B.48)
dg
dt
=
g1   g
g
(B.49)
g1 =
1:0
1 + e(V+60:0)=6:6
(B.50)
g =
1:0
g + g
(B.51)
g = 0:015e
 (V+71:7)=83:3 (B.52)
g = 0:015e
(V+71:7)=15:4 (B.53)
B.1.5 Transient outward potassium current, Ito;1
Ito;1 = gto;1a(0:8i+ 0:2i2)(V   EK) (B.54)
da
dt
=
a1   a
a
(B.55)
a1 =
a
a + a
(B.56)
a =
1:0
a + a
(B.57)
a = 25
e(V 76)=20
1 + e(V 76)=20
(B.58)
a = 25
e (V+54)=20
1 + e (V+54)=20
(B.59)
di
dt
=
i1   i
i
(B.60)
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i1 =
i
i + i
(B.61)
i = 6 +
5
1 + e(V 16:5)=10
(B.62)
i =
0:03
1 + e(V+25)=15
(B.63)
i = 0:1
e(V 40)=15
1 + e(V 40)=15
(B.64)
di2
dt
=
i2;1   i2
i2
(B.65)
i2;1 =
i2
i2 + i2
(B.66)
i2 = 21:5 +
30
1 + e(V 25)=10
(B.67)
i2 =
0:00442
1 + e(V+26)=15
(B.68)
i2 = 0:05
e(V 10)=15
1 + e(V 10)=15
(B.69)
B.1.6 Rapid delayed rectier current, IK;r
IK;r = gK;rxrrr;1(V   EK) (B.70)
gK;r = 0:040008488
r
[K+]o
5:4
(B.71)
rr;1 =
1:0
1 + e(V 5:4)=20:4
(B.72)
dxr
dt
=
xr;1   xr
xr
(B.73)
xr;1 =
1:0
1 + e (V+0:085)=12:25
(B.74)
xr =
900
1 + eV=5
+ 100 (B.75)
B.1.7 Slow delayed rectier current, IK;s
IK;s = gK;sxs;1xs;2(V   EK;s) (B.76)
gK;s = 0:052581329
 
1 +
0:6
1 + (0:000038=[Ca2+]i)
1:4
!
(B.77)
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dxs;1
dt
=
xs;1   xs;1
xs;1
(B.78)
dxs;2
dt
=
xs;1   xs;2
xs;2
(B.79)
xs;1 =
1:0
1 + e (V 9)=13:7
(B.80)
xs;1 =

0:0000761(V + 44:6)
1  e 9:97(V+44:6) +
0:00036(V   0:55)
e0:128(V 0:55)   1
 1
(B.81)
xs;2 = 2xs;1 (B.82)
B.1.8 Inward rectier current, IK;1
IK;1 = (gK;1xK;1 + 0:004)(V   EK) (B.83)
gK;1 = 0:25
r
[K+]o
5:4
(B.84)
xK;1 =
K;1
K;1 + K;1
(B.85)
K;1 =
1:02
1 + e0:2385(V EK 59:215)
(B.86)
K;1 =
0:49124e0:08032(V EK+5:476) + e0:06175(V EK 594:31)
1 + e 0:5143(V EK+4:753)
(B.87)
B.1.9 Plateau current, IK;p
IK;p = gK;pkp(V   EK) (B.88)
kp =
1:0
1 + e(7:488 V )=5:98
(B.89)
B.1.10 Calcium-dependent transient outward chloride cur-
rent, Ito;2
Ito;2 = 20ito;2y (B.90)
ito;2 = pClz
2
Cl
V F 2
RT
[Cl ]i   [Cl ]oe zClV F=RT
1  e zClV F=RT (B.91)
dy
dt
=
y1   y
y
(B.92)
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y1 =
1:0
1 + km;to;2=[Ca
2+]r
(B.93)
y = 1:0 (B.94)
B.1.11 Na+=Ca2+ exchange current, INaCa
INaCa =
XNaCaiNaCa;max[Na
+]3i [Ca
2+]oe
0:35V F=RT   1:5[Na+]3o[Ca2+]ie 0:65V F=RT
(1 + (km;Ca;ct=1:5[Ca
2+]i)
2
)(1 + ksate 0:65V F=RT )(dNaCa;1 + dNaCa;2)
(B.95)
dNaCa;1 = km;Cao [Na
+]3i + 1:5k
3
m;Nao [Ca
2+]i + k
3
m;Nai;1
[Ca2+]o(1 + 1:5[Ca
2+]i=km;Cai)
(B.96)
dNaCa;2 = km;Cai [Na
+]3o(1 + ([Na
+]i=km;Nai;1)
3
) + [Na+]3i [Ca
2+]o + 1:5[Na
+]3o[Ca
2+]i
(B.97)
B.1.12 Na+=K+ pump current, INaK
INaK = gNaKfNaK
1:0
1 + (km;Nai;2=[Na
+]i)
2
[K+]o
([K+]o + km;Ko)
(B.98)
fNaK =
1:0
1 + 0:1245e 0:1V F=RT + 0:0365e V F=RT
(B.99)
 =
1
7
(e[Na
+]o=67:3   1) (B.100)
B.1.13 Calcium pump current, ICa;p
ICa;p = ICa;p
[Ca2+]i
[Ca2+]i + km;Ca;p
(B.101)
B.1.14 K+=Cl  co-transporter
CTK Cl = CTK Cl
(EK   ECl)
(EK   ECl + 87:8251) (B.102)
B.1.15 Na+=Cl  co-transporter
CTNa Cl = CTNa Cl
(ENa   ECl)4
(ENa   ECl)4 + 87:82514
(B.103)
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B.1.16 Background currents, Ib
INa;b = gNa;b(V   ENa) (B.104)
IK;b = gK;b(V   EK) (B.105)
ICl;b = gCl;b(V   ECl) (B.106)
ICa;b = pCa;bz
2
Ca
V F 2
RT
Cai [Ca
2+]ie
zCaV F=RT   Cao [Ca2+]o
ezCaV F=RT   1 (B.107)
B.1.17 Intracellular ion concentrations
d[Na+]i
dt
=  (INa + INa;L + INa;b + 3INaK + 3INaCa)acap
VolmyoF
+ CTNa Cl (B.108)
d[K+]i
dt
=  (Ito;1 + IK;1 + IK;r + IK;s + IK;p + IK;b   2INaK)acap
VolmyoF
+ CTK Cl
(B.109)
d[Cl ]i
dt
=  (Ito;2 + ICl;b)acap
VolmyoF
+ CTNa Cl + CTK Cl (B.110)
B.1.18 Intracellular calcium concentration
d[Ca2+]i
dt
=  (ICa;b + ICa;p   2INaCa)acap
2VolmyoF
+ (qup   qleak) Volnsr
Volmyo
  qdi Volss
Volmyo
(B.111)
dmyo =  km;TRPNkm;CMDN[Ca2+]tot (B.112)
cmyo = km;CMDNkm;TRPN   [Ca2+]tot(km;TRPN + km;CMDN)
+TRPN km;CMDN + CMDN km;TRPN
(B.113)
bmyo = CMDN+ TRPN  [Ca2+]tot + km;TRPN + km;CMDN (B.114)
[Ca2+]tot = TRPN + CMDN+ d[Ca
2+]i + [Ca
2+]i (B.115)
CMDN = CMDN

[Ca2+]i
[Ca2+]i + km;CMDN

(B.116)
TRPN = TRPN

[Ca2+]i
[Ca2+]i + km;TRPN

(B.117)
[Ca2+]i =
2
3
q
b2myo   3cmyocos
 
1
3
arccos
 
9bmyocmyo   2b3myo   27dmyo
2(b2myo   3cmyo)1:5
!!
  bmyo
3
(B.118)
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B.1.19 Calcium/calmodulin-dependent protein kinase
CaMK;act = CaMK;bound + CaMK;trap (B.119)
dCaMK;trap
dt
= Ca;MKCaMK;bound(CaMK;bound + CaMK;trap)  Ca;MKCaMK;trap
(B.120)
CaMK;bound =
CaMK;0(1  CaMK;trap)
1 + km;Ca;MK=[Ca
2+]r
(B.121)
B.1.20 NSR calcium concentration
d[Ca2+]NSR
dt
= qup   qleak   qtr VolJSR
VolNSR
(B.122)
B.1.21 JSR calcium concentration
d[Ca2+]JSR
dt
=
qtr   qrel
1 + CSQNkm;CSQN=(km;CSQN + [Ca
2+]JSR)
2 (B.123)
B.1.22 Restricted space calcium concentration
[Ca2+]r =
2
3
q
b21   3c1cos

1
3
arccos

9b1c1   2b31   27d1
2(b21   3c1)1:5

  b1
3
(B.124)
d1 =  km;b;SRkm;b;SL[Ca2+]r;tot (B.125)
c1 = km;b;SRkm;b;SL [Ca2+]r;tot(km;b;SR+km;b;SL)+bSRkm;b;SL+bSLkm;b;SR (B.126)
b1 = bSR +bSL   [Ca2+]r;tot + km;b;SR + km;b;SL (B.127)
[Ca2+]r;tot = [Ca
2+]r + bSR + bSL + d[Ca
2+]r (B.128)
bSL = bSL

[Ca2+]r
[Ca2+]r + km;b;SL

(B.129)
bSR = bSR

[Ca2+]r
[Ca2+]r + km;b;SR

(B.130)
d[Ca2+]r
dt
=   ICa;Lacap
VolsszCaF
+ qrel
VolJSR
Volss
  [Ca
2+]r   [Ca2+]i
ss
(B.131)
B.1.23 SR release ux
qrel = grelrori([Ca
2+]JSR   [Ca2+]r) (B.132)
grel = 3000g (B.133)
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g =
1:0
1 + e(gCa;LiCa+13)=5
(B.134)
dri
dt
=
ri;1   ri
ri
(B.135)
ri;1 =
1:0
1 + e([Ca
2+]r 0:0004+0:002Cafac)=0:000025
(B.136)
ri =
350  Ca;MK
1 + e([Ca
2+]r 0:003+0:003Cafac)=0:0002
+ 3:0 + Ca;MK (B.137)
Cafac =
1:0
1 + e(ICa;L+0:05)=0:015
(B.138)
Ca;MK = Ca;MK
CaMK;act
km;Ca;MK + CaMK;act
(B.139)
dro
dt
=
ro;1   ro
ro
(B.140)
ro;1 = ro;1;JSR
I2Ca;L
I2Ca;L + 1
(B.141)
ro;1;JSR =
[Ca2+]1:9JSR
[Ca2+]1:9JSR + (49:28[Ca
2+]r=([Ca
2+]r + 0:0028))
1:9 (B.142)
B.1.24 SR leak ux
qleak = qleak
[Ca2+]NSR
NSR
(B.143)
B.1.25 SR uptake ux
qup = Xqup(dqup;Ca;MK + 1)qup
[Ca2+]i
[Ca2+]i + km;up   dkm;plb
(B.144)
dqup;Ca;MK = dqup;Ca;MK
CaMK;act
km;Ca;MK + CaMK;act
(B.145)
dkm;plb = dkm;plb
CaMK;act
km;Ca;MK + CaMK;act
(B.146)
B.1.26 SR transfer ux
qtr =
[Ca2+]NSR   [Ca2+]JSR
tr
(B.147)
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B.1.27 Equilibrium potentials
ENa =
RT
F
ln
[Na+]o
[Na+]i
(B.148)
EK =
RT
F
ln
[K+]o
[K+]i
(B.149)
ECa =
RT
2F
ln
[Ca2+]o
[Ca2+]i
(B.150)
ECl =
RT
F
ln
[Cl ]o
[Cl ]i
(B.151)
EK;s =
RT
F
ln

[K+]o + rNaK[Na
+]o
[K+]i + rNaK[Na
+]i

(B.152)
B.2 Model parameters
B.2.1 Parameters
parameter value
R 8314 JK 1 kmol 1
F 96487Cmol 1
T 310K
[Na+]o 140mM
[Ca2+]o 1:8mM
[K+]o 5:4mM
[Cl ]o 100mM
zNa 1 (dimensionless)
zK 1 (dimensionless)
zCa 2 (dimensionless)
zCl -1 (dimensionless)
Nai 0.75 (dimensionless)
Nao 0.75 (dimensionless)
Ki 0.75 (dimensionless)
Ko 0.75 (dimensionless)
Cai 1.0 (dimensionless)
Cao 0.341 (dimensionless)
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parameter value
gNa 8:0 pApF
 1
gNa;L 0:037375 pApF
 1
pCa 0:000243 cm s
 1
gCa;L 0:3392328 pApF
 1
gCa;T 0:13 pApF
 1
pCa;b 1:995084 10 7 cm s 1
gto;1 0:14135944 pApF
 1
rNaK 0.01833 (dimensionless)
gK;p 0:00276 pApF
 1
km;to;2 0:1502mM
pCl 0:0000004 cm s
 1
gCl;b 0:000225 pApF
 1
XNaCa 0.4 (dimensionless)
iNaCa;max 4:5 pApF
 1
km;Ca;act 0:000125mM
km;Nai;1 12:3mM
km;Nao 87:5mM
km;Cai 0:0036mM
km;Cao 1:3mM
ksat 0.27 (dimensionless)
gNaK 0:61875 pApF
 1
km;Nai;2 10mM
km;Ko 1:5mM
ip;Ca 0:0575 pApF
 1
km;p;Ca 0:0005mM
CTK Cl 7:0756 10 6mMms 1
CTNa Cl 9:8443 10 6mMms 1
ro 3:0ms
qleak 0:004375mMms
 1
NSR 15:0mM
Xqup 0.5 (dimensionless)
dqup;Ca;MK 0.75 (dimensionless)
dkm;plb 0.00017 (dimensionless)
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parameter value
km;up 0:00092mM
qup 0:004375mMms
 1
tr 120:0ms
bSR 0:047mM
km;b;SR 0:00087mM
bSL 1:124mM
km;b;SL 0:0087mM
ss 0:2ms
CSQN 10:0mM
km;CSQN 0:8mM
CMDN 0:05mM
km;CMDN 0:00238mM
TRPN 0:07mM
km;TRPN 0:0005mM
CaMK;0 0.05 (dimensionless)
Ca;MK 0:05ms
 1
Ca;MK 0:00068ms
 1
km;Ca;MK 0.15 (dimensionless)
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B.2.2 Initial conditions
parameter value
V  86:9351482mV
m 0.00111859
h 0.990199813
j 0.993630289
d 0.00000138
f 0.999967371
f2 0.999964108
fCa 0.985118263
fCa;2 1.0
b 0.000087458
g 0.989496155
xs;1 0.018988645
xs;2 0.018988645
xr 0.000000014
a 0.01303108
i 0.999972058
i2 0.999813749
y 0.000555155
mL 0.00111859
hL 0.339310414
ri 0.999950186
ro 0.0
[Ca2+]r 0:0000834mM
[Ca2+]JSR 1:27169598mM
[Ca2+]NSR 1:271695903mM
[Na+]i 9:875593321mM
[K+]i 142:0142622mM
[Cl ]i 18:90029866mM
[Ca2+]i 0:0000834mM
CaMK;act 0.003264868
CaMK;trap 0.000632046
